WO2002070483A1 - Heterocyclic diamide invertebrate pest control agents - Google Patents

Heterocyclic diamide invertebrate pest control agents Download PDF

Info

Publication number
WO2002070483A1
WO2002070483A1 PCT/US2002/006582 US0206582W WO02070483A1 WO 2002070483 A1 WO2002070483 A1 WO 2002070483A1 US 0206582 W US0206582 W US 0206582W WO 02070483 A1 WO02070483 A1 WO 02070483A1
Authority
WO
WIPO (PCT)
Prior art keywords
ocf
compound
ring
alkyl
halogen
Prior art date
Application number
PCT/US2002/006582
Other languages
French (fr)
Inventor
Gary David Annis
Bruce Lawrence Finkelstein
Original Assignee
E. I. Du Pont De Nemours And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to CA002437840A priority Critical patent/CA2437840A1/en
Priority to PL02364660A priority patent/PL364660A1/en
Priority to KR1020037011596A priority patent/KR100874324B1/en
Priority to HU0303183A priority patent/HUP0303183A2/en
Priority to US10/469,263 priority patent/US20040102324A1/en
Priority to AT02723322T priority patent/ATE509913T1/en
Priority to IL15699402A priority patent/IL156994A0/en
Priority to JP2002569803A priority patent/JP4370098B2/en
Application filed by E. I. Du Pont De Nemours And Company filed Critical E. I. Du Pont De Nemours And Company
Priority to MXPA03007935A priority patent/MXPA03007935A/en
Priority to EP02723322A priority patent/EP1373210B1/en
Priority to BR0207996-8A priority patent/BR0207996A/en
Priority to AU2002254107A priority patent/AU2002254107B2/en
Publication of WO2002070483A1 publication Critical patent/WO2002070483A1/en
Priority to US11/158,200 priority patent/US7560564B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
    • A01N43/06—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom five-membered rings
    • A01N43/10—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom five-membered rings with sulfur as the ring hetero atom
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/40—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/54—1,3-Diazines; Hydrogenated 1,3-diazines
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/56—1,2-Diazoles; Hydrogenated 1,2-diazoles
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/80—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • C07D231/40—Acylated on said nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Definitions

  • This invention relates to certain heterocyclic diamides, their N-oxides, suitable salts and compositions, and a method of their use for controlling invertebrate pests in both agronomic and nonagronomic environments.
  • invertebrate pests The control of invertebrate pests is extremely important in achieving high crop efficiency. Damage by invertebrate pests to growing and stored agronomic crops can cause significant reduction in productivity and thereby result in increased costs to the consumer.
  • the control of invertebrate pests in forestry, greenhouse crops, ornamentals, nursery crops, stored food and fiber products, livestock, household, and public and animal health is also important. Many products are commercially available for these purposes, but the need continues for new compounds that are more effective, less costly, less toxic, environmentally safer or have different modes of action.
  • ⁇ L 9202078 discloses ⁇ -acyl anthranilic acid derivatives of Formula i as insecticides
  • X is a direct bond
  • Y is H or C r C 6 alkyl
  • Z is ⁇ H 2 , NH(C r C 3 alkyl) or N(C r C 3 alkyl) 2
  • R 1 through R 9 are independently H, halogen, C Cg alkyl, phenyl, hydroxy, Cj-Cg alkoxy or C 1 -C 7 acyloxy.
  • WOO 1/070671 discloses N-acyl anthranilic acid derivatives of Formula i as arthropodicides
  • a and B are independently O or S;
  • J is an optionally substituted phenyl ring, 5- or 6-membered heteroaromatic ring, naphthyl ring system or an aromatic 8-, 9- or 10-membered fused heterobicyclic ring system;
  • R 1 and R 3 are independently H or optionally substituted C r C 6 alkyl;
  • R 2 is H or C Cg alkyl;
  • each R 4 is independently H, C C 6 alkyl, C Cg haloalkyl, halogen or CN; and
  • n is 1 to 4.
  • a and B are independently O or S; each J is independently a phenyl ring, a naphthyl ring system, a 5- or 6-membered heteroaromatic ring or an aromatic 8-, 9- or 10-membered fused heterobicyclic ring system wherein each ring or ring system is optionally substituted with 1 to 4
  • R 5 K is, together with the two contiguous linking carbon atoms, a 5- or 6-membered heteroaromatic ring optionally substituted with 1 to 3 R 4 ; n is 1 to 3; R 1 is H; or Cj-C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl or C 3 -C 6 cycloalkyl each optionally substituted with one or more substituents selected from the group consisting of halogen, C ⁇ , ⁇ O 2 , hydroxy, C Ct alkoxy, C r C 4 alkylthio, C r C 4 alkylsulfinyl, C 1 -C 4 alkylsulfonyl, C 2 -C 4 alkoxycarbonyl, C r C alkylamino, C 2 -Cg dialkylamino and C 3 -C 6 cycloalkylamino; or R 1 is C 2 -C 6 alkylcarbonyl, C
  • R 3 is H; G; or C r C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, C 3 -C 6 cycloalkyl, each optionally substituted with one or more substituents selected from the group consisting of G, halogen, CN, NO 2 , hydroxy, C j -C 4 alkoxy, C j -C 4 haloalkoxy,
  • each R 4 is independently H, C r C 6 alkyl, C 2 -C 6 alkenyl, C -C 6 alkynyl, C 3 -C 6 cycloalkyl, C r C 6 haloalkyl, C 2 -C 6 haloalkenyl, C 2 -C 6 haloalkynyl, C 3 -C 6 halocycloalkyl, halogen, CN, NO 2 , hydroxy, C 1 -C 4 alkoxy, C j -C haloalkoxy,
  • each R 5 is independently a phenyl, benzyl, benzoyl, phenoxy, 5- or 6-membered heteroaromatic ring or an aromatic 8-, 9
  • each R 6 is independently C]_-C 4 alkyl, C 2 -C alkenyl, C 2 -C 4 alkynyl, C 3 -Cg cycloalkyl, C r C haloalkyl, C 2 -C 4 haloalkenyl, C 2 -C 4 haloalkynyl, C 3 -C 6 halocycloalkyl, halogen, CN, NO 2 , C C 4 alkoxy, Cj-C 4 haloalkoxy, C ⁇ -C 4 alkylthio, C j -C alkylsulfinyl, C !
  • each R 10 is independently H, C ⁇ C alkyl or C j -C haloalkyl; each R 11 is independently H or C]-C 4 alkyl; and each R 12 is independently Cj-C 2 alkyl, halogen, CN, NO 2 or Cj-C 2 alkoxy.
  • This invention also pertains to a method for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of a compound of Formula I, an N-oxide thereof or a suitable salt of the compound (e.g., as a composition described herein).
  • This invention also relates to such a method wherein the invertebrate pest or its environment is contacted with a biologically effective amount of a compound of Formula I or a composition comprising a compound of Formula I, an N-oxide thereof or a suitable salt of the compound and a biologically effective amount of at least one additional compound or agent for controlling invertebrate pests.
  • This invention also pertains to a composition for controlling an invertebrate pest comprising a biologically effective amount of a compound of Formula I, an N-oxide thereof or a suitable salt of the compound and at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents.
  • This invention also pertains to a composition comprising a biologically effective amount of a compound of Formula I, an N-oxide thereof or a suitable salt of the compound and an effective amount of at least one additional biologically active compound or agent.
  • alkyl used either alone or in compound words such as “alkylthio” or “haloalkyl” includes straight-chain or branched alkyl, such as, methyl, ethyl, 7 -propyl, /-propyl, or the different butyl, pentyl or hexyl isomers.
  • alkenyl includes straight-chain or branched alkenes such as ethenyl, 1-propenyl, 2-propenyl, and the different butenyl, pentenyl and hexenyl isomers.
  • Alkenyl also includes polyenes such as 1,2-propadienyl and 2,4-hexadienyl.
  • Alkynyl includes straight-chain or branched alkynes such as ethynyl, 1-propynyl, 2-propynyl and the different butynyl, pentynyl and hexynyl isomers.
  • Alkynyl can also include moieties comprised of multiple triple bonds such as 2,5-hexadiynyl.
  • Alkoxy includes, for example, methoxy, ethoxy, ⁇ -propyloxy, isopropyloxy and the different butoxy, pentoxy and hexyloxy isomers.
  • Alkoxyalkyl denotes alkoxy substitution on alkyl. Examples of “alkoxyalkyl” include CH 3 OCH 2 , CH 3 OCH 2 CH 2 , CH 3 CH 2 OCH 2 , CH 3 CH 2 CH 2 CH 2 OCH 2 and CH 3 CH 2 OCH 2 CH 2 .
  • Alkylthio includes branched or straight-chain alkylthio moieties such as methylthio, ethylthio, and the different propylthio and butylthio isomers.
  • Alkylsulfinyl includes both enantiomers of an alkylsulfinyl group.
  • alkylsulfinyl include CH 3 S(O), CH 3 CH 2 S(O), CH 3 CH 2 CH 2 S(O), (CH 3 ) 2 CHS(O) and the different butylsulfinyl isomers.
  • alkylsulfonyl include CH 3 S(O) 2 , CH 3 CH 2 S(O) 2 , CH 3 CH 2 CH 2 S(O) 2 , (CH 3 ) 2 CHS(O) 2 and the different butylsulfonyl isomers.
  • Alkylamino "dialkylamino”, “alkenylthio”, “alkenylsulfinyl”, “alkenylsulfonyl”, “alkynylthio”, “alkynylsulfinyl”, “alkynylsulfonyl”, and the like, are defined analogously to the above examples.
  • Cycloalkyl includes, for example, cyclopropyl, cyclobutyl, cyclopentyl, and cyclohexyl.
  • Aromatic indicates that each of the ring atoms is essentially in the same plane and has ap-orbital perpendicular to the ring plane, and in which (4n + 2) ⁇ electrons, when n is 0 or a positive integer, are associated with the ring to comply with H ⁇ ckel's rule.
  • aromatic ring system denotes fully unsaturated carbocycles and heterocycles in which at least one ring of a polycyclic ring system is aromatic.
  • aromatic carbocyclic ring or ring system includes fully aromatic carbocycles and carbocycles in which at least one ring of a polycyclic ring system is aromatic (e.g. phenyl and naphthyl).
  • nonaromatic carbocyclic ring or ring system denotes fully saturated carbocycles as well as partially or fully unsaturated carbocycles where the H ⁇ ckel rule is not satisfied by any of the rings in the ring system.
  • hetero in connection with rings or ring systems refers to a ring or ring system in which at least one ring atom is not carbon and which can contain 1 to 4 heteroatoms independently selected from the group consisting of nitrogen, oxygen and sulfur, provided that each ring contains no more than 4 nitrogens, no more than 2 oxygens and no more than 2 sulfurs.
  • heterocyclic ring or ring system and “aromatic fused heterobicyclic ring system” includes fully aromatic heterocycles and heterocycles in which at least one ring of a polycyclic ring system is aromatic (where aromatic indicates that the H ⁇ ckel rule is satisfied).
  • nonaromatic heterocyclic ring or ring system denotes fully saturated heterocycles as well as partially or fully unsaturated heterocycles where the H ⁇ ckel rule is not satisfied by any of the rings in the ring system.
  • the heterocyclic ring or ring system can be attached through any available carbon or nitrogen by replacement of a hydrogen on said carbon or nitrogen.
  • halogen either alone or in compound words such as “haloalkyl” includes fluorine, chlorine, bromine or iodine. Further, when used in compound words such as “haloalkyl”, said alkyl may be partially or fully substituted with halogen atoms which may be the same or different. Examples of “haloalkyl” include F 3 C, C1CH 2 , CF 3 CH 2 and CF 3 CC1 2 .
  • haloalkenyl “haloalkynyl”, “haloalkoxy”, “haloalkylthio”, and the like, are defined analogously to the term “haloalkyl”.
  • haloalkynyl examples include HC ⁇ CCHCl, CF 3 C ⁇ C, CC1 3 C ⁇ C and FCH 2 C ⁇ CCH 2 .
  • haloalkoxy examples include CF 3 O, CCl 3 CH 2 O, HCF 2 CH 2 CH 2 O and CF 3 CH 2 O.
  • haloalkylthio examples include CC1 3 S, CF 3 S, CC1 3 CH 2 S and C1CH 2 CH 2 CH 2 S.
  • haloalkylsulfinyl examples include CF 3 S(O), CCl 3 S(O), CF 3 CH 2 S(O) and CF 3 CF 2 S(O).
  • haloalkylsulfonyl examples include CF 3 S(O) 2 , CCl 3 S(O) 2 , CF 3 CH 2 S(O) 2 and CF 3 CF 2 S(O) 2 .
  • alkylcarbonyl examples include C(O)CH 3 , C(O)CH 2 CH 2 CH 3 and C(O)CH(CH 3 ) 2 .
  • C j -C j The total number of carbon atoms in a substituent group is indicated by the "C j -C j " prefix where i and j are numbers from 1 to 6.
  • C ] -C 3 alkylsulfonyl designates methylsulfonyl through propylsulfonyl
  • C 2 alkoxyalkyl designates CH 3 OCH 2
  • C 3 alkoxyalkyl designates, for example, CH 3 CH(OCH 3 ), CH 3 OCH 2 CH 2 or CH 3 CH 2 OCH 2
  • C 4 alkoxyalkyl designates the various isomers of an alkyl group substituted with an alkoxy group containing a total of four carbon atoms, examples including CH 3 CH 2 CH 2 OCH 2 and CH 3 CH 2 OCH 2 CH 2 .
  • substituents When a compound is substituted with a substituent bearing a subscript that indicates the number of said substituents can exceed 1, said substituents (when they exceed 1) are independently selected from the group of defined substituents. Further, when the subscript indicates a range, e.g. (R)i_ j , then the number of substituents may be selected from the integers between i and j inclusive.
  • Stereoisomers of this invention can exist as one or more stereoisomers.
  • the various stereoisomers include enantiomers, diastereomers, atropisomers and geometric isomers.
  • one stereoisomer may be more active and/or may exhibit beneficial effects when enriched relative to the other stereoisomer(s) or when separated from the other stereoisomer(s).
  • the skilled artisan knows how to separate, enrich, and/or to selectively prepare said stereoisomers.
  • the present invention comprises compounds selected from Formula I, N-oxides and agriculturally suitable salts thereof.
  • the compounds of the invention may be present as a mixture of stereoisomers, individual stereoisomers, or as an optically active form.
  • nitrogen containing heterocycles can form N-oxides since the nitrogen requires an available lone pair for oxidation to the oxide; one skilled in the art will recognize those nitrogen containing heterocycles which can form N-oxides.
  • nitrogen containing heterocycles which can form N-oxides.
  • tertiary amines can form N-oxides.
  • N-oxides of heterocycles and tertiary amines are very well known by one skilled in the art including the oxidation of heterocycles and tertiary amines with peroxy acids such as peracetic and m-chloroperbenzoic acid (MCPBA), hydrogen peroxide, alkyl hydroperoxides such as t-butyl hydroperoxide, sodium perborate, and dioxiranes such as dimethydioxirane.
  • MCPBA peroxy acids
  • alkyl hydroperoxides such as t-butyl hydroperoxide
  • sodium perborate sodium perborate
  • dioxiranes such as dimethydioxirane
  • the salts of the compounds of the invention include acid-addition salts with inorganic or organic acids such as hydrobromic, hydrochloric, nitric, phosphoric, sulfuric, acetic, butyric, fumaric, lactic, maleic, malonic, oxalic, propionic, salicylic, tartaric, 4-toluenesulfonic or valeric acids.
  • inorganic or organic acids such as hydrobromic, hydrochloric, nitric, phosphoric, sulfuric, acetic, butyric, fumaric, lactic, maleic, malonic, oxalic, propionic, salicylic, tartaric, 4-toluenesulfonic or valeric acids.
  • the salts of the compounds of the invention also include those formed with organic bases (e.g., pyridine, ammonia, or triethylamine) or inorganic bases (e.g., hydrides, hydroxides, or carbonates of sodium, potassium, lithium, calcium, magnesium or barium) when the compound contains an acidic group such as a carboxylic acid or phenol.
  • organic bases e.g., pyridine, ammonia, or triethylamine
  • inorganic bases e.g., hydrides, hydroxides, or carbonates of sodium, potassium, lithium, calcium, magnesium or barium
  • J is a phenyl ring, a naphthyl ring system, a 5- or 6-membered heteroaromatic ring or an aromatic 8-, 9- or 10-membered fused heterobicyclic ring system wherein each ring or ring system is optionally substituted with 1 to 4 R 5 .
  • optionally substituted in connection with these J groups refers to groups which are unsubstituted or have at least one non-hydrogen substituent that does not extinguish the biological activity possessed by the unsubstituted analog.
  • An example of phenyl optionally substituted with 1 to 4 R 5 is the ring illustrated as U-1 in Exhibit 1, wherein R v is R 5 and r is an integer from 1 to 4.
  • An example of a naphthyl group optionally substituted with 1 to 4 R 5 is illustrated as U-85 in Exhibit 1, wherein R v is R 5 and r is an integer from 1 to 4.
  • Examples of 5- or 6-membered heteroaromatic rings optionally substituted with 1 to 4 R 5 include the rings U-2 through U-53 illustrated in Exhibit 1 wherein R v is R 5 and r is an integer from 1 to 4.
  • J-l through J-13 below also denote 5- or 6-membered heteroaromatic rings.
  • U-2 through U-20 are examples of J-l
  • U-21 through U-35 and U-40 are examples of J-2
  • U-36 through U-39 are examples of J-3
  • U-41 through U-48 are examples of J-4
  • U-49 through U-53 are examples of J-5.
  • J-6 is a subset of U-11, J-7 or J-10 are a subset of U-26, J-8 is a subset of U-42, J-9 is a subset of U-45, J-l 1 is a subset of U-4 and J-l 2 or J-13 are a subset of U-24. Also note that in J-6 through J-13 that R 7 and R 9 are subsets of R 5 .
  • Examples of aromatic 8-, 9- or 10-membered fused heterobicyclic ring systems optionally substituted with 1 to 4 R 5 include U-54 through U-84 illustrated in Exhibit 1 wherein R v is R 5 and r is an integer from 1 to 4.
  • R v groups are shown in the structures U-1 through U-85, it is noted that they do not need to be present since they are optional substituents. Note that when R v is H when attached to an atom, this is the same as if said atom is unsubstituted. The nitrogen atoms that require substitution to fill their valence are substituted with H or R v . Note that some U groups can only be substituted with less than 4 R v groups (e.g. U-14, U-15, U-18 through
  • K is, together with the two contiguous linking carbon atoms, a 5- or 6- membered heteroaromatic ring optionally substituted with 1 to 3 R 4 .
  • K rings wherein said rings are optionally substituted with 1 to 3 R 4 include the ring systems illustrated as K-l to K-37 in Exhibit 2, wherein n is an integer from 1 to 3 and R 4 is as defined above.
  • the term "optionally substituted" in connection with these K groups refers to K groups which are unsubstituted or have at least one non-hydrogen substituent that does not extinguish the biological activity possessed by the unsubstituted analog.
  • R 4 As with the carbon atoms in the ring, the nitrogen atoms that require substitution to fill their valence are substituted with hydrogen or with R 4 .
  • R 4 n groups are shown in the structures K-l to K-37, it is noted that R 4 does not need to be present since it is an optional substituent. Note that some K groups can only be substituted with less than 3 R 4 groups (e.g. K-7 through K-10, K-l 5, K-16, K-20, K-21, K-23, K-24, K-26 and K-27 can only be substituted with one R 4 ).
  • the wavy line indicates that the K ring is attached to the remainder of Formula I as illustrated below.
  • K rings include optionally substituted thiophene, isoxazole, isothiazole, pyrazole, pyridine and pyrimidine rings. More preferred K rings include K-l, K-l 4, K-l 5, K-l 8, K-23, K-28, K-29, K-30, K-31 and K-33. Most preferred are K-28, K-31 and K-33.
  • R 3 can be (among others) C ] -C 6 alkyl, C 2 -Cg alkenyl, C 2 -C 6 alkynyl, C3- cycloalkyl, each optionally substituted with one or more substituents selected from the group consisting of a phenyl ring, or 5- or 6-membered heteroaromatic ring, each ring optionally substituted with one to three substituents independently selected from R 6 .
  • R 3 groups examples include the rings illustrated as U-1 through U-53 and U-86 illustrated in Exhibit 1, except that such rings are optionally substituted with 1 to 3 substituents independently selected from R 6 rather than (R v ) r and are attached to an R 3 group selected from the list immediately above.
  • R 3 can be (among others) G, or C j -C 6 alkyl, C 2 -C6 alkenyl, C 2 -Cg alkynyl, C3-C6 cycloalkyl, each optionally substituted with G; wherein G is a 5- or
  • the term "optionally substituted" in connection with these G groups refers to groups which are unsubstituted or have at least one non-hydrogen substituent that does not extinguish the biological activity possessed by the unsubstituted analog. Note that when the attachment point on the G group is illustrated as floating, the G group can be attached to the remainder of Formula I through any available carbon of the G group by replacement of a hydrogen atom. The optional substituents can be attached to any available carbon by replacing a hydrogen atom.
  • Examples of 5- or 6- membered nonaromatic carbocyclic rings as G include the rings illustrated as G-1 through G-8 of Exhibit 3.
  • Examples of 5- or 6-membered nonaromatic heterocyclic rings as G include the rings illustrated as G-9 through G-48 of Exhibit 3.
  • G comprises a ring selected from G-31 through G-34, G-37 and G-38, Q 1 is selected from O, S or N.
  • G is G-11, G13, G-14, G16, G-23, G-24, G-30 through G-34, G-37 and G-38 and Q 1 is N, the nitrogen atom can complete its valence by substitution with either H or C ⁇ -C alkyl.
  • each R 4 can be independently (among others) a phenyl, benzyl, phenoxy or 5- or 6-membered heteroaromatic ring, each ring optionally substituted with one to three substituents independently selected from R 6 .
  • R 4 groups include the rings or ring systems illustrated as U-1 through U-53, U-86 and U-87 illustrated in Exhibit 1, except that such rings are optionally substituted with 1 to 3 substituents independently selected from R 6 rather than (R v ) r .
  • each R 5 can be independently (among others) a phenyl, benzyl, benzoyl, phenoxy, 5- or 6-membered heteroaromatic ring or an aromatic 8-, 9- or 10- membered fused heterobicyclic ring system, each ring optionally substituted with one to three substituents independently selected from R 6 .
  • R 5 groups include the rings or ring systems illustrated as U-1 through U-88 illustrated in Exhibit 1, except that such rings are optionally substituted with 1 to 3 substituents independently selected from R 6 rather than (R ) r .
  • Preferred compounds for reasons of better activity and or ease of synthesis are: Preferred 1. Compounds of Formula I above, and N-oxides and suitable salts thereof, wherein A and B are both O and J is a phenyl ring optionally substituted with 1 to 4 R 5 . Preferred 2.
  • Q is O, S or NR 5 ;
  • W, X, Y and Z are independently N or CR 5 , provided that in J-4 and J-5 at least one of W, X, Y or Z is N.
  • Preferred 6 Compounds of Preferred 5 wherein each R 4 is independently C r C 4 alkyl, C C 4 haloalkyl, halogen, CN, NO 2 or
  • Preferred 7 Compounds of Preferred 6 wherein
  • J substituted with 1 to 3 R 5 is selected from the group consisting of J-6, J-7, J-8, J-9, J-10, J-l 1, J-12 and J-13
  • R 5 is H, C r C 4 alkyl, C r C 4 haloalkyl, or
  • V is N, CH, CF, CC1, CBr or CI; each R 6 and R 7 is independently H, C r C 6 alkyl, C 3 -C 6 cycloalkyl, C,-C 6 haloalkyl, halogen, CN, C r C 4 alkoxy, C r C 4 haloalkoxy or C r C 4 haloalkylthio; and R9 is H, C,-C 6 alkyl, C,-C 6 haloalkyl, C 3 -C 6 alkenyl, C 3 -C 6 haloalkenyl, C 3 -C 6 alkynyl or C 3 -C 6 haloalkynyl; provided R 7 and R 9 are not both H.
  • Preferred 8 Compounds of Prefe ⁇ ed 7 wherein V is N.
  • R 6 is C,-C 4 alkyl, C r C 4 haloalkyl, halogen or CN;
  • R 7 is H, CH 3 , CF 3 , OCH 2 CF 3 , OCHF 2 or halogen; and p is 0, 1 or 2.
  • Prefe ⁇ ed 12 Compounds of Prefe ⁇ ed 11 wherein J substituted with 1 to 3 R 5 is J-6; R 6 is CI or Br; and R 7 is halogen, OCH 2 CF 3 or CF 3 .
  • Prefe ⁇ ed 13 Compounds of Prefe ⁇ ed 12 wherein V is N; R 3 is methyl, ethyl, isopropyl, tertiary butyl or N(CH 3 ) 2 ; and R 7 is Br, CI, OCH 2 CF 3 or CF 3 .
  • Prefe ⁇ ed 14 Compounds of Prefe ⁇ ed 11 wherein J substituted with 1 to 3 R 5 is J-7; R 6 is CI or Br; and R 9 is CF 3 , CHF 2 , CH 2 CF 3 or CF 2 CHF 2 .
  • Prefe ⁇ ed 15 Compounds of Prefe ⁇ ed 11 wherein J substituted with 1 to 3 R 5 is J-8;
  • R 6 is CI or Br; and R 7 is halogen, OCH 2 CF 3 or CF 3 .
  • Prefe ⁇ ed 16 Compounds of Prefe ⁇ ed 11 wherein J substituted with 1 to 3 R 5 is J-9;
  • R 6 is CI or Br; and R 7 is OCH 2 CF 3 or CF 3 .
  • Preferred 17. Compounds of Prefe ⁇ ed 11 wherein J substituted with 1 to 3 R 5 is J-10; R 6 is CI or Br; and R 9 is CF 3 , CHF 2 , CH 2 CF 3 or CF 2 CHF 2 .
  • R 6 is CI or Br; and R 7 is halogen, OCH 2 CF 3 , or CF 3 .
  • Preferred 19 Compounds of Prefe ⁇ ed 11 wherein J substituted with 1 to 3 R 5 is J-l 2; R 6 is CI or Br; R 7 is H, halogen or CF 3 , and R 9 is H, CF 3 , CHF 2 , CH 2 CF 3 , or CF 2 CHF 2 .
  • Prefe ⁇ ed 20 Compounds of Prefe ⁇ ed 11 wherein J substituted with 1 to 3 R 5 is J-13; R 6 is CI or Br; R 7 is H, halogen or CF 3 , and R 9 is H, CF 3 , CHF 2 , CH 2 CF 3 or CF 2 CHF 2 .
  • Most prefe ⁇ ed is the compound of Formula I selected from the group consisting of:
  • This invention also pertains to a composition for controlling an invertebrate pest comprising a biologically effective amount of a compound of Formula I, an N-oxide thereof or a suitable salt thereof and at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents.
  • This invention also pertains to a composition comprising a biologically effective amount of a compound of Formula I, an N-oxide thereof or a suitable salt thereof and an effective amount of at least one additional biologically active compound or agent.
  • the prefe ⁇ ed compositions of the present invention are those which comprise the above prefe ⁇ ed compounds.
  • This invention also pertains to a method for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of a compound of Formula I, an N-oxide thereof or a suitable salt thereof (e.g., as a composition described herein).
  • This invention also relates to such a method wherein the invertebrate pest or its environment is contacted with a biologically effective amount of a compound of Formula I or a composition comprising a compound of Formula I, an N-oxide thereof or a suitable salt thereof and a biologically effective amount of at least one additional compound or agent for controlling invertebrate pests.
  • the prefe ⁇ ed methods of use are those involving the above prefe ⁇ ed compounds.
  • each J is independently a phenyl ring, a naphthyl ring system, a 5- or 6-membered heteroaromatic ring or an aromatic 8-, 9- or 10-membered fused heterobicyclic ring system wherein each ring or ring system is optionally substituted with 1 to 4
  • K is, together with the two contiguous linking carbon atoms, a 5- or 6-membered heteroaromatic ring optionally substituted with 1 to 3 R 4 ; n is 1 to 3; R 1 is H; or Cj-C 6 alkyl, C 2 -Cg alkenyl, C 2 -C 6 alkynyl or C 3 -C 6 cycloalkyl each optionally substituted with one or more substituents selected from the group consisting of halogen, C ⁇ , ⁇ O 2 , hydroxy, C j -C 4 alkoxy, C j -C 4 alkylthio, C 1 -C 4 alkylsulfinyl, C]-C 4 alkylsulfonyl, C 2 -C 4 alkoxycarbonyl, C j -C 4 alkylamino,
  • R 2 is H, C r C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, C 3 -C 6 cycloalkyl, C r C 4 alkoxy,
  • R 3 is H;
  • C 3 -C 6 trialkylsilyl; C C 4 alkoxy; C]-C alkylamino; C 2 -C 8 dialkylamino; C 3 -C 6 cycloalkylamino; C 2 -C 6 alkoxycarbonyl or C 2 -Cg alkylcarbonyl; or R 2 and R 3 can be taken together with the nitrogen to which they are attached to form a ring containing 2 to 6 atoms of carbon and optionally one additional atom of nitrogen, sulfur or oxygen, said ring may be optionally substituted with 1 to 4 substituents selected from the group consisting of Cj-C 2 alkyl, halogen, CN, NO 2 and Cj-C alkoxy; G is a 5- or 6-membered nonaromatic carbocyclic or heterocyclic ring, optionally including one or two ring members selected from the group consisting of C( O), SO or S(O) 2 and optionally substituted with 1 to 4 substituents selected from the group consisting of C]
  • each R 4 is independently phenyl, benzyl or phenoxy, each optionally substituted with C r C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 3 -C 6 cycloalkyl, C r C 4 haloalkyl, C 2 -C haloalkenyl, C 2 -C 4 haloalkynyl, C 3 -C 6 halocycloalkyl, halogen, CN,
  • each R 5 is independently H, C C 6 alkyl, C 2 -Cg alkenyl, C 2 -Cg alkynyl, C 3 -C 6 cycloalkyl, Cj-C 6 haloalkyl, C 2 -Cg alkenyl, C 2 -Cg alkynyl, C 3 -C 6 cycloalkyl, Cj-C 6 haloalkyl, C 2
  • Selection A Compounds of Formula 1 wherein K is, together with the two linking atoms, a thiophene, pyrazole, isoxazole, pyridine or pyrimidine optionally substituted with 1 to 3 R 4 .
  • Selection B Compounds of Selection A wherein J is independently a phenyl ring or a 5- or 6-membered heteroaromatic ring wherein each ring is optionally substituted with 1 to 2 R 5 .
  • J is a phenyl ring or a 5- or 6-membered heteroaromatic ring selected from the group consisting of J-l, J-2, J-3, J-4 and J-5, each ring optionally substituted with 1 to 3 R 5
  • Q is O, S or NR5;
  • W, X, Y and Z are independently N or CR 5 , provided that in J-4 and J-5 at least one of W, X, Y or Z is N.
  • Selection D Compounds of Selection B or Selection C wherein A and B are both O; n is 1 to 2;
  • R 1 is H, C r C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 3 -C 6 cycloalkyl, C 2 -C 6 alkylcarbonyl or C 2 -C 6 alkoxycarbonyl;
  • R 2 is H, C]-C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 3 -C 6 cycloalkyl, C 2 -C 6 alkylcarbonyl or C 2 -Cg alkoxycarbonyl;
  • R 3 is C j -Cg alkyl, 2 -C alkenyl, C 2 -C 6 alkynyl or C 3 -C 6 cycloalkyl each optionally substituted with one or more substituents selected from the group consisting of halogen, CN, C ⁇ -C 2 alkoxy, C ⁇ -C 2 alkylthio, C j -C alkylsulfinyl and alkylsulfonyl; one of the R 4 groups is attached to the heteroaromatic ring at one of the two positions ortho to the two linking atoms, and said R 4 is Cj-C alkyl, Cj-C haloalky
  • each ring optionally substituted with C]-C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 3 -C 6 cycloalkyl, C r C 4 haloalkyl, C -C 4 haloalkenyl, C -C 4 haloalkynyl, C 3 -Cg halocycloalkyl, halogen, CN, NO 2 , C r C 4 alkoxy, C C 4 haloalkoxy, Cj-C alkylthio, C 1 -C 4 alkylsulfinyl, C C alkylsulfonyl, C C 4 alkylamino, C 2 -C 8 dialkylamino, C 3 -C 6 cycloalkylamino, C 3 -C 6 (alkyl)cycloalkylamino, C 2 -C 4 alkylcarbonyl, C
  • J is selected from the group consisting of phenyl, pyridine, pyrimidine, pyrazole, imidazole, triazole, thiophene, thiazole and oxazole, furan, isothiazole and isoxazole, each optionally substituted with 1 to 2 R 5 .
  • Selection F Compounds of Selection E wherein J is selected from the group consisting of phenyl, pyridine, pyrimidine, pyrazole, thiophene and thiazole, each optionally substituted with 1 to 2 R 5 ;
  • R 1 and R 2 are both H;
  • R 3 is C r C 4 alkyl optionally substituted with halogen, CN, OCH 3 , S(O) p CH 3 ;
  • each R 4 is independently CH 3 , CF 3 , OCF 3 , OCHF 2 , S(O) p CF 3 , S(O) p CHF 2 ,
  • each R 5 is independently H, halogen, CH 3 , CF 3 , OCHF 2 , S(O) p CF 3 ,
  • Selection H Compounds of Selection G wherein J is a phenyl optionally substituted with 1 to 2 R 5 .
  • Selection I Compounds of Selection H wherein one R 5 is a phenyl optionally substituted with C 1 -C4 alkyl, C1-C4 haloalkyl, halogen or CN.
  • Selection J Compounds of Selection H wherein one R 5 is a pyrazole, imidazole, triazole, pyridine or pyrimidine, each ring optionally substituted with C1-C4 alkyl, C C 4 haloalkyl, halogen or CN.
  • Selection K Compounds of Selection I wherein J is a pyridine optionally substituted with 1 to 2 R 5 .
  • Selection L Compounds of Selection K wherein one R 5 is a phenyl optionally substituted with C ] -C 4 alkyl, C j -C 4 haloalkyl, halogen or CN.
  • Selection M Compounds of Selection K wherein one R 5 is a pyrazole, imidazole, triazole, pyridine or pyrimidine, each ring optionally substituted with Cj-C 4 alkyl, C ] -C 4 haloalkyl, halogen or CN.
  • Selection N Compounds of Selection I wherein J is a pyrimidine optionally substituted with 1 to 2 R 5 .
  • Selection O Compounds of Selection K wherein one R 5 is a phenyl optionally substituted with C ] -C 4 alkyl, C j -C 4 haloalkyl, halogen or CN.
  • Selection S Compounds of Selection Q wherein one R 5 is a pyrazole, imidazole, triazole, pyridine or pyrimidine, each ring optionally substituted with Cj-C 4 alkyl, C r C 4 haloalkyl, halogen or CN.
  • Selection T Compounds of Selection S wherein one R 5 is a pyridine optionally substituted with C r C 4 alkyl, C r C haloalkyl, halogen or CN.
  • the compounds of Formula I can be prepared by one or more of the following methods and variations as described in Schemes 1-19.
  • the definitions of A, B, J, K, R 1 , R 2 , R 3 , R 4 , R 5 and n in the compounds of Formulae I and 2-41 below are as defined above in the Summary of the Invention.
  • Compounds of Formulae Ia-c, 2a-b and 4a-g are various subsets of the compounds of Formula I, 2 and 4, respectively.
  • K is selected from the group consisting of optionally substituted thiophene, isoxazole, isothiazole, pyrazole, pyridine and pyrimidine rings.
  • K is K-l, K-14, K-15, K-18, K-23, K-28, K-29, K-30, K-31 and K-33.
  • K is K-28, K-31 and K-33.
  • Compounds of Formula I can be prepared by procedures outlined in Schemes 1-19.
  • a typical procedure is detailed in Scheme 1 and involves coupling of an ortho amino carboxylic acid amide of Formula 2 with an acid chloride of Formula 3 in the presence of an acid scavenger to provide the compound of Formula la.
  • Typical acid scavengers include amine bases such as triethylamine, diisopropylethylamine and pyridine; other scavengers include hydroxides such as sodium and potassium hydroxide and carbonates such as sodium carbonate and potassium carbonate.
  • polymer-supported acid scavengers such as polymer-bound diisopropylethylamine and polymer- bound dimethylaminopyridine.
  • amides of Formula la can be converted to thioamides of Formula lb using a variety of standard thio transfer reagents including phosphorus pentasulfide and Lawesson's reagent.
  • An alternate procedure for the preparation of compounds of Formula la involves coupling of an amide of Formula 2 with an acid of Formula 4 in the presence of a dehydrating agent such as dicyclohexylcarbodiimide (DCC).
  • a dehydrating agent such as dicyclohexylcarbodiimide (DCC).
  • DCC dicyclohexylcarbodiimide
  • Polymer supported reagents are useful here, such as polymer-bound cyclohexylcarbodiimide.
  • acid chlorides of Formula 3 may be prepared from acids of Formula 4 by numerous well-known methods.
  • An alternate procedure for the preparation of compounds of Formula la involves coupling of an ortho amino carboxylic acid ester of Formula 5 with an acid chloride of Formula 3 by a method similar to that described in Scheme 1, followed by transformation of the ester group into an amide functionality. This transformation can be achieved by an amination with an amine of Formula 7.
  • a Lewis acid such as frimethylaluminum as shown in Scheme 3 may catalyze this reaction.
  • ester 6 can be transformed to an amide (6a) as shown in Scheme 4 by saponification with a base such as aqueous sodium hydroxide followed by dehydrative coupling with an amine of Formula 7 by a procedure similar to that described in Scheme 2.
  • a base such as aqueous sodium hydroxide
  • Benzoic acids of Formula 4 (J is optionally substituted phenyl) are generally well known in the art as are procedures for their preparation.
  • One particularly useful subset of benzoic acids of this invention are 2-methyl-4-perfluoroalkyl benzoic acids of Formula 4a (R 5 (a) equals e.g. CF 3 , C 2 F 5 , C 3 F 7 ).
  • R 5 (a) equals e.g. CF 3 , C 2 F 5 , C 3 F 7 ).
  • the synthesis for these compounds is outlined in Schemes 5-9.
  • Benzoic acids of Formula 4a may be prepared from the benzonitriles of Formula 8 by hydrolysis.
  • the conditions used may involve the use of a base such as an alkaline metal hydroxide or alkoxide (e.g.
  • the hydrolysis may be carried out using an acid such as sulfuric acid or phosphoric acid in a suitable solvent such as water (e.g. Org. Synth. 1955, Coll. vol. 3, 557).
  • a solvent such as water, ethanol or ethylene glycol
  • the hydrolysis may be carried out using an acid such as sulfuric acid or phosphoric acid in a suitable solvent such as water (e.g. Org. Synth. 1955, Coll. vol. 3, 557).
  • the choice of the conditions is contingent on the stability of R 5 to the reaction conditions and elevated temperatures are usually employed to achieve this transformation.
  • Nitriles of Formula 8 may be prepared from anilines of Formula 9 by the classical sequence involving diazotization and treatment of the intermediate diazonium salt with a copper cyanide salt (e.g. J. Amer. Chem. Soc. 1902, 24, 1035).
  • Anilines of Formula 9 may be prepared from compounds of Formula 10. This transformation may be achieved by a well-known procedure that employs Raney Nickel (Org. Synth. Coll. Vol. VI, 581). Alternatively, the same transformation may be effected by the use of a suitable catalyst such as palladium in the presence of hydrogen. The reaction is usually conducted at pressures of 10 4 to 10 7 kPa in a suitable organic solvent such as, but not limited to, toluene. Elevated temperatures of 80-110 °C are usually required to achieve the transformation. As one skilled in the art will realize, numerous chemical modifications of the thioether moiety are possible, and may be employed when necessary to facilitate this transformation.
  • Compounds of Formula 10 may be prepared from iminosulfuranes of Formula 11.
  • the transformation may be achieved in a protic solvent such as methanol or water, in a non-protic solvent such as dichloromethane or toluene in the presence of a suitable base such as triethylamine (e.g. Org. Synth. Coll. Vol. VI, 581) or sodium methoxide, or in a combination of a protic solvent, a protic solvent and a base.
  • a protic solvent such as methanol or water
  • a non-protic solvent such as dichloromethane or toluene
  • a suitable base such as triethylamine (e.g. Org. Synth. Coll. Vol. VI, 581) or sodium methoxide
  • the temperature at which the reaction is conducted is usually in the range 40-110 °C.
  • suitable salts of compounds of Formula 11 such as, but not limited to a hydrochloride, a sulfate or a bisulfate may also be employed, provided that the appropriate amount of base is first used to generate the free base 11. This may be done as a separate step or as an integral part of the step involving the transformation of compounds of Formula 11 to compounds of Formula 10.
  • Compounds of Formula 11 may be prepared from anilines of Formula 12 by reaction with dimethyl sulfide and a suitable chlorinating agent such as, but not limited to N-chlorosuccinimide (e.g. Org. Synth. Coll. Vol. VI, 581), chlorine or N-chlorobenzotriazole.
  • anilines of Formula 12 may be treated with dimethyl sulfoxide which has been "activated” by treatment with an agent such as acetic anhydride, trifluoroacetic, anhydride, trifluoromethanesulfonic anhydride, cyclohexylcarbodiimide, sulfur trioxide, or phosphorus pentoxide.
  • the reaction is conducted in a suitable organic solvent such as dichloromethane or dimethyl sulfoxide.
  • the reaction is conducted at a temperature of -70 °C to 25 °C and is dependent on the solvent and reagent used.
  • Intermediate ortho amino carboxylic acid amides of Formula 2a and 2b may also be prepared from isatoic anhydrides of Formula 13 and 14 (Scheme 10). Typical procedures involve combination of equimolar amounts of the amine 7 with the isatoic anhydride in polar aprotic solvents such as pyridine and dimethylformamide at temperatures ranging from room temperature to 100 °C.
  • polar aprotic solvents such as pyridine
  • R 1 substituents such as alkyl and substituted alkyl may be introduced by the base catalyzed alkylation of isatoic anhydride 13 with known alkylating reagents R J -Lg (wherein Lg is a leaving group such as halogen, alkyl or aryl suphonates or alkyl sulfates) to provide the alkyl substituted intermediates 14.
  • Isatoic anhydrides of Formula 13 may be made by methods described in Coppola, Synthesis 1980, 505 and Fabis et al Tetrahedron, 1998, 10789. Scheme 10
  • An alternate procedure for the preparation of specific compounds of Formula I involves reaction of an amine 7 with a heterocyclic fused oxazinone of Formula 15.
  • Typical procedures involve combination of the amine with the oxazinone in solvents such as tetrahydrofuran or pyridine at temperatures ranging from room temperature to the reflux temperature of the solvent.
  • Oxazinones are well documented in the chemical literature and are available via known methods that involve the coupling of either an ortho amino carboxylic acid with an acid chloride.
  • references to the synthesis and chemistry of heterocyclic fused oxazinones see Jakobsen et al, Biorganic and Medicinal Chemistry, 2000, 8, 2803-2812 and references cited therein.
  • R 1 is H
  • Heterocyclic acids of Formula 4, wherein J is an optionally substituted heterocycle can be prepared by procedures outlined in Schemes 12-17. Both general and specific references to a wide variety of heterocyclic acids including thiophenes, furans, pyridines, pyrimidines, triazoles, imidazoles, pyrazoles, thiazoles, oxazoles, isothiazoles, thiadiazoles, oxadiazoles, triazines, pyrazines, pyridazines, and isoxazoles can be found in the following compendia: Rodd's Chemistry of Chemistry of Carbon Compounds, Vol. IVa to IVL, S.
  • heterocyclic acids of this invention include pyridine acids, pyrimidine acids and pyrazole acids. Procedures for the synthesis of representative examples of each are detailed in Schemes 12-17. A variety of heterocyclic acids and general methods for their synthesis may be found in World Patent Application WO 98/57397.
  • the alkylating agent R 5 (b)-Lg (wherein Lg is a leaving group such as CI, Br, I, sulfonates such as p- toluenesulfonate or methanesulfonate or sulfates such as -SO 2 OR 7 (b)) includes R 7 (b) groups such as Cj-Cg alkyl, C 2 -Cg alkenyl, C -C 6 alkynyl, C 3 -Cg cycloalkyl, C r C 6 haloalkyl, C 2 - C 6 haloalkenyl, C 2 -Cg haloalkynyl, C 3 -C 6 halocycloalkyl, C 2 -Cg alkylcarbonyl, C 2 -C 6 alkoxycarbonyl, C 3 -C dialkylaminocarbonyl, C 3 -C 6 trialkylsilyl; or phenyl, benzyl,
  • pyrazoles 4e are described in Scheme 15. These pyrazole acids may be prepared via metallation and carboxylation of pyrazoles of formula 28 as the key step.
  • the R 5 (b) group is introduced in a manner similar to that of Scheme 14, i.e. via alkylation with a R 5 (b) alkylating agent.
  • Representative R 5 (a) groups include e.g. cyano, and haloalkyl.
  • Pyrazoles 4f are described in Scheme 16. These can be prepared via reaction of an optionally substituted phenyl hydrazine 29 with a pyruvate 30 to yield pyrazole esters 31. Hydrolysis of the ester affords the pyrazole acids 4f. This procedure is particularly useful for the preparation of compounds where R 5 (b) is optionally substituted phenyl and R 5 (a) is haloalkyl.
  • Pyrazoles acids of Formula 4g are described in Scheme 17. These can be prepared via 3+2 cycloaddition of an appropriately substituted nitrilimine (32) with either substituted propiolates (33) or acrylates (36). Cycloaddition with acrylates requires additional oxidation of the intermediate pyrazoline to the pyrazole. Hydrolysis of the ester affords the pyrazole acids 4g.
  • Prefe ⁇ ed iminohalides for this reaction include the trifluoromethyl iminochloride (38) and the iminodibromide (39). Compounds such as 38 are known (J. Heterocycl. Chem. 1985, 22(2), 565-8).
  • Ortb ⁇ -amino carboxylic acid esters of Formula 5 wherein R 1 is H can be prepared from monoesters of ortho dicarboxylic acids of Formula 40 via rearrangement of the co ⁇ esponding acyl azide and hydrolysis of the resulting isocyanate (or alternatively by trapping of the isocyanate with an alcohol and cleaving of the resulting carbamate) as shown in Scheme 18.
  • Step A Preparation of ethyl 4-azido-5-methyl-3-pyridinecarboxylate A slurry of 14.1 g (78 mmol) of ethyl l,4-dihydro-5-methyl-4-oxo-3- pyridinecarboxylate (prepared according to Horvath, G.; Dvortsak, P. J. Heterocycl. Chem. 1980, 359) in 30 mL of phosphorous oxychloride was refluxed for 1 hour.
  • Step B Preparation of ethyl 4-amino-5-methyl-3-pyridinecarboxylate 0.50 g of material prepared in Step A was dissolved in 15 mL of ethanol. 0.15g of
  • Step C Preparation of ethyl 5-methyl-4-r[4-frifluoromethoxy)benzoyl1amino]-3- pyridinecarboxylate l.Og (5.6 mmol) of material prepared in Step C was dissolved in 30 mL of dichloromethane.
  • Step D Preparation of 5-methyl-N-(l-methylethvD-4-IT4- trifluoromethoxy)benzovnamino]-3-pyridinecarboxamide
  • a solution of 0.049 mL (0.57 mmol) of isopropylamine in 20 mL of dichloroethane at 0 °C was added 0.64 mL (1.3 mmol) of a 2M solution of frimethylaluminum in toluene dropwise.
  • Step A Preparation of 5 -amino- 1 -methyl - ⁇ -( 1 -methylethyl - 1 H-pyrazole-4- carboxamide l.Og (8.0 mmol) of 2-cyano-N-(l-methylethyl)acetamide (prepared according to the procedure of Cheikh et al J. Org.
  • reaction mixture was refluxed for 5 hours and then allowed to stand at room temperature overnight.
  • the solvent was removed with a rotary evaporator.
  • the residue was purified by MPLC (ethyl acetate as eluant) to afford 0.14g of the title compound as a solid.
  • Step B Preparation of l-methyl-N-d-methylethyl)-5-rr4- trifluorometho ⁇ y)benzovnamino]- 1 H-pyrazole-4-carboxamide 0.14 g (0J7 mmol) of the material from Step A was dissolved in 20 mL of tetrahydrofuran and 0.12 mL (0.85 mmol) of triethylamine and 0.12 mL (0.77 mmol) of 4-(trifluoromethoxy)benzoyl chloride were added.
  • Step C Preparation of 4-methyl-N-f 1 -methylethylV3-IT4- trifluoromethyl)benzoyl]amino]-2-thiophenecarboxamide
  • Step A Preparation of 1-(1 -dimethylethyl 4-ethyl-2-acetyl-3-amino-2-butenedioate
  • Step B Preparation of 5-(l.l-dimethylethyl) hydrogen 6-methyl-4.5- pyrimidinedicarboxylate
  • a solution of 11.6g (45 mmol) of the material from Step A in 55 mL of ethanol was added 10.9g (135 mmol) of formamidine hydrochloride.
  • the reaction mixture was cooled in an ice bath and 17 mL (135 mmol) of 1,1,3,3-tetramethylguanidine was added dropwise. After the mixture was stirred overnight the solvent was removed with a rotary evaporator. The residue was partitioned between ethyl acetate and water.
  • Step C Preparation of 5-(T J-dimethylethyl) 4-methyl 6-methyl-4.5- pyrimidinedicarboxylate To a solution of 9.12g (38 mmol) of the material from Step B in 100 mL of
  • NN-dimethyl formamide (DMF) was added 3.1 mL (50 mmol) of iodomethane and 3Jg (50 mmol) of lithium carbonate.
  • the reaction mixture was heated at 60 °C for 3 hours. After cooling the reaction mixture was partitioned between dichloromethane and water. The organic layer was dried (sodium sulfate) and the solvent was removed with a rotary evaporator and then a vacuum pump. The residue was purified by MPLC with a gradient of 20-30% ethyl acetate in hexanes as eluant to afford 7.58g of the title compound as an off- white solid.
  • Step D Preparation of methyl 5-IT( 1,1 -dimethylethoxy)carbonyll amino] -6-methyl-4- pyrimidinecarboxylate 7.55g of the material from Step C was dissolved in 40 mL of dichloromethane. 20 mL of trifluoroacetic acid was added. After two days the reaction mixture was refluxed for 6 hours. After an additional day the volatiles were removed with a rotary evaporator. Toluene was added and the solvent was removed with a rotary evaporator.
  • Step E Preparation of methyl 5-amino-6-methyl-4-pyrimidinecarbo ⁇ ylate
  • Step I Preparation of 3-chloro-2-(3-chloro-lH-pyrazol-l-yl)pyridine To a mixture of 2,3 -dichloropyri dine (92.60 g, 0.629 mol) and 3-chloropyrazole
  • Step L Preparation of 5 - [ [ ⁇ 3 -Chloro- 1 -(3 -chloro-2-pyridinylV 1 H-pyrazol-5 - yncarbonyl1aminol-N,6-dimethyl-4-pyrimidinecarboxamide 2 mL of a 2M solution of methylamine in tetrahydrofuran was added to 0.090g of material from Step K. After sti ⁇ ing overnight the solvent was removed with a rotary evaporator to afford 0.07 lg of the title compound, a compound of the invention, as a tan solid; m.p. 205-207 °C.
  • Step C Preparation of 3-amino-2,6-dichloro-4-pyridinecarbo ⁇ ylic monopotassium salt
  • ethyl 3-amino-2,6-dichloro-4- pyridinecarboxylate was added 622 mg (11.1 mmol) of potassium hydroxide at room temperature and the reaction mixture was warmed at 90 °C for lhour.
  • Step F Preparation of 1 -(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazole-5- carboxylic acid
  • a solution of the pyrazole product from Step E (105.0 g, 425 mmol) in dry tetrahydrofuran (700 mL) at -75 °C was added via cannula a -30 °C solution of lithium diisopropylamide (425 mmol) in dry tetrahydrofuran (300 mL).
  • the deep red solution was stirred for 15 minutes, after which time carbon dioxide was bubbled through at -63 °C until the solution became pale yellow and the exothermicity ceased.
  • reaction was sti ⁇ ed for an additional 20 minutes and then quenched with water (20 mL).
  • the solvent was removed under reduced pressure, and the reaction mixture partitioned between ether and 0.5 N aqueous sodium hydroxide solution.
  • the aqueous extracts were washed with ether (3x), filtered through Celite® diatomaceous filter aid to remove residual solids, and then acidified to a pH of approximately 4, at which point an orange oil formed.
  • the aqueous mixture was sti ⁇ ed vigorously and additional acid was added to lower the pH to 2.5-3.
  • Step G Preparation of 2,6-dichloro-3-
  • l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)- lH-pyrazole-5-carboxylic acid was added 160 ⁇ L (1.84 mmol) of oxalyl chloride and two drops of DMF in sequence at room temperature.
  • t is tertiary, s is secondary, n is normal, i is iso, c is cyclo, Me is methyl, Et is ethyl, Pr is propyl, i-Pr is isopropyl, t-Bu is tertiary butyl, Ph is phenyl, OMe is methoxy, OEt is ethoxy, SMe is methylthio, SEt is ethylthio, C ⁇ is cyano, ⁇ O 2 is nitro, TMS is trimethylsilyl, S(O)Me is methylsulfinyl, and S(O) 2 Me is methylsulfonyl. Structures of K for Tables 15, 16 and 17 can be found in Exhibit 2. Table 1

Abstract

This invention provides compounds of Formula (I), N-oxides and suitable salts thereof, wherein A and B are independently O or S; each J is independently a phenyl ring, a naphthyl ring system, a 5- or 6-membered heteroaromatic ring or an aromatic 8-, 9- or 10-membered fused heterobicyclic ring system wherein each ring or ring system is optionally substituted with 1 to 4 R5; K is, together with the two contiguous linking carbon atoms, a 5- or 6-membered heteroaromatic ring optionally substituted with 1 to 3 R?4; and R1 R2, R3, R4, R5¿ and n are as defined in the disclosure. Also disclosed are methods for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of a compound of Formula (I), an N-oxide thereof or a suitable salt of the compound (e.g., as a composition described herein). This invention also pertains to a composition for controlling an invertebrate pest comprising a biologically effective amount of a compound of Formula (I), an N-oxide thereof or a suitable salt of the compound and at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents.

Description

HETEROCYCLIC DIAMIDE INVERTEBRATE PEST CONTROL AGENTS
BACKGROUND OF THE INVENTION This invention relates to certain heterocyclic diamides, their N-oxides, suitable salts and compositions, and a method of their use for controlling invertebrate pests in both agronomic and nonagronomic environments.
The control of invertebrate pests is extremely important in achieving high crop efficiency. Damage by invertebrate pests to growing and stored agronomic crops can cause significant reduction in productivity and thereby result in increased costs to the consumer. The control of invertebrate pests in forestry, greenhouse crops, ornamentals, nursery crops, stored food and fiber products, livestock, household, and public and animal health is also important. Many products are commercially available for these purposes, but the need continues for new compounds that are more effective, less costly, less toxic, environmentally safer or have different modes of action.
ΝL 9202078 discloses Ν-acyl anthranilic acid derivatives of Formula i as insecticides
Figure imgf000002_0001
wherein, inter alia, X is a direct bond; Y is H or CrC6 alkyl; Z is ΝH2, NH(CrC3 alkyl) or N(CrC3 alkyl)2; and R1 through R9 are independently H, halogen, C Cg alkyl, phenyl, hydroxy, Cj-Cg alkoxy or C1-C7 acyloxy.
WOO 1/070671 discloses N-acyl anthranilic acid derivatives of Formula i as arthropodicides
Figure imgf000003_0001
wherein, inter alia, A and B are independently O or S; J is an optionally substituted phenyl ring, 5- or 6-membered heteroaromatic ring, naphthyl ring system or an aromatic 8-, 9- or 10-membered fused heterobicyclic ring system; R1 and R3 are independently H or optionally substituted CrC6 alkyl; R2 is H or C Cg alkyl; each R4 is independently H, C C6 alkyl, C Cg haloalkyl, halogen or CN; and n is 1 to 4.
SUMMARY OF THE INVENTION This invention pertains to compounds of Formula I, and N-oxides or suitable salts thereof
Figure imgf000003_0002
wherein
A and B are independently O or S; each J is independently a phenyl ring, a naphthyl ring system, a 5- or 6-membered heteroaromatic ring or an aromatic 8-, 9- or 10-membered fused heterobicyclic ring system wherein each ring or ring system is optionally substituted with 1 to 4
R5; K is, together with the two contiguous linking carbon atoms, a 5- or 6-membered heteroaromatic ring optionally substituted with 1 to 3 R4; n is 1 to 3; R1 is H; or Cj-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl or C3-C6 cycloalkyl each optionally substituted with one or more substituents selected from the group consisting of halogen, CΝ, ΝO2, hydroxy, C Ct alkoxy, CrC4 alkylthio, CrC4 alkylsulfinyl, C1-C4 alkylsulfonyl, C2-C4 alkoxycarbonyl, CrC alkylamino, C2-Cg dialkylamino and C3-C6 cycloalkylamino; or R1 is C2-C6 alkylcarbonyl, C -C6 alkoxycarbonyl, C -C6 alkylaminocarbonyl, C3-C8 dialkylaminocarbonyl or C(=A)J; R2 is H, CrC6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, CrC4 alkoxy,
Cj-C4 alkylamino, C2-Cg dialkylamino, C3-C6 cycloalkylamino, C2-Cg alkoxycarbonyl or C2-C6 alkylcarbonyl; R3 is H; G; or CrC6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, each optionally substituted with one or more substituents selected from the group consisting of G, halogen, CN, NO2, hydroxy, C j -C4 alkoxy, C j -C4 haloalkoxy,
CrC4 alkylthio, CrC4 alkylsulfinyl, CrC4 alkylsulfonyl, C2-C6 alkoxycarbonyl, C2-C6 alkylcarbonyl, C3-C6 trialkylsilyl, or a phenyl, phenoxy or 5- or 6-membered heteroaromatic ring, each ring optionally substituted with one to three substituents independently selected from R6; or R2 and R3 can be taken together with the nitrogen to which they are attached to form a ring containing 2 to 6 atoms of carbon and optionally one additional atom of nitrogen, sulfur or oxygen, and said ring may be optionally substituted with one to four substituents selected from R12; and G is a 5- or 6-membered nonaromatic carbocyclic or heterocyclic ring, optionally including one or two ring members selected from the group consisting of C(=O),
SO or S(O)2 and optionally substituted with one to four substituents selected
each R4 is independently H, CrC6 alkyl, C2-C6 alkenyl, C -C6 alkynyl, C3-C6 cycloalkyl, CrC6 haloalkyl, C2-C6 haloalkenyl, C2-C6 haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, NO2, hydroxy, C1-C4 alkoxy, Cj-C haloalkoxy,
C1-C4 alkylthio, C]-C4 alkylsulfinyl, Cj-C4 alkylsulfonyl, C]-C4 haloalkylthio, Cj-C4 haloalkylsulfinyl, Cj- haloalkylsulfonyl, C C4 alkylamino, C2-C8 dialkylamino, C3-C6 cycloalkylamino, - alkoxyalkyl, Cj-C4 hydroxyalkyl, C(O)R10, CO2R10, C(O)NRlθRH, NR^RH, N(RH)CO2R10; or each R4 is independently a phenyl, benzyl, phenoxy or 5- or 6-membered heteroaromatic ring, each ring optionally substituted with one to three substituents independently selected from R6; each R5 is independently H, Cj-C6 alkyl, C -C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, CrC6 haloalkyl, C2-C6 haloalkenyl, C2-C6 haloalkynyl, ^- -Cξ, halocycloalkyl, halogen, CN, CO2H, CONH2, NO2, hydroxy, CrC4 alkoxy,
CrC4 haloalkoxy, CrC4 alkylthio, CrC4 alkylsulfinyl, CrC4 alkylsulfonyl, CrC4 haloalkylthio, CrC4 haloalkylsulfinyl, C -C haloalkylsulfonyl, CrC4 alkylamino, C2-C8 dialkylamino, C3-C6 cycloalkylamino, C2-Cg alkylcarbonyl, C2-C6 alkoxycarbonyl, C2-Cg alkylaminocarbonyl, C3-C8 dialkylaminocarbonyl, C3-C6 trialkylsilyl; or each R5 is independently a phenyl, benzyl, benzoyl, phenoxy, 5- or 6-membered heteroaromatic ring or an aromatic 8-, 9- or 10-membered fused heterobicyclic ring system, each ring or ring system optionally substituted with one to three substituents independently selected from R6; or (R5) when attached to adjacent carbon atoms can be taken together as -OCF2O-,
-CF2CF2O-, or -OCF2CF2O-; and each R6 is independently C]_-C4 alkyl, C2-C alkenyl, C2-C4 alkynyl, C3-Cg cycloalkyl, CrC haloalkyl, C2-C4 haloalkenyl, C2-C4 haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, NO2, C C4 alkoxy, Cj-C4 haloalkoxy, Cγ-C4 alkylthio, Cj-C alkylsulfinyl, C!-C4 alkylsulfonyl, C C4 alkylamino, C2-C dialkylamino, C3-C6 cycloalkylamino, C3-C6 (alkyl)cycloalkylamino, C2-C alkylcarbonyl, C2-C6 alkoxycarbonyl, C2-C6 alkylaminocarbonyl, C3-C dialkylaminocarbonyl or C3-C6 trialkylsilyl; each R10 is independently H, Cι~C alkyl or C j-C haloalkyl; each R11 is independently H or C]-C4 alkyl; and each R12 is independently Cj-C2 alkyl, halogen, CN, NO2 or Cj-C2 alkoxy. This invention also pertains to a method for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of a compound of Formula I, an N-oxide thereof or a suitable salt of the compound (e.g., as a composition described herein). This invention also relates to such a method wherein the invertebrate pest or its environment is contacted with a biologically effective amount of a compound of Formula I or a composition comprising a compound of Formula I, an N-oxide thereof or a suitable salt of the compound and a biologically effective amount of at least one additional compound or agent for controlling invertebrate pests.
This invention also pertains to a composition for controlling an invertebrate pest comprising a biologically effective amount of a compound of Formula I, an N-oxide thereof or a suitable salt of the compound and at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents. This invention also pertains to a composition comprising a biologically effective amount of a compound of Formula I, an N-oxide thereof or a suitable salt of the compound and an effective amount of at least one additional biologically active compound or agent.
DETAILS OF THE INVENTION In the above recitations, the term "alkyl", used either alone or in compound words such as "alkylthio" or "haloalkyl" includes straight-chain or branched alkyl, such as, methyl, ethyl, 7 -propyl, /-propyl, or the different butyl, pentyl or hexyl isomers. "Alkenyl" includes straight-chain or branched alkenes such as ethenyl, 1-propenyl, 2-propenyl, and the different butenyl, pentenyl and hexenyl isomers. "Alkenyl" also includes polyenes such as 1,2-propadienyl and 2,4-hexadienyl. "Alkynyl" includes straight-chain or branched alkynes such as ethynyl, 1-propynyl, 2-propynyl and the different butynyl, pentynyl and hexynyl isomers. "Alkynyl" can also include moieties comprised of multiple triple bonds such as 2,5-hexadiynyl. "Alkoxy" includes, for example, methoxy, ethoxy, Λ-propyloxy, isopropyloxy and the different butoxy, pentoxy and hexyloxy isomers. "Alkoxyalkyl" denotes alkoxy substitution on alkyl. Examples of "alkoxyalkyl" include CH3OCH2, CH3OCH2CH2, CH3CH2OCH2, CH3CH2CH2CH2OCH2 and CH3CH2OCH2CH2. "Alkylthio" includes branched or straight-chain alkylthio moieties such as methylthio, ethylthio, and the different propylthio and butylthio isomers. "Alkylsulfinyl" includes both enantiomers of an alkylsulfinyl group. Examples of "alkylsulfinyl" include CH3S(O), CH3CH2S(O), CH3CH2CH2S(O), (CH3)2CHS(O) and the different butylsulfinyl isomers. Examples of "alkylsulfonyl" include CH3S(O)2, CH3CH2S(O)2, CH3CH2CH2S(O)2, (CH3)2CHS(O)2 and the different butylsulfonyl isomers. "Alkylamino", "dialkylamino", "alkenylthio", "alkenylsulfinyl", "alkenylsulfonyl", "alkynylthio", "alkynylsulfinyl", "alkynylsulfonyl", and the like, are defined analogously to the above examples. "Cycloalkyl" includes, for example, cyclopropyl, cyclobutyl, cyclopentyl, and cyclohexyl. "Aromatic" indicates that each of the ring atoms is essentially in the same plane and has ap-orbital perpendicular to the ring plane, and in which (4n + 2) π electrons, when n is 0 or a positive integer, are associated with the ring to comply with Hϋckel's rule. The term "aromatic ring system" denotes fully unsaturated carbocycles and heterocycles in which at least one ring of a polycyclic ring system is aromatic. The term "aromatic carbocyclic ring or ring system" includes fully aromatic carbocycles and carbocycles in which at least one ring of a polycyclic ring system is aromatic (e.g. phenyl and naphthyl). The term "nonaromatic carbocyclic ring or ring system" denotes fully saturated carbocycles as well as partially or fully unsaturated carbocycles where the Hϋckel rule is not satisfied by any of the rings in the ring system. The term "hetero" in connection with rings or ring systems refers to a ring or ring system in which at least one ring atom is not carbon and which can contain 1 to 4 heteroatoms independently selected from the group consisting of nitrogen, oxygen and sulfur, provided that each ring contains no more than 4 nitrogens, no more than 2 oxygens and no more than 2 sulfurs. The terms "heteroaromatic ring or ring system" and "aromatic fused heterobicyclic ring system" includes fully aromatic heterocycles and heterocycles in which at least one ring of a polycyclic ring system is aromatic (where aromatic indicates that the Hϋckel rule is satisfied). The term "nonaromatic heterocyclic ring or ring system" denotes fully saturated heterocycles as well as partially or fully unsaturated heterocycles where the Hϋckel rule is not satisfied by any of the rings in the ring system. The heterocyclic ring or ring system can be attached through any available carbon or nitrogen by replacement of a hydrogen on said carbon or nitrogen. The term "halogen", either alone or in compound words such as "haloalkyl", includes fluorine, chlorine, bromine or iodine. Further, when used in compound words such as "haloalkyl", said alkyl may be partially or fully substituted with halogen atoms which may be the same or different. Examples of "haloalkyl" include F3C, C1CH2, CF3CH2 and CF3CC12. The terms "haloalkenyl", "haloalkynyl", "haloalkoxy", "haloalkylthio", and the like, are defined analogously to the term "haloalkyl". Examples of "haloalkenyl" include (C1)2C=CHCH2 and CF3CH2CH=CHCH2. Examples of "haloalkynyl" include HC≡CCHCl, CF3C≡C, CC13C≡C and FCH2C≡CCH2. Examples of "haloalkoxy" include CF3O, CCl3CH2O, HCF2CH2CH2O and CF3CH2O. Examples of "haloalkylthio" include CC13S, CF3S, CC13CH2S and C1CH2CH2CH2S. Examples of "haloalkylsulfinyl" include CF3S(O), CCl3S(O), CF3CH2S(O) and CF3CF2S(O). Examples of "haloalkylsulfonyl" include CF3S(O)2, CCl3S(O)2, CF3CH2S(O)2 and CF3CF2S(O)2.
Examples of "alkylcarbonyl" include C(O)CH3, C(O)CH2CH2CH3 and C(O)CH(CH3)2. Examples of "alkoxycarbonyl" include CH3OC(=O), CH3CH2OC(=O), CH3CH2CH2OC(=O), (CH3)2CHOC(=O) and the different butoxy- or pentoxycarbonyl isomers. Examples of "alkylaminocarbonyl" include CH3NHC(=O), CH3CH2NHC(=O), CH3CH2CH2NHC(=O), (CH3)2CHNHC(=O) and the different butylamino- or pentylaminocarbonyl isomers. Examples of "dialkylaminocarbonyl" include (CH3)2NC(=O), (CH3CH2)2NC(=O), CH3CH2(CH3)NC(=O), CH3CH2CH2(CH3)NC(=O) and (CH3)2CHN(CH3)C(=O).
The total number of carbon atoms in a substituent group is indicated by the "Cj-Cj" prefix where i and j are numbers from 1 to 6. For example, C]-C3 alkylsulfonyl designates methylsulfonyl through propylsulfonyl; C2 alkoxyalkyl designates CH3OCH2; C3 alkoxyalkyl designates, for example, CH3CH(OCH3), CH3OCH2CH2 or CH3CH2OCH2; and C4 alkoxyalkyl designates the various isomers of an alkyl group substituted with an alkoxy group containing a total of four carbon atoms, examples including CH3CH2CH2OCH2 and CH3CH2OCH2CH2.
In the above recitations, when a compound of Formula I is comprised of one or more heterocyclic rings, all substituents are attached to these rings through any available carbon or nitrogen by replacement of a hydrogen on said carbon or nitrogen.
When a compound is substituted with a substituent bearing a subscript that indicates the number of said substituents can exceed 1, said substituents (when they exceed 1) are independently selected from the group of defined substituents. Further, when the subscript indicates a range, e.g. (R)i_j, then the number of substituents may be selected from the integers between i and j inclusive.
The term "optionally substituted with one to three substituents" and the like indicates that one to three of the available positions on the group may be substituted. When a group contains a substituent which can be hydrogen, for example R1 or R5, then, when this substituent is taken as hydrogen, it is recognized that this is equivalent to said group being unsubstituted.
Compounds of this invention can exist as one or more stereoisomers. The various stereoisomers include enantiomers, diastereomers, atropisomers and geometric isomers. One skilled in the art will appreciate that one stereoisomer may be more active and/or may exhibit beneficial effects when enriched relative to the other stereoisomer(s) or when separated from the other stereoisomer(s). Additionally, the skilled artisan knows how to separate, enrich, and/or to selectively prepare said stereoisomers. Accordingly, the present invention comprises compounds selected from Formula I, N-oxides and agriculturally suitable salts thereof. The compounds of the invention may be present as a mixture of stereoisomers, individual stereoisomers, or as an optically active form.
One skilled in the art will appreciate that not all nitrogen containing heterocycles can form N-oxides since the nitrogen requires an available lone pair for oxidation to the oxide; one skilled in the art will recognize those nitrogen containing heterocycles which can form N-oxides. One skilled in the art will also recognize that tertiary amines can form N-oxides. Synthetic methods for the preparation of N-oxides of heterocycles and tertiary amines are very well known by one skilled in the art including the oxidation of heterocycles and tertiary amines with peroxy acids such as peracetic and m-chloroperbenzoic acid (MCPBA), hydrogen peroxide, alkyl hydroperoxides such as t-butyl hydroperoxide, sodium perborate, and dioxiranes such as dimethydioxirane. These methods for the preparation of N-oxides have been extensively described and reviewed in the literature, see for example: T. L. Gilchrist in Comprehensive Organic Synthesis, vol. 7, pp 748-750, S. V. Ley, Ed., Pergamon Press; M. Tisler and B. Stanovnik in Comprehensive Heterocyclic Chemistry, vol. 3, pp 18-20, A. J. Boulton and A. McKillop, Eds., Pergamon Press; M. R. Grimmett and B. R. T. Keene in Advances in Heterocyclic Chemistry, vol. 43, pp 149-161, A. R. Katritzky, Ed., Academic Press; M. Tisler and B. Stanovnik in Advances in Heterocyclic Chemistry, vol. 9, pp 285-291, A. R. Katritzky and A. J. Boulton, Eds., Academic Press; and G. W. H. Cheeseman and E. S. G. Werstiuk in Advances in Heterocyclic Chemistry, vol. 22, pp 390-392, A. R. Katritzky and A. J. Boulton, Eds., Academic Press. The salts of the compounds of the invention include acid-addition salts with inorganic or organic acids such as hydrobromic, hydrochloric, nitric, phosphoric, sulfuric, acetic, butyric, fumaric, lactic, maleic, malonic, oxalic, propionic, salicylic, tartaric, 4-toluenesulfonic or valeric acids. The salts of the compounds of the invention also include those formed with organic bases (e.g., pyridine, ammonia, or triethylamine) or inorganic bases (e.g., hydrides, hydroxides, or carbonates of sodium, potassium, lithium, calcium, magnesium or barium) when the compound contains an acidic group such as a carboxylic acid or phenol. As noted above, J is a phenyl ring, a naphthyl ring system, a 5- or 6-membered heteroaromatic ring or an aromatic 8-, 9- or 10-membered fused heterobicyclic ring system wherein each ring or ring system is optionally substituted with 1 to 4 R5. The term "optionally substituted" in connection with these J groups refers to groups which are unsubstituted or have at least one non-hydrogen substituent that does not extinguish the biological activity possessed by the unsubstituted analog. An example of phenyl optionally substituted with 1 to 4 R5 is the ring illustrated as U-1 in Exhibit 1, wherein Rv is R5 and r is an integer from 1 to 4. An example of a naphthyl group optionally substituted with 1 to 4 R5 is illustrated as U-85 in Exhibit 1, wherein Rv is R5 and r is an integer from 1 to 4. Examples of 5- or 6-membered heteroaromatic rings optionally substituted with 1 to 4 R5 include the rings U-2 through U-53 illustrated in Exhibit 1 wherein Rv is R5 and r is an integer from 1 to 4. Note that J-l through J-13 below also denote 5- or 6-membered heteroaromatic rings. Note that U-2 through U-20 are examples of J-l, U-21 through U-35 and U-40 are examples of J-2, U-36 through U-39 are examples of J-3, U-41 through U-48 are examples of J-4 and U-49 through U-53 are examples of J-5. Note that J-6 is a subset of U-11, J-7 or J-10 are a subset of U-26, J-8 is a subset of U-42, J-9 is a subset of U-45, J-l 1 is a subset of U-4 and J-l 2 or J-13 are a subset of U-24. Also note that in J-6 through J-13 that R7 and R9 are subsets of R5. Examples of aromatic 8-, 9- or 10-membered fused heterobicyclic ring systems optionally substituted with 1 to 4 R5 include U-54 through U-84 illustrated in Exhibit 1 wherein Rv is R5 and r is an integer from 1 to 4.
Although Rv groups are shown in the structures U-1 through U-85, it is noted that they do not need to be present since they are optional substituents. Note that when Rv is H when attached to an atom, this is the same as if said atom is unsubstituted. The nitrogen atoms that require substitution to fill their valence are substituted with H or Rv. Note that some U groups can only be substituted with less than 4 Rv groups (e.g. U-14, U-15, U-18 through
U-21 and U-32 through U-34 can only be substituted with one Rv). Note that when the attachment point between (Rv)r and the U group is illustrated as floating, (Rv)r can be attached to any available carbon atom of the U group. Note that when the attachment point on the U group is illustrated as floating, the U group can be attached to the remainder of Formula I through any available carbon of the U group by replacement of a hydrogen atom.
Exhibit 1
Figure imgf000009_0001
Figure imgf000010_0001
1 U-22 U-23 U-24 U-25 U-26
Figure imgf000010_0002
Figure imgf000010_0003
ΛXΛ
U-32 U-33 U-34 U-35 U-36 U-37
Figure imgf000010_0004
U-38 U-39 U-40 U-41 U-42
Figure imgf000011_0001
U-54
U-53 U-55 U-56
Figure imgf000011_0002
U-65 U-66 u-67 U-68
Figure imgf000011_0003
Figure imgf000012_0001
U-77 U-78 U-79 U-80
Figure imgf000012_0002
As noted above, K is, together with the two contiguous linking carbon atoms, a 5- or 6- membered heteroaromatic ring optionally substituted with 1 to 3 R4. Examples of said K rings wherein said rings are optionally substituted with 1 to 3 R4 include the ring systems illustrated as K-l to K-37 in Exhibit 2, wherein n is an integer from 1 to 3 and R4 is as defined above. The term "optionally substituted" in connection with these K groups refers to K groups which are unsubstituted or have at least one non-hydrogen substituent that does not extinguish the biological activity possessed by the unsubstituted analog. As with the carbon atoms in the ring, the nitrogen atoms that require substitution to fill their valence are substituted with hydrogen or with R4. Although (R4)n groups are shown in the structures K-l to K-37, it is noted that R4 does not need to be present since it is an optional substituent. Note that some K groups can only be substituted with less than 3 R4 groups (e.g. K-7 through K-10, K-l 5, K-16, K-20, K-21, K-23, K-24, K-26 and K-27 can only be substituted with one R4). In the exemplified K groups, the upper right bond is attached through the available linking carbon atom to the nitrogen atom of the NR](=A)J portion of Formula I and the lower right bond is attached through the available linking carbon atom to the carbon atom of the C(=B)NR2R3 portion of Formula I. The wavy line indicates that the K ring is attached to the remainder of Formula I as illustrated below.
Figure imgf000013_0001
Exhibit 2
Figure imgf000013_0002
K-l l K-12
Figure imgf000013_0003
Figure imgf000014_0001
K-28 K-29 K-30 K-31
Figure imgf000014_0002
K-36 K-37
Preferred K rings include optionally substituted thiophene, isoxazole, isothiazole, pyrazole, pyridine and pyrimidine rings. More preferred K rings include K-l, K-l 4, K-l 5, K-l 8, K-23, K-28, K-29, K-30, K-31 and K-33. Most preferred are K-28, K-31 and K-33. As noted above, R3 can be (among others) C]-C6 alkyl, C2-Cg alkenyl, C2-C6 alkynyl, C3- cycloalkyl, each optionally substituted with one or more substituents selected from the group consisting of a phenyl ring, or 5- or 6-membered heteroaromatic ring, each ring optionally substituted with one to three substituents independently selected from R6. Examples of such rings incorporated into said R3 groups include the rings illustrated as U-1 through U-53 and U-86 illustrated in Exhibit 1, except that such rings are optionally substituted with 1 to 3 substituents independently selected from R6 rather than (Rv)r and are attached to an R3 group selected from the list immediately above.
As noted above, R3 can be (among others) G, or Cj-C6 alkyl, C2-C6 alkenyl, C2-Cg alkynyl, C3-C6 cycloalkyl, each optionally substituted with G; wherein G is a 5- or
6-membered nonaromatic carbocyclic or heterocyclic ring, optionally including one or two ring members selected from the group consisting of C(=O), SO or S(O)2 and optionally substituted with 1 to 4 substituents selected from R12. The term "optionally substituted" in connection with these G groups refers to groups which are unsubstituted or have at least one non-hydrogen substituent that does not extinguish the biological activity possessed by the unsubstituted analog. Note that when the attachment point on the G group is illustrated as floating, the G group can be attached to the remainder of Formula I through any available carbon of the G group by replacement of a hydrogen atom. The optional substituents can be attached to any available carbon by replacing a hydrogen atom. Examples of 5- or 6- membered nonaromatic carbocyclic rings as G include the rings illustrated as G-1 through G-8 of Exhibit 3. Examples of 5- or 6-membered nonaromatic heterocyclic rings as G include the rings illustrated as G-9 through G-48 of Exhibit 3. Note that when G comprises a ring selected from G-31 through G-34, G-37 and G-38, Q1 is selected from O, S or N. Note that when G is G-11, G13, G-14, G16, G-23, G-24, G-30 through G-34, G-37 and G-38 and Q1 is N, the nitrogen atom can complete its valence by substitution with either H or Cι-C alkyl.
Exhibit 3
Figure imgf000015_0001
G-1 G-2 G-3 G-4 G-5
Figure imgf000015_0002
Figure imgf000016_0001
G-32 G-33
G-30 G-31 G-34
Figure imgf000016_0002
G-35 G-36 G-37 G-38
As noted above, each R4 can be independently (among others) a phenyl, benzyl, phenoxy or 5- or 6-membered heteroaromatic ring, each ring optionally substituted with one to three substituents independently selected from R6. Examples of such R4 groups include the rings or ring systems illustrated as U-1 through U-53, U-86 and U-87 illustrated in Exhibit 1, except that such rings are optionally substituted with 1 to 3 substituents independently selected from R6 rather than (Rv)r.
As noted above, each R5 can be independently (among others) a phenyl, benzyl, benzoyl, phenoxy, 5- or 6-membered heteroaromatic ring or an aromatic 8-, 9- or 10- membered fused heterobicyclic ring system, each ring optionally substituted with one to three substituents independently selected from R6. Examples of such R5 groups include the rings or ring systems illustrated as U-1 through U-88 illustrated in Exhibit 1, except that such rings are optionally substituted with 1 to 3 substituents independently selected from R6 rather than (R )r.
Preferred compounds for reasons of better activity and or ease of synthesis are: Preferred 1. Compounds of Formula I above, and N-oxides and suitable salts thereof, wherein A and B are both O and J is a phenyl ring optionally substituted with 1 to 4 R5. Preferred 2. Compounds of Preferred 1 wherein each R4 is independently CrC alkyl, C]-C4 haloalkyl, halogen, CΝ, ΝO or C C4 alkoxy, and one R4 group is attached to the K ring at the atom adjacent to either the NRJC(=A)J moiety or the C(=B)NR2R3 moiety; and each R5 is independently H, halogen, CrC4 alkyl, Cj-C2 alkoxy, CrC4 haloalkyl, CN, NO2, CrC4 haloalkoxy, CrC4 alkylthio, CrC4 alkylsulfinyl, CrC4 alkylsulfonyl, CrC4 haloalkylthio, CrC4 haloalkylsulfinyl, Cι-C4 haloalkylsulfonyl or C2-C alkoxycarbonyl; or each R5 is independently a phenyl or a 5- or 6-membered heteroaromatic ring, each ring optionally substituted with one to three substituents independently selected from R6; or (R5)2 when attached to adjacent carbon atoms can be taken together as -OCF2O-, -CF2CF2O- or -OCF2CF2O-.
Preferred 3. Compounds of Preferred 2 wherein R1 is H; R2 is H or CH3;
R3 is C]-C4 alkyl optionally substituted with one or more substituents independently selected from halogen, CN, OCH3 or S(O)pCH3; each R4 is independently CH3, CF3, CN or halogen, and one R4 group is attached to the K ring at the atom adjacent to the NR!C(=A)J moiety; each R5 is independently H, halogen, methyl, CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, OCH2CF3, OCF2CHF2, S(O)pCH2CF3 or S(O)pCF2CHF2; or a phenyl, pyrazole, imidazole, triazole, pyridine or pyrimidine ring, each ring optionally substituted with one to three substituents independently selected from CpC alkyl, Cj-C haloalkyl, halogen or CN; and p is 0, 1 or 2. Preferred 4. Compounds of Preferred 3 wherein R3 is Cj-C4 alkyl.
Preferred 5. Compounds of Formula I wherein A and B are both O; J is a 5- or 6-membered heteroaromatic ring selected from the group consisting of J-l, J-2, J-3, J-4 and J-5, each J optionally substituted with 1 to 3 R5
Figure imgf000017_0001
J-l J-2 J-3 J-4 J-5
Q is O, S or NR5; and
W, X, Y and Z are independently N or CR5, provided that in J-4 and J-5 at least one of W, X, Y or Z is N. Preferred 6. Compounds of Preferred 5 wherein each R4 is independently CrC4 alkyl, C C4 haloalkyl, halogen, CN, NO2 or
C]-C4 alkoxy, and one R4 group is attached to the K ring at the atom adjacent to either the NR*C(=A)J moiety or the C(=B)NR2R3 moiety; and each R5 is independently H, CrC alkyl, Cj-C haloalkyl, halogen, CN, NO2, C C4 haloalkoxy, C C alkylthio, C C alkylsulfinyl, Cj-C alkylsulfonyl, C C4 haloalkylthio, Cι-C4 haloalkylsulfinyl, C\-C4 haloalkylsulfonyl or C2-C4 alkoxycarbonyl; or a phenyl or a 5- or 6-membered heteroaromatic ring, each ring optionally substituted with R6. Preferred 7. Compounds of Preferred 6 wherein
J substituted with 1 to 3 R5 is selected from the group consisting of J-6, J-7, J-8, J-9, J-10, J-l 1, J-12 and J-13
Figure imgf000018_0001
Figure imgf000018_0002
R5 is H, CrC4 alkyl, CrC4 haloalkyl, or
Figure imgf000018_0003
V is N, CH, CF, CC1, CBr or CI; each R6 and R7 is independently H, CrC6 alkyl, C3-C6 cycloalkyl, C,-C6 haloalkyl, halogen, CN, CrC4 alkoxy, CrC4 haloalkoxy or CrC4 haloalkylthio; and R9 is H, C,-C6 alkyl, C,-C6 haloalkyl, C3-C6 alkenyl, C3-C6 haloalkenyl, C3-C6 alkynyl or C3-C6 haloalkynyl; provided R7 and R9 are not both H. Preferred 8. Compounds of Prefeπed 7 wherein V is N. Preferred 9. Compounds of Prefeπed 7 wherein V is CH, CF, CC1 or CBr.
Preferred 10. Compounds of Prefeπed 8 or Prefeπed 9 wherein R1 is H; R is H or CH3;
R3 is C C4 alkyl optionally substituted with one or more substituents independently selected from halogen, CN, OCH3 or S(O)pCH3; each R4 is independently CH3, CF3, CN or halogen, and one R4 group is attached to the K ring at the atom adjacent to the NRJC(=A)J moiety; R6 is C,-C4 alkyl, CrC4 haloalkyl, halogen or CN; R7 is H, CH3, CF3, OCH2CF3, OCHF2 or halogen; and p is 0, 1 or 2.
Prefeπed 11. Compounds of Prefeπed 10 wherein R3 is Cj-C alkyl; one R4 group is independently CH3, CI, Br or I and is attached to the K ring at the atom adjacent to the NR!C(=A)J moiety; and a second optional R4 is H, F, CI, Br, I or CF3. Prefeπed 12. Compounds of Prefeπed 11 wherein J substituted with 1 to 3 R5 is J-6; R6 is CI or Br; and R7 is halogen, OCH2CF3 or CF3.
Prefeπed 13. Compounds of Prefeπed 12 wherein V is N; R3 is methyl, ethyl, isopropyl, tertiary butyl or N(CH3)2; and R7 is Br, CI, OCH2CF3 or CF3. Prefeπed 14. Compounds of Prefeπed 11 wherein J substituted with 1 to 3 R5 is J-7; R6 is CI or Br; and R9 is CF3, CHF2, CH2CF3 or CF2CHF2. Prefeπed 15. Compounds of Prefeπed 11 wherein J substituted with 1 to 3 R5 is J-8;
R6 is CI or Br; and R7 is halogen, OCH2CF3 or CF3. Prefeπed 16. Compounds of Prefeπed 11 wherein J substituted with 1 to 3 R5 is J-9;
R6 is CI or Br; and R7 is OCH2CF3 or CF3. Preferred 17. Compounds of Prefeπed 11 wherein J substituted with 1 to 3 R5 is J-10; R6 is CI or Br; and R9 is CF3, CHF2, CH2CF3 or CF2CHF2.
Preferred 18. Compounds of Prefeπed 11 wherein J substituted with 1 to 3 R5 is J-l 1;
R6 is CI or Br; and R7 is halogen, OCH2CF3, or CF3. Preferred 19. Compounds of Prefeπed 11 wherein J substituted with 1 to 3 R5 is J-l 2; R6 is CI or Br; R7 is H, halogen or CF3, and R9 is H, CF3, CHF2, CH2CF3, or CF2CHF2.
Prefeπed 20. Compounds of Prefeπed 11 wherein J substituted with 1 to 3 R5 is J-13; R6 is CI or Br; R7 is H, halogen or CF3, and R9 is H, CF3, CHF2, CH2CF3 or CF2CHF2. Most prefeπed is the compound of Formula I selected from the group consisting of:
4-[[[l-(2-Chlorophenyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]carbonyl]amino]-5- methyl-N- 1 -methylethyl)-3 -pyridincarboxamide,
4-Methyl-N-(l-methylethyl)-3-[[2-methyl-4-(trifluoromethyl)benzoyl]amino]-2- thiophencarboxamide, l-Methyl-N-(l-methylethyl)-5-[[4-(trifluoromethyl)benzoyl]amino]-lH-pyrazole-4- carboxamide;
4-[[[3-Bromo- 1 -(3-chloro-2-pyridinyl)- lH-pyrazol-5-yl]carbonyl]amino]-5-chloro- N-methyl-3 -pyridinecarboxamide ; 3-[[[3-Bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]carbonyl]amino]-2,6- dichloro-N-methyl-4-pyridinecarboxamide;
2,6-dichloro-3 -[ [[ 1 -(3 -chloro-2-pyridinyl)-3 -(trifluoromethyl)- 1 H-pyrazol-5- yl] carbonyl] amino] -N-( 1 -methylethyl)- 4-pyridinecarboxamide; 3-[[[3-Bromo- 1 -(3-chloro-2-pyridinyl)- lH-pyrazol-5-yl]carbonyl]amino]-6-chloro- N,4-dimethyl-2 -pyridinecarboxamide;
3-[[[3-Bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]carbonyl]amino]-4,6- dichloro-N-methyl-2 -pyridinecarboxamide;
5 - [ [[3 -Chloro- 1 -(3 -chloro-2-pyridinyl)- 1 H-pyrazol-5 -yl]carbonyl] amino] -N,6- dimethyl-4-pyrimidinecarboxamide; and 5-[[[3-Bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]carbonyl]amino]-NN,2,6- tetramethyl-4-pyridinecarboxamide. This invention also pertains to a composition for controlling an invertebrate pest comprising a biologically effective amount of a compound of Formula I, an N-oxide thereof or a suitable salt thereof and at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents. This invention also pertains to a composition comprising a biologically effective amount of a compound of Formula I, an N-oxide thereof or a suitable salt thereof and an effective amount of at least one additional biologically active compound or agent. The prefeπed compositions of the present invention are those which comprise the above prefeπed compounds. This invention also pertains to a method for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of a compound of Formula I, an N-oxide thereof or a suitable salt thereof (e.g., as a composition described herein). This invention also relates to such a method wherein the invertebrate pest or its environment is contacted with a biologically effective amount of a compound of Formula I or a composition comprising a compound of Formula I, an N-oxide thereof or a suitable salt thereof and a biologically effective amount of at least one additional compound or agent for controlling invertebrate pests. The prefeπed methods of use are those involving the above prefeπed compounds. Of note are compounds of Formula 1 (a subset of Formula I) and N-oxides or suitable salts thereof
Figure imgf000021_0001
wherein A and B are independently O or S; each J is independently a phenyl ring, a naphthyl ring system, a 5- or 6-membered heteroaromatic ring or an aromatic 8-, 9- or 10-membered fused heterobicyclic ring system wherein each ring or ring system is optionally substituted with 1 to 4
R5; K is, together with the two contiguous linking carbon atoms, a 5- or 6-membered heteroaromatic ring optionally substituted with 1 to 3 R4; n is 1 to 3; R1 is H; or Cj-C6 alkyl, C2-Cg alkenyl, C2-C6 alkynyl or C3-C6 cycloalkyl each optionally substituted with one or more substituents selected from the group consisting of halogen, CΝ, ΝO2, hydroxy, C j -C4 alkoxy, C j -C4 alkylthio, C 1 -C4 alkylsulfinyl, C]-C4 alkylsulfonyl, C2-C4 alkoxycarbonyl, Cj-C4 alkylamino,
C2-C8 dialkylamino and C3-C6 cycloalkylamino; or R1 is C2-C6 alkylcarbonyl, C2-C6 alkoxycarbonyl, C2-Cg alkylaminocarbonyl, C3-C8 dialkylaminocarbonyl or C(=A)J; R2 is H, CrC6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, CrC4 alkoxy,
Cj-C4 alkylamino, C2-C dialkylamino, C3-Cg cycloalkylamino, C -Cg alkoxycarbonyl or C2-Cg alkylcarbonyl; R3 is H; G; CrC6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, each optionally substituted with one or more substituents selected from the group consisting of halogen, G, CN, NO2, hydroxy, Cj-C4 alkoxy, Cι-C4 haloalkoxy,
CrC4 alkylthio, CrC4 alkylsulfinyl, CrC4 alkylsulfonyl, C2-C6 alkoxycarbonyl, C2-C6 alkylcarbonyl, C3-C6 trialkylsilyl, or a phenyl, phenoxy or 5- or 6-membered heteroaromatic ring, each ring optionally substituted with one to three substituents independently selected from the group consisting of CrC4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, C3-C6 cycloalkyl, CrC4 haloalkyl, C -C4 haloalkenyl, C2-C4 haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, NO2, Cj-C4 alkoxy, Cj-C4 haloalkoxy, C C4 alkylthio, Cι~C alkylsulfinyl, Cj-C4 alkylsulfonyl, C C4 alkylamino, C2-C8 dialkylamino, C3-C6 cycloalkylamino, C3-C6 (alkyl)cycloalkylamino, C2-C alkylcarbonyl, C2-Cg alkoxycarbonyl, C2-Cg alkylaminocarbonyl, C3-C dialkylaminocarbonyl or
C3-C6 trialkylsilyl; C C4 alkoxy; C]-C alkylamino; C2-C8 dialkylamino; C3-C6 cycloalkylamino; C2-C6 alkoxycarbonyl or C2-Cg alkylcarbonyl; or R2 and R3 can be taken together with the nitrogen to which they are attached to form a ring containing 2 to 6 atoms of carbon and optionally one additional atom of nitrogen, sulfur or oxygen, said ring may be optionally substituted with 1 to 4 substituents selected from the group consisting of Cj-C2 alkyl, halogen, CN, NO2 and Cj-C alkoxy; G is a 5- or 6-membered nonaromatic carbocyclic or heterocyclic ring, optionally including one or two ring members selected from the group consisting of C(=O), SO or S(O)2 and optionally substituted with 1 to 4 substituents selected from the group consisting of C]-C2 alkyl, halogen, CN, NO2 and C C2 alkoxy; each R4 is independently H, CrC6 alkyl, C2-Cg alkenyl, C2-Cg alkynyl, C3-C6 cycloalkyl, C C6 haloalkyl, C2-C6 haloalkenyl, C2-C6 haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, NO2, hydroxy, C C4 alkoxy, Cj-C4 haloalkoxy, C j -C4 alkylthio, C l -C4 alkylsulfinyl, C { -C4 alkylsulfonyl, C l -C4 haloalkylthio,
Cj-C4 haloalkylsulfinyl, CrC haloalkylsulfonyl, Cj-C4 alkylamino, C2-C8 dialkylamino, C3-C6 cycloalkylamino, or C3-C6 trialkylsilyl; or each R4 is independently phenyl, benzyl or phenoxy, each optionally substituted with CrC4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, C3-C6 cycloalkyl, CrC4 haloalkyl, C2-C haloalkenyl, C2-C4 haloalkynyl, C3-C6 halocycloalkyl, halogen, CN,
NO2, C C4 alkoxy, C]-C4 haloalkoxy, Cj-C4 alkylthio, C]-C4 alkylsulfinyl, Cj-C alkylsulfonyl, Cj-C4 alkylamino, C -C8 dialkylamino, C3-C6 cycloalkylamino, C3-Cg (alkyl)cycloalkylamino, C2-C4 alkylcarbonyl, C2-Cg alkoxycarbonyl, C2-C6 alkylaminocarbonyl, C3-Cg dialkylaminocarbonyl or C3-C6 trialkylsilyl; each R5 is independently H, C C6 alkyl, C2-Cg alkenyl, C2-Cg alkynyl, C3-C6 cycloalkyl, Cj-C6 haloalkyl, C2-C6 haloalkenyl, C2-C6 haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, CO2H, CONH2, NO2, hydroxy, C,-C4 alkoxy, C}-C haloalkoxy, Cj-C alkylthio, Cj-C alkylsulfinyl, Cj-C alkylsulfonyl, CrC4 haloalkylthio, CrC4 haloalkylsulfinyl, CrC4 haloalkylsulfonyl, CrC4 alkylamino, C2-C8 dialkylamino, C3-C6 cycloalkylamino, C2-C6 alkylcarbonyl, C2-C6 alkoxycarbonyl, C2-Cg alkylaminocarbonyl, C3-C8 dialkylaminocarbonyl, C3-C6 trialkylsilyl; or each R5 is independently a phenyl, benzyl, benzoyl, phenoxy, 5- or 6-membered heteroaromatic ring or an aromatic 8-, 9- or 10-membered fused heterobicyclic ring system, each ring optionally substituted with one to three substituents independently selected from the group consisting of CpC4 alkyl, C2-C alkenyl, C2-C alkynyl, C3-C6 cycloalkyl, Cj-C haloalkyl, C2-C4 haloalkenyl, C2-C4 haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, NO2, Cj-C alkoxy, CrC4 haloalkoxy, CrC alkylthio, C alkylsulfinyl, Cj-C4 alkylsulfonyl, Cj-C4 alkylamino, C2-C8 dialkylamino, C3- cycloalkylamino, C3-C6 (alkyl)cycloalkylamino, C2-C4 alkylcarbonyl, C2-Cg alkoxycarbonyl, C2-Cg alkylaminocarbonyl, C3-C8 dialkylaminocarbonyl or C3-C6 trialkylsilyl; or
(R5)2 when attached to adjacent carbon atoms can be taken together as -OCF2O-,
-CF2CF2O-, or -OCF2CF2O-. Also of note are selected compounds for reasons of cost, ease of synthesis and/or biological efficacy: Selection A. Compounds of Formula 1 wherein K is, together with the two linking atoms, a thiophene, pyrazole, isoxazole, pyridine or pyrimidine optionally substituted with 1 to 3 R4. Selection B. Compounds of Selection A wherein J is independently a phenyl ring or a 5- or 6-membered heteroaromatic ring wherein each ring is optionally substituted with 1 to 2 R5.
Selection C. Compounds of Selection A wherein
J is a phenyl ring or a 5- or 6-membered heteroaromatic ring selected from the group consisting of J-l, J-2, J-3, J-4 and J-5, each ring optionally substituted with 1 to 3 R5
Figure imgf000023_0001
J-l J-2 J-3
Figure imgf000023_0002
J-4 J-5
Q is O, S or NR5; and
W, X, Y and Z are independently N or CR5, provided that in J-4 and J-5 at least one of W, X, Y or Z is N. Selection D. Compounds of Selection B or Selection C wherein A and B are both O; n is 1 to 2;
R1 is H, CrC4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, C3-C6 cycloalkyl, C2-C6 alkylcarbonyl or C2-C6 alkoxycarbonyl;
R2 is H, C]-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, C3-C6 cycloalkyl, C2-C6 alkylcarbonyl or C2-Cg alkoxycarbonyl; R3 is Cj-Cg alkyl, 2-C alkenyl, C2-C6 alkynyl or C3-C6 cycloalkyl each optionally substituted with one or more substituents selected from the group consisting of halogen, CN, C \ -C2 alkoxy, C ι -C2 alkylthio, C j -C alkylsulfinyl and
Figure imgf000024_0001
alkylsulfonyl; one of the R4 groups is attached to the heteroaromatic ring at one of the two positions ortho to the two linking atoms, and said R4 is Cj-C alkyl, Cj-C haloalkyl, halogen, CN, NO2, Cj-C alkoxy, C C4 haloalkoxy, C i -C4 alkylthio, C -C4 alkylsulfinyl, C x -C4 alkylsulfonyl, C x -C4 haloalkylthio, Cι-C haloalkylsulfinyl or C C haloalkylsulfonyl; each R5 is independently H, C1-C4 alkyl, C1-C4 haloalkyl, halogen, CN, NO , C C haloalkoxy, Cj-C alkylthio, Cj-C alkylsulfinyl, C C4 alkylsulfonyl, Cj-C4 haloalkylthio, Cj-C4 haloalkylsulfinyl, C1-C4 haloalkylsulfonyl or C2-C4 alkoxycarbonyl; or a phenyl or a 5- or
6-membered heteroaromatic ring, each ring optionally substituted with C]-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, C3-C6 cycloalkyl, CrC4 haloalkyl, C -C4 haloalkenyl, C -C4 haloalkynyl, C3-Cg halocycloalkyl, halogen, CN, NO2, CrC4 alkoxy, C C4 haloalkoxy, Cj-C alkylthio, C1-C4 alkylsulfinyl, C C alkylsulfonyl, C C4 alkylamino, C2-C8 dialkylamino, C3-C6 cycloalkylamino, C3-C6 (alkyl)cycloalkylamino, C2-C4 alkylcarbonyl, C2-C6 alkoxycarbonyl, C2-Cg alkylaminocarbonyl, C3-C8 dialkylaminocarbonyl or C3-C6 trialkylsilyl; or (R5)2 when attached to adjacent carbon atoms can be taken together as -
OCF2O-, -CF2CF2O- or -OCF2CF2O-. Selection E. Compounds of Selection D wherein
J is selected from the group consisting of phenyl, pyridine, pyrimidine, pyrazole, imidazole, triazole, thiophene, thiazole and oxazole, furan, isothiazole and isoxazole, each optionally substituted with 1 to 2 R5.
Selection F. Compounds of Selection E wherein J is selected from the group consisting of phenyl, pyridine, pyrimidine, pyrazole, thiophene and thiazole, each optionally substituted with 1 to 2 R5;
R1 and R2 are both H; R3 is CrC4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; each R4 is independently CH3, CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2,
CN or halogen; each R5 is independently H, halogen, CH3, CF3, OCHF2, S(O)pCF3,
S(O)pCHF2, OCH2CF3, OCF2CHF2, S(O)pCH2CF3, S(O)pCF2CHF2; or phenyl, pyrazole, imidazole, triazole, pyridine or pyrimidine, each ring optionally substituted with
Figure imgf000025_0001
C]-C4 haloalkyl, C1-C4 alkoxy, C1-C4 haloalkoxy, C1-C4 alkylthio, C1-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, halogen or CN; and p is 0, 1 or 2. Selection G. Compounds of Selection F wherein R3 is C1-C4 alkyl.
Selection H. Compounds of Selection G wherein J is a phenyl optionally substituted with 1 to 2 R5. Selection I. Compounds of Selection H wherein one R5 is a phenyl optionally substituted with C1-C4 alkyl, C1-C4 haloalkyl, halogen or CN. Selection J. Compounds of Selection H wherein one R5 is a pyrazole, imidazole, triazole, pyridine or pyrimidine, each ring optionally substituted with C1-C4 alkyl, C C4 haloalkyl, halogen or CN. Selection K. Compounds of Selection I wherein J is a pyridine optionally substituted with 1 to 2 R5. Selection L. Compounds of Selection K wherein one R5 is a phenyl optionally substituted with C]-C4 alkyl, Cj-C4 haloalkyl, halogen or CN. Selection M. Compounds of Selection K wherein one R5 is a pyrazole, imidazole, triazole, pyridine or pyrimidine, each ring optionally substituted with Cj-C4 alkyl, C]-C4 haloalkyl, halogen or CN. Selection N. Compounds of Selection I wherein J is a pyrimidine optionally substituted with 1 to 2 R5. Selection O. Compounds of Selection N wherein one R5 is a phenyl optionally substituted with CrC alkyl, CrC haloalkyl, halogen or CN. Selection P. Compounds of Selection N wherein one R5 is a pyrazole, imidazole, triazole, pyridine or pyrimidine, each ring optionally substituted with Cι-C4 alkyl, C C4 haloalkyl, halogen or CN. Selection Q. Compounds of Selection I wherein J is a pyrazole optionally substituted with 1 to 2 R5. Selection R. Compounds of Selection Q wherein one R5 is a phenyl optionally substituted with Cx-C4 alkyl, CrC4 haloalkyl, halogen or CN.
Selection S. Compounds of Selection Q wherein one R5 is a pyrazole, imidazole, triazole, pyridine or pyrimidine, each ring optionally substituted with Cj-C4 alkyl, CrC4 haloalkyl, halogen or CN.
Selection T. Compounds of Selection S wherein one R5 is a pyridine optionally substituted with CrC4 alkyl, CrC haloalkyl, halogen or CN.
Most select is the compound of Formula 1 selected from the group consisting of:
4-[[[l-(2-Chlorophenyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]carbonyl]amino]-5- methyl-N- 1 -methylethyl)-3 -pyridincarboxamide,
4-Methyl-N-(l-methylethyl)-3-[[2-methyl-4-(trifluoromethyl)benzoyl]amino]-2- thiophencarboxamide, and
1 -Methyl -N-( 1 -methylethyl)-5 - [ [4-(trifluoromethyl)benzoyl] amino] - 1 H-pyrazole-4- carboxamide. The compounds of Formula I can be prepared by one or more of the following methods and variations as described in Schemes 1-19. The definitions of A, B, J, K, R1, R2, R3, R4, R5 and n in the compounds of Formulae I and 2-41 below are as defined above in the Summary of the Invention. Compounds of Formulae Ia-c, 2a-b and 4a-g are various subsets of the compounds of Formula I, 2 and 4, respectively. Of note are compounds of Formulae I, 2, 5, 6, 6a, 13, 14, 15, 40 and 41 wherein K is selected from the group consisting of optionally substituted thiophene, isoxazole, isothiazole, pyrazole, pyridine and pyrimidine rings. Also of note are compounds of Formulae I, 2, 5, 6, 6a, 13, 14, 15, 40 and 41 wherein K is K-l, K-14, K-15, K-18, K-23, K-28, K-29, K-30, K-31 and K-33. Of particular note are compounds of Formulae I, 2, 5, 6, 6a, 13, 14, 15, 40 and 41 wherein K is K-28, K-31 and K-33.
Compounds of Formula I can be prepared by procedures outlined in Schemes 1-19. A typical procedure is detailed in Scheme 1 and involves coupling of an ortho amino carboxylic acid amide of Formula 2 with an acid chloride of Formula 3 in the presence of an acid scavenger to provide the compound of Formula la. Typical acid scavengers include amine bases such as triethylamine, diisopropylethylamine and pyridine; other scavengers include hydroxides such as sodium and potassium hydroxide and carbonates such as sodium carbonate and potassium carbonate. In certain instances it is useful to use polymer- supported acid scavengers such as polymer-bound diisopropylethylamine and polymer- bound dimethylaminopyridine. In a subsequent step, amides of Formula la can be converted to thioamides of Formula lb using a variety of standard thio transfer reagents including phosphorus pentasulfide and Lawesson's reagent. Scheme 1
Figure imgf000027_0001
An alternate procedure for the preparation of compounds of Formula la involves coupling of an amide of Formula 2 with an acid of Formula 4 in the presence of a dehydrating agent such as dicyclohexylcarbodiimide (DCC). Polymer supported reagents are useful here, such as polymer-bound cyclohexylcarbodiimide. Synthetic procedures of Schemes 1 and 2 are only representative examples of useful methods for the preparation of Formula I compounds as the synthetic literature is extensive for this type of reaction.
Scheme 2
+ °γ-J dehydrative coupling reagent^
OH la
4
One skilled in the art will also realize that acid chlorides of Formula 3 may be prepared from acids of Formula 4 by numerous well-known methods.
An alternate procedure for the preparation of compounds of Formula la involves coupling of an ortho amino carboxylic acid ester of Formula 5 with an acid chloride of Formula 3 by a method similar to that described in Scheme 1, followed by transformation of the ester group into an amide functionality. This transformation can be achieved by an amination with an amine of Formula 7. A Lewis acid such as frimethylaluminum as shown in Scheme 3 may catalyze this reaction.
Scheme 3
Figure imgf000027_0002
Alternatively the ester 6 can be transformed to an amide (6a) as shown in Scheme 4 by saponification with a base such as aqueous sodium hydroxide followed by dehydrative coupling with an amine of Formula 7 by a procedure similar to that described in Scheme 2.
Scheme 4
Figure imgf000028_0001
Benzoic acids of Formula 4 (J is optionally substituted phenyl) are generally well known in the art as are procedures for their preparation. One particularly useful subset of benzoic acids of this invention are 2-methyl-4-perfluoroalkyl benzoic acids of Formula 4a (R5(a) equals e.g. CF3, C2F5, C3F7). The synthesis for these compounds is outlined in Schemes 5-9. Benzoic acids of Formula 4a may be prepared from the benzonitriles of Formula 8 by hydrolysis. The conditions used may involve the use of a base such as an alkaline metal hydroxide or alkoxide (e.g. potassium or sodium hydroxide) in a solvent such as water, ethanol or ethylene glycol (e.g. J. Chem. Soc. 1948, 1025). Alternatively, the hydrolysis may be carried out using an acid such as sulfuric acid or phosphoric acid in a suitable solvent such as water (e.g. Org. Synth. 1955, Coll. vol. 3, 557). The choice of the conditions is contingent on the stability of R5 to the reaction conditions and elevated temperatures are usually employed to achieve this transformation.
Scheme 5
Figure imgf000028_0002
Nitriles of Formula 8 may be prepared from anilines of Formula 9 by the classical sequence involving diazotization and treatment of the intermediate diazonium salt with a copper cyanide salt (e.g. J. Amer. Chem. Soc. 1902, 24, 1035).
Figure imgf000029_0001
9 R5(b) is Me
Anilines of Formula 9 may be prepared from compounds of Formula 10. This transformation may be achieved by a well-known procedure that employs Raney Nickel (Org. Synth. Coll. Vol. VI, 581). Alternatively, the same transformation may be effected by the use of a suitable catalyst such as palladium in the presence of hydrogen. The reaction is usually conducted at pressures of 104 to 107 kPa in a suitable organic solvent such as, but not limited to, toluene. Elevated temperatures of 80-110 °C are usually required to achieve the transformation. As one skilled in the art will realize, numerous chemical modifications of the thioether moiety are possible, and may be employed when necessary to facilitate this transformation.
Scheme 7
Figure imgf000029_0002
10
Compounds of Formula 10 may be prepared from iminosulfuranes of Formula 11. The transformation may be achieved in a protic solvent such as methanol or water, in a non-protic solvent such as dichloromethane or toluene in the presence of a suitable base such as triethylamine (e.g. Org. Synth. Coll. Vol. VI, 581) or sodium methoxide, or in a combination of a protic solvent, a protic solvent and a base. The temperature at which the reaction is conducted is usually in the range 40-110 °C. As one skilled in the art will realize, suitable salts of compounds of Formula 11 such as, but not limited to a hydrochloride, a sulfate or a bisulfate may also be employed, provided that the appropriate amount of base is first used to generate the free base 11. This may be done as a separate step or as an integral part of the step involving the transformation of compounds of Formula 11 to compounds of Formula 10. Scheme 8
Figure imgf000030_0001
Compounds of Formula 11 may be prepared from anilines of Formula 12 by reaction with dimethyl sulfide and a suitable chlorinating agent such as, but not limited to N-chlorosuccinimide (e.g. Org. Synth. Coll. Vol. VI, 581), chlorine or N-chlorobenzotriazole. Alternatively, anilines of Formula 12 may be treated with dimethyl sulfoxide which has been "activated" by treatment with an agent such as acetic anhydride, trifluoroacetic, anhydride, trifluoromethanesulfonic anhydride, cyclohexylcarbodiimide, sulfur trioxide, or phosphorus pentoxide. The reaction is conducted in a suitable organic solvent such as dichloromethane or dimethyl sulfoxide. The reaction is conducted at a temperature of -70 °C to 25 °C and is dependent on the solvent and reagent used.
Scheme 9
Figure imgf000030_0002
Intermediate ortho amino carboxylic acid amides of Formula 2a and 2b may also be prepared from isatoic anhydrides of Formula 13 and 14 (Scheme 10). Typical procedures involve combination of equimolar amounts of the amine 7 with the isatoic anhydride in polar aprotic solvents such as pyridine and dimethylformamide at temperatures ranging from room temperature to 100 °C. R1 substituents such as alkyl and substituted alkyl may be introduced by the base catalyzed alkylation of isatoic anhydride 13 with known alkylating reagents RJ-Lg (wherein Lg is a leaving group such as halogen, alkyl or aryl suphonates or alkyl sulfates) to provide the alkyl substituted intermediates 14. Isatoic anhydrides of Formula 13 may be made by methods described in Coppola, Synthesis 1980, 505 and Fabis et al Tetrahedron, 1998, 10789. Scheme 10
Figure imgf000031_0001
14 2b (R1 is other than H)
An alternate procedure for the preparation of specific compounds of Formula I (wherein A is O, B is O and R1 is H) involves reaction of an amine 7 with a heterocyclic fused oxazinone of Formula 15. Typical procedures involve combination of the amine with the oxazinone in solvents such as tetrahydrofuran or pyridine at temperatures ranging from room temperature to the reflux temperature of the solvent. Oxazinones are well documented in the chemical literature and are available via known methods that involve the coupling of either an ortho amino carboxylic acid with an acid chloride. For references to the synthesis and chemistry of heterocyclic fused oxazinones see Jakobsen et al, Biorganic and Medicinal Chemistry, 2000, 8, 2803-2812 and references cited therein.
Scheme 11
Figure imgf000031_0002
, R1 is H)
Heterocyclic acids of Formula 4, wherein J is an optionally substituted heterocycle, can be prepared by procedures outlined in Schemes 12-17. Both general and specific references to a wide variety of heterocyclic acids including thiophenes, furans, pyridines, pyrimidines, triazoles, imidazoles, pyrazoles, thiazoles, oxazoles, isothiazoles, thiadiazoles, oxadiazoles, triazines, pyrazines, pyridazines, and isoxazoles can be found in the following compendia: Rodd's Chemistry of Chemistry of Carbon Compounds, Vol. IVa to IVL, S. Coffey editor, Elsevier Scientific Publishing, New York, 1973; Comprehensive Heterocyclic Chemistry, Vol. 1-7, A. R. Katritzky and C. W. Rees editors, Pergamon Press, New York, 1984; Comprehensive Heterocyclic Chemistry II, Vol. 1-9, A. R. Katritzky, C. W. Rees, and E. F. Scriven editors, Pergamon Press, New York, 1996; and the series, The Chemistry of Heterocyclic Compounds, E. C. Taylor, editor, Wiley, New York. Particularly useful heterocyclic acids of this invention include pyridine acids, pyrimidine acids and pyrazole acids. Procedures for the synthesis of representative examples of each are detailed in Schemes 12-17. A variety of heterocyclic acids and general methods for their synthesis may be found in World Patent Application WO 98/57397.
The synthesis of representative pyridine acids (4b) is depicted in Scheme 12. This procedure involves the known synthesis of pyridines from β-ketoesters and 4- aminobutenones (19). Substituent groups R5(a) and R5(b) include e.g. alkyl and haloalkyl.
Scheme 12
Figure imgf000032_0001
4b 20
The synthesis of representative pyrimidine acids (4c) is depicted in Scheme 13. This procedure involves the known synthesis of pyrimidines from vinylidene-β-ketoesters (22) and amidines. Substituent groups R5(a) and R5(b) include e.g. alkyl and haloalkyl. Scheme 13
Figure imgf000033_0001
23 4c
The synthesis of representative pyrazole acids (4d-4g) is depicted in Schemes 14-17. Pyrazoles 4d are described in Scheme 14. The synthesis of Scheme 14 involves as the key step introduction of the R5(b) substituent via alkylation of the pyrazole. The alkylating agent R5(b)-Lg (wherein Lg is a leaving group such as CI, Br, I, sulfonates such as p- toluenesulfonate or methanesulfonate or sulfates such as -SO2OR7(b)) includes R7(b) groups such as Cj-Cg alkyl, C2-Cg alkenyl, C -C6 alkynyl, C3-Cg cycloalkyl, CrC6 haloalkyl, C2- C6 haloalkenyl, C2-Cg haloalkynyl, C3-C6 halocycloalkyl, C2-Cg alkylcarbonyl, C2-C6 alkoxycarbonyl, C3-C dialkylaminocarbonyl, C3-C6 trialkylsilyl; or phenyl, benzyl, benzoyl, 5- or 6-membered heteroaromatic ring or an aromatic 8-, 9- or 10-membered fused heterobicyclic ring system, each ring or ring system optionally substituted. Oxidation of the methyl group affords the pyrazole carboxylic acid. Some of the more prefeπed R5(a) groups include haloalkyl.
Scheme 14
Figure imgf000033_0002
Pyrazoles 4e are described in Scheme 15. These pyrazole acids may be prepared via metallation and carboxylation of pyrazoles of formula 28 as the key step. The R5(b) group is introduced in a manner similar to that of Scheme 14, i.e. via alkylation with a R5(b) alkylating agent. Representative R5(a) groups include e.g. cyano, and haloalkyl.
Scheme 15
Figure imgf000034_0001
Pyrazoles 4f are described in Scheme 16. These can be prepared via reaction of an optionally substituted phenyl hydrazine 29 with a pyruvate 30 to yield pyrazole esters 31. Hydrolysis of the ester affords the pyrazole acids 4f. This procedure is particularly useful for the preparation of compounds where R5(b) is optionally substituted phenyl and R5(a) is haloalkyl.
Scheme 16
Figure imgf000034_0002
Pyrazoles acids of Formula 4g are described in Scheme 17. These can be prepared via 3+2 cycloaddition of an appropriately substituted nitrilimine (32) with either substituted propiolates (33) or acrylates (36). Cycloaddition with acrylates requires additional oxidation of the intermediate pyrazoline to the pyrazole. Hydrolysis of the ester affords the pyrazole acids 4g. Prefeπed iminohalides for this reaction include the trifluoromethyl iminochloride (38) and the iminodibromide (39). Compounds such as 38 are known (J. Heterocycl. Chem. 1985, 22(2), 565-8). Compounds such as 39 are available by known methods (Tetrahedron Letters 1999, 40, 2605). These procedures are particularly useful for the preparation of compounds where R5(b) is optionally substituted phenyl and R5(a) is haloalkyl or bromo. Scheme 17
C02Et
Figure imgf000035_0001
32 36
34 8
I. E.3N 2. Oxidation
X] is halogen
Figure imgf000035_0002
38 39
Ortbø-amino carboxylic acid esters of Formula 5 wherein R1 is H can be prepared from monoesters of ortho dicarboxylic acids of Formula 40 via rearrangement of the coπesponding acyl azide and hydrolysis of the resulting isocyanate (or alternatively by trapping of the isocyanate with an alcohol and cleaving of the resulting carbamate) as shown in Scheme 18.
Scheme 18
1) (COC
Figure imgf000035_0003
or
40 5 (R1 is H)
1) (PhO) P(=0)N3, ROH
2) hydrolysis ». Alternatively ort/zo-amino carboxylic acid esters of Formula 5 can be prepared from ortho carboxamide carboxylic esters of Formula 41 by Hoffman rearrangement with reagents such as sodium hydroxide and bromine as shown in Scheme 19. Scheme 19
Figure imgf000036_0001
41 5 (R1 is H)
Compounds of Formulae 40 and 41 are known in the art or can be readily prepared from compounds known in the art. (For example, see Tetrahedron, 1997, 53, 14497; J. Chem. Soc, Perkin Trans. I, 1996, 10, 1035; WO92/08724 and EP 418667).
It is recognized that some reagents and reaction conditions described above for preparing compounds of Formula I may not be compatible with certain functionalities present in the intermediates. In these instances, the incorporation of protection/deprotection sequences or functional group interconversions into the synthesis will aid in obtaining the desired products. The use and choice of the protecting groups will be apparent to one skilled in chemical synthesis (see, for example, Greene, T. W.; Wuts, P. G. M. Protective Groups in Organic Synthesis, 2nd ed.; Wiley: New York, 1991 ). One skilled in the art will recognize that, in some cases, after the introduction of a given reagent as it is depicted in any individual scheme, it may be necessary to perform additional routine synthetic steps not described in detail to complete the synthesis of compounds of Formula I. One skilled in the art will also recognize that it may be necessary to perform a combination of the steps illustrated in the above schemes in an order other than that implied by the particular sequence presented to prepare the compounds of Formula I.
One skilled in the art will also recognize that compounds of Formula I and the intermediates described herein can be subjected to various electrophilic, nucleophilic, radical, organometallic, oxidation, and reduction reactions to add substituents or modify existing substituents.
Without further elaboration, it is believed that one skilled in the art using the preceding description can utilize the present invention to its fullest extent. The following Examples are, therefore, to be construed as merely illustrative, and not limiting of the disclosure in any way whatsoever. Percentages are by weight except for chromatographic solvent mixtures or where otherwise indicated. Parts and percentages for chromatographic solvent mixtures are by volume unless otherwise indicated. *H NMR spectra are reported in ppm downfield from tetramethylsilane; s is singlet, d is doublet, t is triplet, q is quartet, m is multiplet, dd is doublet of doublets, dt is doublet of triplets, brs is broad singlet. EXAMPLE 1
Preparation of 5-methyl-N-(l -methylethyl)-4-[r4-trifluoromethoxy)benzoyl]amino]-3- pyridinecarboxamide Step A: Preparation of ethyl 4-azido-5-methyl-3-pyridinecarboxylate A slurry of 14.1 g (78 mmol) of ethyl l,4-dihydro-5-methyl-4-oxo-3- pyridinecarboxylate (prepared according to Horvath, G.; Dvortsak, P. J. Heterocycl. Chem. 1980, 359) in 30 mL of phosphorous oxychloride was refluxed for 1 hour. After cooling, the volatiles were removed with a rotary evaporator. The residue was poured into cold saturated aqueous sodium bicarbonate. Dichloromethane was added and the mixture was filtered through celite. The layers were separated. The organic layer was dried (sodium sulfate) and the solvent was removed with a rotary evaporator. The residue was dissolved in 150 mL of dimethylformamide. 15.2g (234 mmol) of sodium azide was added. The mixture was heated at 95°C for lhour. After cooling, the solvent was removed with a rotary evaporator. The residue was partitioned between ethyl acetate and water. The organic layer was dried (sodium sulfate) and the solvent was removed with a rotary evaporator. The residue was passed through a plug of silica gel with 25% ethyl acetate in hexanes as eluant to afford 11.9g of the title compound as a cream colored solid.
IH ΝMR (CDC13) δ 1.41 (t,3H), 2.12 (s,3H), 4.36 (q,2H), 8.12 (s,lH), 8.83 (s,lH). Step B: Preparation of ethyl 4-amino-5-methyl-3-pyridinecarboxylate 0.50 g of material prepared in Step A was dissolved in 15 mL of ethanol. 0.15g of
10% palladium on carbon was added. The reaction mixture was placed under one atmosphere of hydrogen for 2 hours. The catalyst was removed by filtration. The solvent was removed with a rotary evaporator to afford 0.43 g of the title compound as a white solid. IH ΝMR (CDCI3) δ 1.42 (t,3H), 2.30 (s,3H), 4.45 (q,2H), 8.47 (s,lH), 8.87 (s,lH). Step C: Preparation of ethyl 5-methyl-4-r[4-frifluoromethoxy)benzoyl1amino]-3- pyridinecarboxylate l.Og (5.6 mmol) of material prepared in Step C was dissolved in 30 mL of dichloromethane. 0.77 mL (5.6 mmol) of triethylamine, a catalytic amount of 4-dimethylaminopyridine and 0.88 mL (5.6 mmol) of 4-(trifluoromethoxy)benzoyl chloride were added. The mixture was stiπed overnight. The reaction mixture was washed with water. The organic layer was dried (sodium sulfate) and the solvent was removed with a rotary evaporator. The residue was purified by medium-pressure liquid chromatography (MPLC) with a gradient of 15-100% ethyl acetate in hexanes as eluant. The bisacylation product eluted first, then 0.42 g of the title compound as white solid. Starting material (0.52 g) was also recovered.
Η ΝMR (CDCI3) δ 1.41 (t,3H), 2.32 (s,3H), 4.39 (q,2H), 7.37 (d,2H), 8.08 (d,2H), 8.63 (brs,lH), 9.04 (brs,lH), 10.78 (brs,lH). Step D: Preparation of 5-methyl-N-(l-methylethvD-4-IT4- trifluoromethoxy)benzovnamino]-3-pyridinecarboxamide To a solution of 0.049 mL (0.57 mmol) of isopropylamine in 20 mL of dichloroethane at 0 °C was added 0.64 mL (1.3 mmol) of a 2M solution of frimethylaluminum in toluene dropwise. A solution of 0.21 g (0.57 mmol) of the material prepared in Step C in 5 mL of dichloroethane was added dropwise. Four days later an additional 0.049 mL of isopropylamine and 0.64 mL of frimethylaluminum were added. The reaction was refluxed for 6h. After cooling 20 mL of IN HCl was added. The layers were separated. The aqueous layer was made basic with a saturated sodium bicarbonate solution. Dichloromethane was added and the mixture was filtered through celite. The dichloromethane was separated, combined with the dichloroethane layer from above and dried (sodium sulfate). The solvent was removed with a rotary evaporator. The residue was purified by MPLC with a gradient of 25-50% ethyl acetate in hexanes as eluant to afford 0.047 g of the title compound, a compound of the invention, as a white solid; m.p. 202-204 °C. IH ΝMR (CDC13) δ 1.27 (d,6H), 2.33 (s,3H), 4.23 (m,lH), 6.46 (br,lH), 7.35 (d,2H),
8.07 (d,2H), 8.56 (brs,lH), 8.69 (brs,lH), 11.15 (brs,lH).
EXAMPLE 2
Preparation of l-methyl-Ν-Q -methylethyl -5-ff4-trifluoromethoxy)benzoyl]amino]-lH- pyrazole-4-carboxamide Step A: Preparation of 5 -amino- 1 -methyl -Ν-( 1 -methylethyl - 1 H-pyrazole-4- carboxamide l.Og (8.0 mmol) of 2-cyano-N-(l-methylethyl)acetamide (prepared according to the procedure of Cheikh et al J. Org. Chem., 1991, 56, 970) was combined with 3.1 mL of triethylorthoforrnate, 5 mL of acetic anhydride and 0.0 lg of anhydrous zinc chloride. The mixture was refluxed for 1 hour. A distillation head was placed on the flask and the reaction was heated at 120 °C for 8 hours. After standing for two days the mixture was heated again for 12 hours at 120 °C for 12 hours. The volatiles were removed with a rotary evaporator. Ethanol was added and the volatiles were again removed with a rotary evaporator. This material was dissolved in 15 mL of ethanol. 0.34 mL (6.4 mmol) of methyl hydrazine was added. The reaction mixture was refluxed for 5 hours and then allowed to stand at room temperature overnight. The solvent was removed with a rotary evaporator. The residue was purified by MPLC (ethyl acetate as eluant) to afford 0.14g of the title compound as a solid.
!H ΝMR (CDCI3) δ 1.23 (d,6H), 3.61 (s,3H), 4.21 (m,lH), 5.17 (br,2H), 5.34 (br,lH), 7.38 (s, IH). Step B: Preparation of l-methyl-N-d-methylethyl)-5-rr4- trifluoromethoχy)benzovnamino]- 1 H-pyrazole-4-carboxamide 0.14 g (0J7 mmol) of the material from Step A was dissolved in 20 mL of tetrahydrofuran and 0.12 mL (0.85 mmol) of triethylamine and 0.12 mL (0.77 mmol) of 4-(trifluoromethoxy)benzoyl chloride were added. Three days later 0.12 mL (0.85 mmol) of triethylamine and 0.12 mL (0.77 mmol) of 4-(trifluoromethoxy)benzoyl chloride were added. The reaction mixture was refluxed for two days. After cooling the reaction mixture was partitioned between ethyl acetate and water. The organic layer was dried (sodium sulfate) and the solvent was removed with a rotary evaporator. The residue was purified by MPLC with 50% ethyl acetate in hexanes as eluant to afford 0.18 g of the title compound, a compound of the invention, as a white solid; m.p. 68-75 °C.
IH NMR (CDC13) δ 1.22 (d,6H), 3.91 (s,3H), 4.14 (m,lH), 5.92 (brd,lH), 7.32 (d,2H), 7.62 (s,lH), 8.08 (d,2H), 10.78 (brs,lH).
EXAMPLE 3 Preparation of 4-methyl-N-( 1 -methylethyl)-3 - r r4-trifluoromethyl benzoyl] amino] -2- thiophenecarboxamide Step A: Preparation of 7-methyl-2H-thienor3,2-d][l,3]oxazine-2,4(lH)-dione
Phosgene in toluene (4.4 g, 20%, 8.88 mmol) was added to the sodium salt of 3-amino- 4-methyl-thiophene-2-carbocyclic acid (1 g, 5.58 mmol) in water (17 mL) at 0 C. The mixture was allowed to warm to room temperature and was stiπed for 1 hour. The mixture was filtered. After drying in vacuum the product was obtained as a solid 0.49 g (47%). IR (Νujol®) 1785, 1696, 1580, 1513, 1236, 988, 918, 848, 826 cm-1. 'H ΝMR (OMSO-d6) δ 2.20 (s,3H), 7.88 (s,lH). Step B: Preparation of 7-methyl-2-r4-('trifluoromethyl)phenyl1-4H-thienor3.2- t 1|"L3]oxazin-4-one
4-(Dimethylamino)pyridine (0.66 g, 5.41 mmol) was added to the product from Step A in dioxane (10 mL). 4-(Trifluoromethyl)benzoyl chloride (1.13 g, 5.42 mmol) was added to the mixture and the mixture was boiled for approximately 3 hours. The mixture was allowed to cool to room temperature and was poured into hydrochloric acid (100 mL, 1 N). The mixture was extracted with ethyl acetate (3 x 50 mL) and the combined extracts were dried and evaporated. Chromatography on silicon gel (eluted with ethyl acetate/hexanes) gave the product as a white solid 1.56 g, (91.7%).
IR (Νujol®) 2923, 1763, 1600, 1572, 1410, 1312, 1234, 1170, 1125, 1068, 1013, 978, 934, 851, 813 cm-1. lH ΝMR (CDCI3) δ 2.47 (s,3H), 7.60 (s,lH), 7J7 (d,2H), 8.45(d,2H). Step C: Preparation of 4-methyl-N-f 1 -methylethylV3-IT4- trifluoromethyl)benzoyl]amino]-2-thiophenecarboxamide A mixture of the product from Step B (0.2 g, 0.043 mmol) and isopropylamine (0.2 g, 3.39 mmol) in THF (5 mL) was stiπed for 6 hours. The solvent was removed under reduced pressure to give the product, a compound of the invention, as a solid 0.21 g, (91%).
IR (Νujol®) 3294, 1664, 1625, 1573, 1524, 1409, 1327, 1207, 1167 1126, 1068, 1018, 954, 885, 857 cm-1. lH ΝMR (CDC13) δ 1.22 (d,6H), 2.30 (s,3H), 4.22-4.11 (m,lH), 5.58 (d,lH), 7.03 (s,lH), 7.75 (d, 2H), 8.13 (d,2H), 10.63 (5,1H). EXAMPLE 4
Preparation of 5 - [ [ [3 -Chloro- 1 -(3 -chloro-2-pyridinvD- 1 H-pyrazol-5 -yl] carbonyl] amino] -
N,6-dimethyl-4-pyrimidinecarboxamide Step A: Preparation of 1-(1 -dimethylethyl 4-ethyl-2-acetyl-3-amino-2-butenedioate
To a mixture of 17.15g (108 mmol) of t-butyl acetoacetate and 12.8 mL (130 mmol) of ethyl cyanoformate in 25 mL of dichloromethane was added 1.64g of zinc acetylacetonate hydrate. After stirring overnight the volatiles were removed with a rotary evaporator. The residue was dissolved in ethyl acetate and filtered through celite. The solvent was removed with a rotary evaporator to afford 29.9g of the title compound as a white solid as an E/Z isomer mixture. 1Η ΝMR (CDCI3) δ 1.33 (t,3Η), 1.52 (s,9H), 2.35 (s,3H) [minor isomer 2.40 (s,3H)],
4.33 (m,2H).
Step B: Preparation of 5-(l.l-dimethylethyl) hydrogen 6-methyl-4.5- pyrimidinedicarboxylate To a solution of 11.6g (45 mmol) of the material from Step A in 55 mL of ethanol was added 10.9g (135 mmol) of formamidine hydrochloride. The reaction mixture was cooled in an ice bath and 17 mL (135 mmol) of 1,1,3,3-tetramethylguanidine was added dropwise. After the mixture was stirred overnight the solvent was removed with a rotary evaporator. The residue was partitioned between ethyl acetate and water. The aqueous layer was cooled in an ice bath, acidified with concentrated HCl and extracted three times with ethyl acetate. The organic layer was dried (sodium sulfate) and the solvent was removed with a rotary evaporator to afford 9.12g of the title compound as a yellow solid.
1H ΝMR (CDC13) δ 1. 65 (s,9H), 2.68 (s,3H), 9.19 (s,lH). Step C: Preparation of 5-(T J-dimethylethyl) 4-methyl 6-methyl-4.5- pyrimidinedicarboxylate To a solution of 9.12g (38 mmol) of the material from Step B in 100 mL of
NN-dimethyl formamide (DMF) was added 3.1 mL (50 mmol) of iodomethane and 3Jg (50 mmol) of lithium carbonate. The reaction mixture was heated at 60 °C for 3 hours. After cooling the reaction mixture was partitioned between dichloromethane and water. The organic layer was dried (sodium sulfate) and the solvent was removed with a rotary evaporator and then a vacuum pump. The residue was purified by MPLC with a gradient of 20-30% ethyl acetate in hexanes as eluant to afford 7.58g of the title compound as an off- white solid.
IH NMR (CDC13) δ 1.63 (s,9H), 2.67 (s,3H), 4.01 (s,3H), 9.19 (s,lH). Step D: Preparation of methyl 5-IT( 1,1 -dimethylethoxy)carbonyll amino] -6-methyl-4- pyrimidinecarboxylate 7.55g of the material from Step C was dissolved in 40 mL of dichloromethane. 20 mL of trifluoroacetic acid was added. After two days the reaction mixture was refluxed for 6 hours. After an additional day the volatiles were removed with a rotary evaporator. Toluene was added and the solvent was removed with a rotary evaporator. This material (9.2g) was dissolved in 100 mL of t-butanol. 9.2 mL (66 mmol) of triethylamine and 14 mL (66 mmol) of diphenylphosphoryl azide were added. The reaction was refluxed 3 hours. After cooling, the solvent was removed with a rotary evaporator. The residue was partitioned between ethyl acetate and water. The organic layer was dried (sodium sulfate) and the solvent was removed with a rotary evaporator. The residue was purified by MPLC with a gradient of 40-100% ethyl acetate in hexanes as eluant to afford 5.81g of the title compound as a yellow solid. lH NMR (CDCI3) δ 1.52 (s,9H), 2.60 (s,3H), 4.03 (s,3H), 8.07 (br,lH),8.98 (s,lH).
Step E: Preparation of methyl 5-amino-6-methyl-4-pyrimidinecarboχylate
5.8g of the material from Step D was dissolved in 25 mL of trifluoroacetic acid. After stirring for 90 minutes the solvent was removed with a rotary evaporator. Saturated aqueous sodium bicarbonate was added. The aqueous layer was extracted five times with dichloromethane. The organic layer was dried (sodium sulfate) and the solvent was removed with a rotary evaporator to afford 3J8g of the title compound with a small amount of an impurity.
»H NMR (CDCI3) δ 2.50 (s,3H), 4.00 (s,3H), 5.76 (br,2H),8.56 (s,lH). Step F: Preparation of 5-amino-6-methyl-4-pyrimidinecarboχylic acid monosodium salt
2.0g (12 mmol) of the material from Step E was dissolved in 24 mL of methanol. 12 mL of a IN solution of sodium hydroxide was added. After 1 hour the solvent was removed with a rotary evaporator. The residue was dried in a vacuum oven overnight to afford 2.39 g of the title compound as a tan solid. lH NMR (D2O) δ 2.45 (s,3H)s 8.37 (s,lH).
Step G: Preparation of 3-chloro-NN-dimethyl-lH-pyrazole-l-sulfonamide
To a solution of N-dimethylsulfamoylpyrazole (188.0 g, 1.07 mol) in dry tetrahydrofuran (1500 mL) at -78 °C was added dropwise a solution of 2.5 M n-butyl- lithium (472 mL, 1.18 mol) in hexane while maintaining the temperature below -65 °C. Upon completion of the addition the reaction mixture was maintained at -78 °C for an additional 45 minutes, after which time a solution of hexachloroethane (279 g, 1.18 mol) in tetrahydrofuran (120 mL) was added dropwise. The reaction mixture was maintained for an hour at -78 °C, warmed to -20 °C and then quenched with water (1 L). The reaction mixture was extracted with methylene chloride (4x500 mL); the organic extracts were dried over magnesium sulfate and concentrated. The crude product was further purified by chromatography on silica gel using methylene chloride as eluent to afford the title product compound as a yellow oil (160 g). !H NMR (CDC13) δ 3.07 (d, 6H), 6.33 (s, IH), 7.61 (s, IH). Step H: Preparation of 3-chloropyrazole
To trifluoroacetic acid (290 mL) was added dropwise the chloropyrazole product (160 g) from Step G, and the reaction mixture was stirred at room temperature for 1.5 hours and then concentrated at reduced pressure. The residue was taken up in hexane, insoluble solids were filtered off, and the hexane was concentrated to afford the crude product as an oil. The crude product was further purified by chromatography on silica gel using ether/hexane (40:60) as eluent to afford the title product as a yellow oil (64.44 g). !H NMR (CDCI3) δ 6.39 (s, IH), 7.66 (s, IH), 9.6 (br s, IH). Step I: Preparation of 3-chloro-2-(3-chloro-lH-pyrazol-l-yl)pyridine To a mixture of 2,3 -dichloropyri dine (92.60 g, 0.629 mol) and 3-chloropyrazole
(64.44 g, 0.629 mol) in N,N-dimethylformamide (400 mL) was added potassium carbonate (147.78 g, 1.06 mol), and the reaction mixture was then heated to 100 °C for 36 hours. The reaction mixture was cooled to room temperature and slowly poured into ice water. The precipitated solids were filtered and washed with water. The solid filter cake was taken up in ethyl acetate, dried over magnesium sulfate and concentrated. The crude solid was chromatographed on silica gel using 20% ethyl acetate/hexane as eluent to afford the title product as a white solid (39.75 g).
!Η ΝMR (CDCI3) δ 6.43 (s, IH), 7.26 (m, IH), 7.90 (d, IH), 8.09 (s, IH), 8.41 (d, IH). Step J: Preparation of 3-chloro-l-(3-chloro-2-pyridinyl)-lH-pyrazole-5-carboχylic acid
To a solution of the pyrazole product from Step I (39.75 g, 186 mmol) in dry tetrahydrofuran (400 mL) at -78 °C was added dropwise a solution of 2.0 M lithium diisopropylamide (93 mL, 186 mmol) in tetrahydrofuran. Carbon dioxide was bubbled through the amber solution for 14 minutes, after which time the solution became pale brownish-yellow. The reaction was made basic with IN aqueous sodium hydroxide solution and extracted with ether (2x500 mL). The aqueous extracts were acidified with 6Ν hydrochloric acid and extracted with ethyl acetate (3x500 mL). The ethyl acetate extracts were dried over magnesium sulfate and concentrated to afford the title product as an off- white solid (42.96 g). (Product from another run following similar procedure melted at 198- 199 °C.) H NMR (OMSO-d6) δ 6.99 (s, IH), 7.45 (m, IH), 7.93 (d, IH), 8.51 (d, IH). Step K: Preparation of 2-[3-chloro-l-("3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-8- methyl-4H-pyrimidor5.4-./][L31oxazin-4-one
To a solution of 0.26 mL (3.3 mmol) of methanesulfonyl chloride in 18 mL of acetonitrile at 0°C was added 0J7g (3.0 mmol) of 3-chloro-l-(3-chloro-2-pyridinyl)-lH- pyrazol-5-carboxylic acid from Step J. 0.42 mL (3.0 mmol) of triethylamine in 9 mL of acetonitrile was added dropwise. After 20 minutes at 0 °C, 0.525g (3.0 mmol) of material from Step F was added. After 15 minutes 0.42 mL (3.0 mmol) of triethylamine was added dropwise. After 2 hours 0.26 mL (3.3 mmol) of methanesulfonyl chloride was added. After stirring overnight. The reaction mixture was poured into water. Filtration afforded 0.27g of the title compound.
]Η NMR (CDC13) δ 2.20 (s,3H), 7.23 (s,lH), 7.54(dd,lH), 8.01 (dd,lH), 8.57(dd,lH), 9.20 (s,lH).
Step L: Preparation of 5 - [ [ \3 -Chloro- 1 -(3 -chloro-2-pyridinylV 1 H-pyrazol-5 - yncarbonyl1aminol-N,6-dimethyl-4-pyrimidinecarboxamide 2 mL of a 2M solution of methylamine in tetrahydrofuran was added to 0.090g of material from Step K. After stiπing overnight the solvent was removed with a rotary evaporator to afford 0.07 lg of the title compound, a compound of the invention, as a tan solid; m.p. 205-207 °C.
]Η ΝMR (CDCI3) δ 2.48 (s,3H), 3.04 (d,3H), 7.06 (s,lH), 7.41(dd,lH), 7.89 (dd,lH), 8.30 (br,lH), 8.48 (dd,lH), 8.85 (s,lH), 11.57 (br,lH).
EXAMPLE 5 Preparation of 2,6-dichloro-3- [[l-(3-chloro-2-pyridinvπ-3-(trifluoromethyl)-lH-pyrazol-5- yl] carbonyll amino] -N-( 1 -methylethyl)- 4-pyridinecarboxamide Step A: Preparation of ethyl 3-amino-4-pyridinecarboxylate
To a solution of 1 g (7.25 mmol) of 3-amino-4-pyridinecarboxylic acid in 5 mL of ethyl alcohol was added 2 mL of sulfuric acid. The mixture was warmed under reflux for 2 h. It was cooled and basified with cone. ΝΗ4OΗ solution to pH = 8. The resulting solution was extracted with ethyl acetate and the organic layer was washed with brine and water, dried (MgSO4) and concentrated in vacuo to give 1.04 g of the title compound as a white solid (87%). ϊH NMR CDCL δ 8.19 (s IH), 7.93 (d IH, J is 5.1Hz), 7.60 (d, IH, J is 5.1Hz), 5.67 (br s, 2H), 4.36 (q, 2H), 1.40 (t, 3H). Step B: Preparation of ethyl 3-amino-2,6-dichloro-4-pyridinecarboxylate
To a solution of 1.04 g (6.27 mmol) of ethyl 3-amino-4-pyridinecarboxylate in 5 mL of DMF was added 1.67 g of N-chlorosuccinimide (12.5 mmol) in a single portion at room temperature. The mixture was then stiπed at the same temperature for 24 hours. The resulting mixture was concentrated in vacuo and purified by silica gel column to give 1.40 g of the title compound as a white solid (95%).
]H ΝMR (CDC13) δ 7.67 (s IH), 6.18 (br s, 2H), 4.39 (q, 2H), 1.42 (t, 3H). Step C: Preparation of 3-amino-2,6-dichloro-4-pyridinecarboχylic monopotassium salt To a solution of 1.30 g (5.54 mmol) of ethyl 3-amino-2,6-dichloro-4- pyridinecarboxylate in a mixture of 5 mL of water and 20 mL of ethyl alcohol was added 622 mg (11.1 mmol) of potassium hydroxide at room temperature and the reaction mixture was warmed at 90 °C for lhour. The mixture was then concentrated in vacuo and evaporated with benzene three times to give 1.63 g of the title compound as a white solid. The crude product was used in the next reaction without any further purification (98%). lH ΝMR (DMSOd-6) δ 7.31 (s, IH), 7.14 (br s, 2H). Step D: Preparation of 6,8-dichloro-2H-pyridor3,4-t ][ 3]oxazine-2,4(lH)-dione
To a solution of 1.64 g (5.54 mmol) of the material from Step C in 20 mL of dioxane was added 2.2 g (11.1 mmol) of diphosgene at 0 °C. The mixture was allowed to warm to room temperature and stirred for 24 hours. The mixture was then concentrated in vacuo to give 1.70 g of the title compound as a white solid (quantitative).
!Η ΝMR (DMSOd-6) δ 7.99 (s, 1Η). Step E: Preparation of 3 -chloro-2- [3 -(trifluoromethyl)- 1 H-pyrazol- 1 -yl] pyridine
To a mixture of 2,3-dichloropyridine (99.0 g, 0.67 mol) and 3 -trifluoromethyl pyrazole (83 g, 0.61 mol) in dry NN-dimethylformamide (300 mL) was added potassium carbonate (166.0 g, 1.2 mol) and the reaction was then heated to 110-125 °C over 48 hours. The reaction was cooled to 100 °C and filtered through Celite® diatomaceous filter aid to remove solids. NN-Dimethylformamide and excess dichloropyridine were removed by distillation at atmospheric pressure. Distillation of the product at reduced pressure (b.p. 139-141 °C, 7 mm) afforded the desired intermediate as a clear yellow oil (113.4 g). lΗ ΝMR (CDCI3) δ 6.78 (s, 1Η), 7.36 (t, 1Η), 7.93 (d, 1Η), 8.15 (s, 1Η), 8.45 (d, 1Η). Step F: Preparation of 1 -(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazole-5- carboxylic acid To a solution of the pyrazole product from Step E (105.0 g, 425 mmol) in dry tetrahydrofuran (700 mL) at -75 °C was added via cannula a -30 °C solution of lithium diisopropylamide (425 mmol) in dry tetrahydrofuran (300 mL). The deep red solution was stirred for 15 minutes, after which time carbon dioxide was bubbled through at -63 °C until the solution became pale yellow and the exothermicity ceased. The reaction was stiπed for an additional 20 minutes and then quenched with water (20 mL). The solvent was removed under reduced pressure, and the reaction mixture partitioned between ether and 0.5 N aqueous sodium hydroxide solution. The aqueous extracts were washed with ether (3x), filtered through Celite® diatomaceous filter aid to remove residual solids, and then acidified to a pH of approximately 4, at which point an orange oil formed. The aqueous mixture was stiπed vigorously and additional acid was added to lower the pH to 2.5-3. The orange oil congealed into a granular solid, which was filtered, washed successively with water and IN hydrochloric acid, and dried under vacuum at 50 °C to afford the title product as an off-white solid (130 g). (Product from another run following similar procedure melted at 175— 176 °C.)
!H NMR (OMSO-d6) δ 7.61 (s, IH), 7.76 (dd, IH), 8.31 (d, IH), 8.60 (d, IH). Step G: Preparation of 2,6-dichloro-3-|Tπ -(3-chloro-2-pyridinyl)-3-(trifluoromethylV lH-pyrazol-5-yl]carbonyl]amino]-N-(l-methylethyl)- 4-pyridinecarboxamide To a solution of 268 mg (0.92 mmol) of l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)- lH-pyrazole-5-carboxylic acid (from Step F) in 5 mL of dichloromethane was added 160 μL (1.84 mmol) of oxalyl chloride and two drops of DMF in sequence at room temperature. The mixture was then stiπed at the same temperature for 1 hour. The crude mixture was then concentrated in vacuo. The resulting mixture was dissolved with 5 mL of acetonitrile followed by additions of 280 mg (0.92 mmol) of the compound prepared in Step D and 298 μL (3.68 mmol) of pyridine in sequence. The reaction mixture was warmed to 70 °C for 2 hours and allowed to cool to room temperature. A solution of 157 μL (1.84 mmol) of isopropylamine in 1 mL of acetonitrile was added to the mixture and it was warmed to 60 °C for 1 hour. The reaction was allowed to cool to room temperature and quenched with water. The aqueous layer was extracted with ethyl acetate and the organic layer was dried with MgSO4 and concentrated in vacuo. The resulting mixture was purified with a silica gel column to give 250 mg of the title compound, a compound of the invention, as a white solid (52%). m.p. 240-242 °C.
Η ΝMR (CDC13) δ 9.85 (s, 1Η), 8.53 (dd, 1Η), 7.90 (dd, 1Η), 7.56 (s, 1Η), 7.42 (dd, 1Η), 7.22 (s, 1Η), 6.08 (br d, 1Η), 4.13 (m, 1Η), 1.14 (d, 6Η). By the procedures described herein together with methods known in the art, the following compounds of Tables 1 to 32 can be prepared. The following abbreviations are used in the Tables: t is tertiary, s is secondary, n is normal, i is iso, c is cyclo, Me is methyl, Et is ethyl, Pr is propyl, i-Pr is isopropyl, t-Bu is tertiary butyl, Ph is phenyl, OMe is methoxy, OEt is ethoxy, SMe is methylthio, SEt is ethylthio, CΝ is cyano, ΝO2 is nitro, TMS is trimethylsilyl, S(O)Me is methylsulfinyl, and S(O)2Me is methylsulfonyl. Structures of K for Tables 15, 16 and 17 can be found in Exhibit 2. Table 1
Figure imgf000046_0001
F
F
F
F
F
F
Br
Br
Br
Br
Br
Br
Br
Br
Br
Br
Br
OMe
OMe
OMe
OMe
OMe
OMe
OMe
OMe
OMe
Figure imgf000047_0001
O O O O O O O O O O O
CD CD CO 2 rt 2 2 rt rt 2 rt 2 2 2 O O o o o O tr rt rt 2 ft 2 g TI TI O TI Oτι OTI OTI OTI OTJ τOι Oτι Oτι Oτι O Tl O ►n O T) O Tl Tl Tl Tl T) Tl T) to to to to to to to to to to to co co co o o o o co o 2 2 Pi
33 33 33 33 33 33 33 33 33 33 33
Figure imgf000048_0001
o o O o
_ _ « > i TJ Tl Tl Tl T! o a o a oo o o O O O O O
O O O O O O o
Tl Tl Tl Tl Tl Tl Tl π Tl " orl o ^ o ^ o O O ^ o ^ o τl o Tl Tl Tl Tl Tl Tl to to t to to to t to CO C o CO CO CO CO •n O Tl 2 2 t
X X X X X 33 X 33 K
Figure imgf000048_0002
O O O O O O O O O o O Tl T( Tl o Tl o Tl o o O o o o o o
2 2 2 o o o o o o o o l ^ -* Tol o Tl o O
O
Tl Tl Tl Tl Tl Tl
— to to to to to to to o to T) Tl o Tl Tl Tl Tl Tl Tl Tl to to co O O O O CO O CO O O CO 2 2 F
33 33 33 33 33 33 33 33 33 33 33
Figure imgf000048_0003
Rl (Stm ! ffi5)m Rl (S- m
Br 2-Me-4-OCH2CF3 2-Me-4-OCH CF3 OMe 2-Me-4-OCH2CF3
Br 2-Me-4-SCF3 2-Me-4-SCF3 OMe 2-Me-4-SCF3
Br 2-Me-4-SOCF3 2-Me-4-SOCF3 OMe 2-Me-4-SOCF3
Br 2-Me-4-S02CF3 2-Me-4-S02CF3 OMe 2-Me-4-S0 CF3
Br 2-Me-4-SCF2H 2-Me-4-SCF2H OMe 2-Me-4-SCF2H
Br 2-Me-4-SOCF H 2-Me-4-SOCF2H OMe 2-Me-4-SOCF2H
Br 2-Me-4-S02CF2H 2-Me-4-S02CF2H OMe 2-Me-4-S02CF2H
CF3 2-Me-4-CF3 N02 2-Me-4-CF3 SMe 2-Me-4-CF3
CF3 2-Me-4-OCF3 N02 2-Me-4-OCF3 SMe 2-Me-4-OCF3
CF3 2-Me-4-OCF2H N02 2-Me-4-OCF2H SMe 2-Me-4-OCF2H
CF3 2-Me-4-OCH2CF3 N02 2-Me-4-OCH2CF3 SMe 2-Me-4-OCH2CF3
CF3 2-Me-4-SCF3 N02 2-Me-4-SCF3 SMe 2-Me-4-SCF3
CF3 2-Me-4-SOCF3 N02 2-Me-4-SOCF3 SMe 2-Me-4-SOCF3
CF3 2-Me-4-S02CF3 N02 2-Me-4-S02CF3 SMe 2-Me-4-S02CF3
CF3 2-Me-4-SCF2H N02 2-Me-4-SCF2H SMe 2_Me-4-SCF2H
CF3 2-Me-4-SOCF2H N02 2-Me-4-SOCF2H SMe 2-Me-4-SOCF2H
CF3 2-Me-4-S02CF2H N02 2-Me-4-S02CF2H SMe 2-Me-4-S02CF2H Table 2
Me
Me
Me
Me
Me
Me
Me
Me
Figure imgf000049_0001
--. OT rø CD CD CD CD CD CD CO CO CD TJ Tl o o o o o o o o o o 2rt 2rt rt2 P
Figure imgf000050_0001
_ CD CD CD CO CD CO CD CD CO 00 CO Tl Tl Tl Tl o o o o o o o o o o —* 2 rt rt 2 2 rt P
13
Figure imgf000050_0002
_ co co CD CD CD CD CD CD CD CD CD T! Tl Tl O O O O O O O O O O O 2 2 P
Figure imgf000050_0003
El
OMe
OMe
OMe
OMe
OMe
OMe
OMe
OMe
OMe
OMe
OMe
CF3
CF3
CF3
CF3
CF3
CF3
CF3
CF3
CF3
CF3
CF3
OCF2H
OCF2H
OCF2H
OCF2H
OCF2H
Figure imgf000051_0001
El (E^m El ffi≥to El (E )m
OCF2H 2-SCF3 OCF2H 3-SCF3 OCF2H 4-SCF3
OCF2H 2-SOCF3 OCF2H 3-SOCF3 OCF2H 4-SOCF3
OCF2H 2-S02CF3 OCF2H 3-S02CF3 OCF2H 4-S02CF3
OCF2H 2-SCF2H OCF2H 3-SCF2H OCF2H 4-SCF2H
OCF2H 2-SOCF2H OCF2H 3-SOCF2H OCF2H 4-SOCF2H
OCF2H 2-S02CF2H OCF2H 3-S02CF2H OCF2H 4-S02CF2H
Me 2-Me-4-CF3 F 2-Me-4-CF3 CI 2-Me-4-CF3
Me 2-Me-4-OCF3 F 2-Me-4-OCF3 CI 2-Me-4-OCF3
Me 2-Me-4-OCF2H F 2-Me-4-OCF2H CI 2-Me-4-OCF2H
Me 2-Me-4-OCH2CF3 F 2-Me-4-OCH2CF3 CI 2-Me-4-OCH2CF3
Me 2-Me-4-SCF3 F 2-Me-4-SCF3 CI 2-Me-4-SCF3
Me 2-Me-4-SOCF3 F 2-Me-4-SOCF3 CI 2-Me-4-SOCF3
Me 2-Me-4-S02CF3 F 2-Me-4-S02CF3 CI 2-Me-4-S02CF3
Me 2-Me-4-SCF2H F 2-Me-4-SCF2H CI 2-Me-4-SCF H
Me 2-Me-4-S0CF2H F 2-Me-4-SOCF2H CI 2-Me-4-SOCF2H
Me 2-Me-4-S02CF2H F 2-Me-4-S02CF2H CI 2-Me-4-S02CF2H
Br 2-Me-4-CF3 2-Me-4-CF3 OMe 2-Me-4-CF3
Br 2-Me-4-OCF3 2-Me-4-OCF3 OMe 2-Me-4-0CF3
Br 2-Me-4-OCF2H 2-Me-4-OCF2H OMe 2-Me-4-0CF2H
Br 2-Me-4-OCH2CF3 2-Me-4-OCH2CF3 OMe 2-Me-4-OCH2CF3
Br 2-Me-4-SCF3 2-Me-4-SCF3 OMe 2-Me-4-SCF3
Br 2-Me-4-SOCF3 2-Me-4-SOCF3 OMe 2-Me-4-SOCF3
Br 2-Me-4-S02CF3 2-Me-4-S02CF3 OMe 2-Me-4-S02CF3
Br 2-Me-4-SCF2H 2-Me-4-SCF2H OMe 2-Me-4-SCF2H
Br 2-Me-4-SOCF2H 2-Me-4-SOCF2H OMe 2-Me-4-SOCF2H
Br 2-Me-4-S02CF2H 2-Me-4-S02CF2H OMe 2-Me-4-S02CF2H
CF3 2-Me-4-CF3 N02 2-Me-4-CF3 SMe 2-Me-4-CF3
CF3 2-Me-4-0CF3 N02 2-Me-4-OCF3 SMe 2-Me-4-OCF3
CF3 2-Me-4-OCF2H N02 2-Me-4-OCF2H SMe 2-Me-4-OCF2H
CF3 2-Me-4-OCH2CF3 N02 2-Me-4-OCH2CF3 SMe 2-Me-4-OCH2CF3
CF3 2-Me-4-SCF3 N02 2-Me-4-SCF3 SMe 2-Me-4-SCF3
CF3 2-Me-4-SOCF3 N02 2-Me-4-SOCF3 SMe 2-Me-4-SOCF3
CF3 2-Me-4-S02CF3 N02 2-Me-4-S02CF3 SMe 2-Me-4-S02CF3
CF3 2-Me-4-SCF2H N02 2-Me-4-SCF2H SMe 2-Me-4-SCF2H
CF3 2-Me-4-SOCF2H N02 2-Me-4-SOCF2H SMe 2-Me-4-SOCF2H
CF3 2-Me-4-S02CF2H N02 2-Me-4-S02CF2H SMe 2-Me-4-S02CF2H Tl TI 0 0 0 0 0 0 0 0 0 0 0 2 2 2 2 2 2 2 2 P
Figure imgf000053_0001
TI o o o o o o o o o o o 2 2 2 2 rt 2 rt 2 rt rt 2 2 r r 2 n
Figure imgf000053_0002
o o o o o o o o o 2 rt r2 2 to TJ t rt 2rt 2rt 2rt 2rt 2rt 2rt P
Figure imgf000054_0001
O O O O O O O O O Cσ CD Cϋ CO CO OT CD CD CO CD CD
2 2 2 2 2 2 2 2 2 Tl P
C co co co o o co co co O co
O 00 o oo 00 o l o
33 o o O O O co o o o o CO 00 00 τι o do o O
•π to O o T to o 3 τ o O o to O to O o
Tl to Tl to O O o oι O O
3 o TJ o o O τι Tl t Tl to O Tl o Tl to 33 to o o to o ω ■n ■n to to t o o o T to Tl to O O 00 JO τι o τι l Tl t o o o o
Tl Tl t O O TJ TJ to
TJ to to 33 Tl T)
33 T Tl o Tl to TJ CO o
Tl τι Co o T] to 33 o o Tl to X J1 3 33 to to Tl TJ
CO 33 33 c
33 co 33 33 Tl t 33 33 33 J 13
33 3 33
O O O O O O O O O
2 2 2 2 2 2 2 2 2 CO 03 03 CD CO CD CD CO CO CD C wD τ TJ K
Figure imgf000054_0002
Figure imgf000055_0001
El (E }m El (E^m El (Eilm
Br 2-Me-4-OCH2CF3 2-Me-4-OCH2CF3 OMe 2-Me-4-OCH2CF3
Br 2-Me-4-SCF3 2-Me-4-SCF3 OMe 2-Me-4-SCF3
Br 2-Me-4-SOCF3 2-Me-4-SOCF3 OMe 2-Me-4-SOCF3
Br 2-Me-4-S02CF3 2-Me-4-S02CF3 OMe 2-Me-4-S02CF3
Br 2-Me-4-SCF2H 2-Me-4-SCF2H OMe 2-Me-4-SCF2H
Br 2-Me-4-SOCF2H 2-Me-4-SOCF2H OMe 2-Me-4-SOCF2H
Br 2-Me-4-S02CF2H 2-Me-4-S02CF2H OMe 2-Me-4-S02CF2H
CF3 2-Me-4-CF3 N02 2-Me-4-CF3 SMe 2-Me-4-CF3
CF3 2-Me-4-OCF3 N02 2-Me-4-OCF3 SMe 2-Me-4-OCF3
CF3 2-Me-4-OCF2H N02 2-Me-4-OCF2H SMe 2-Me-4-OCF2H
CF3 2-Me-4-OCH2CF3 N02 2-Me-4-OCH2CF3 SMe 2-Me-4-OCH2CF3
CF3 2-Me-4-SCF3 N02 2-Me-4-SCF3 SMe 2-Me-4-SCF3
CF3 2-Me-4-SOCF3 N02 2-Me-4-SOCF3 SMe -Me-4-SOCF3
CF3 2-Me-4-S02CF3 N02 2-Me-4-S02CF3 SMe 2-Me-4-S02CF3
CF3 2-Me-4-SCF2H N02 2-Me-4-SCF2H SMe 2-Me-4-SCF2H
CF3 2-Me-4-SOCF2H N02 2-Me-4-SOCF2H SMe 2-Me-4-S0CF2H
CF3 2-Me-4-S02CF2H N02 2-Me-4-S02CF2H SMe 2-Me-4-S02CF H Table 4
Figure imgf000056_0001
Figure imgf000057_0001
Figure imgf000058_0001
El lE^rn El (E^m El ffi≥b
OCF2H 2-SCF3 OCF2H 3-SCF3 OCF2H 4-SCF3
OCF2H 2-SOCF3 OCF2H 3-SOCF3 OCF2H 4-SOCF3
OCF2H 2-S02CF3 OCF2H 3-S02CF3 OCF2H 4-S02CF3
OCF2H 2-SCF2H OCF2H 3-SCF2H OCF2H 4-SCF2H
OCF2H 2-SOCF2H OCF2H 3-SOCF2H OCF2H 4-SOCF2H
OCF2H 2-S02CF2H OCF2H 3-S02CF2H OCF2H 4-S02CF2H
Me 2-Me-4-CF3 F 2-Me-4-CF3 CI 2-Me-4-CF3
Me 2-Me-4-OCF F 2-Me-4-OCF3 CI 2-Me-4-OCF3
Me 2-Me-4-OCF2H F 2-Me-4-OCF2H CI 2-Me-4-OCF2H
Me 2-Me-4-OCH2CF3 F 2-Me-4-OCH2CF3 CI 2-Me-4-OCH2CF3
Me 2-Me-4-SCF3 F 2-Me-4-SCF3 CI 2-Me-4-SCF3
Me 2-Me-4-SOCF3 F 2-Me-4-SOCF3 CI 2-Me-4-SOCF3
Me 2-Me-4-S02CF3 F 2-Me-4-S02CF3 CI 2-Me-4-S02CF3
Me 2-Me-4-SCF2H F 2-Me-4-SCF2H CI 2-Me-4-SCF2H
Me 2-Me-4-SOCF2H F 2-Me-4-SOCF2H CI 2-Me-4-SOCF2H
Me 2-Me-4-S02CF2H F 2-Me-4-S02CF2H CI 2-Me-4-S02CF2H
Br 2-Me-4-CF3 2-Me-4-CF3 OMe 2-Me-4-CF
Br 2-Me-4-OCF3 2-Me-4-OCF3 OMe 2-Me-4-OCF3
Br 2-Me-4-OCF2H 2-Me-4-OCF2H OMe 2-Me-4-OCF2H
Br 2-Me-4-OCH2CF3 2-Me-4-OCH2CF3 OMe 2-Me-4-OCH2CF3
Br 2-Me-4-SCF3 2-Me-4-SCF3 OMe 2-Me-4-SCF3
Br 2-Me-4-SOCF3 2-Me-4-SOCF3 OMe 2-Me-4-SOCF3
Br 2-Me-4-S02CF3 2-Me-4-S02CF3 OMe 2-Me-4-S02CF3
Br 2-Me-4-SCF2H 2-Me-4-SCF2H OMe 2-Me-4-SCF2H
Br 2-Me-4-SOCF2H 2-Me-4-SOCF2H OMe 2-Me-4-SOCF2H
Br 2-Me-4-S02CF2H 2-Me-4-S02CF2H OMe 2-Me-4-S02CF2H
CF3 2-Me-4-CF3 N02 2-Me-4-CF3 SMe 2-Me-4-CF3
CF3 2-Me-4-OCF3 N02 2-Me-4-OCF3 SMe 2-Me-4-OCF3
CF3 2-Me-4-OCF2H N02 2-Me-4-OCF2H SMe 2-Me-4-OCF2H
CF3 2-Me-4-OCH2CF3 N02 2-Me-4-OCH2CF3 SMe 2-Me-4-OCH2CF3
CF3 2-Me-4-SCF3 N02 2-Me-4-SCF3 SMe 2-Me-4-SCF3
CF3 2-Me-4-SOCF3 N02 2-Me-4-SOCF3 SMe 2-Me-4-SOCF3
CF3 2-Me-4-S02CF3 N02 2-Me-4-S02CF3 SMe 2-Me-4-S02CF3
CF3 2-Me-4-SCF2H N02 2-Me-4-SCF2H SMe 2-Me-4-SCF2H
CF3 2-Me-4-SOCF2H N02 2-Me-4-SOCF2H SMe 2-Me-4-SOCF2H
CF3 2-Me-4-S02CF2H N02 2-Me-4-S02CF2H SMe 2-Me-4-S02CF2H Table 5
Figure imgf000060_0001
Table 6
Figure imgf000061_0001
Table 7
Figure imgf000062_0001
Figure imgf000063_0001
Figure imgf000064_0001
o O O O o O O
O O O O O O O O O O O O
— i — — Tl T Tl Tl o O O O O
Tl Tl τι TJ o Tl Tl Tl o Tl TJ o o
Tl τι j Tj Tj l "τl Tl Tj Tl Tl Tl Tl to to to to to to to to to to t ^ ) ) ) > ) -t > 2rt 2
33 33 33 X 33 33 33 33 X 33 33
Figure imgf000064_0002
O o o o o o o o o o o O O O O O O O O O
Q ~i o o j oj oj oj oi oi oi oj oi oJ oTj oi oi TJ T3 T3 T3 T] Tj Tj Tl Tj o o
2 2 ϊ Ω o o o o o o o _. , to to to to to to to to to to to co co 2 2rt K
Figure imgf000064_0003
2 2 2 O O O O O rt 2rt rt 2rt 2rt r2t rt 2rt P τ τ Tl τ OTl OTJ OTl TI OTJ OTl CD CD CD CO CD CD CD O CO CO O o co o co co Pt
Figure imgf000065_0001
2 2 2 2 2 2 2 2 CΛ CΛ CΛ CO CΛ CO CΛ CΛ CΛ CΛ O O 0 0 0 0 0 ,-
P rt 2 2rt rt2 2rt 2rt 2rt 2rt 2rt 2rt 2rt 2rt 2rt 2rt r2t 2rt 2ct 2rt
Figure imgf000065_0002
_ 03 03 CO C0 CO 03 CO O3 CO O3 O W3 Tl TJ TJ Tl Tl Tl Tl O O O O O O O O O O 2 2
Figure imgf000066_0001
_, CD CO CD CO CO CD CD CD CO CD CO Tl T T] TJ
-t -t -i -t -i Tl O O O O O O O O O O 2 rt 2 rt 2 rt F
Figure imgf000066_0002
_ CD C0 CD CD CD CU CD C0 C0 CD CD Tl TJ TJ TJ O O O O O O O O O O O 2 rt 2 rt rt 2 R.
Figure imgf000066_0003
Figure imgf000067_0001
T oJ T oJ T oJ T oJ T oJ T oJ T ol O O O
Tl Tl Tl CO CO CD CD CD CD CD CD CD CD O CO CO CO CO CO CO O CO CO f 2t 2 rt 2 ft 2 rt 2 2 2 rt rt 2
Figure imgf000068_0001
Figure imgf000068_0002
2! 2 2 2 2 2 2 O O O O O O
2 2 Z
O O O TJ O τι O τι O TJ TI TI to to to to o to o O O O O τι Tl Tl O to to O to to to to t to to to to F -t l- i-l— : J- «-— : -J-i
Figure imgf000068_0003
CΛ CΛ CΛ
2 rt 2rt 2rt
Figure imgf000068_0004
Figure imgf000068_0005
o o o o o o o o o o o 2 rt 2rt 2rt 2rt 2rt rt2 rt2 rt2 2rt 2rt rt2 PI
Figure imgf000069_0001
TJ I TJ O O O O O O O O O O rt 2 2rt 2rt 2rt 2rt 2rt 2rt 2rt 2rt 2rt 2rt Pt
Figure imgf000069_0002
Figure imgf000070_0001
Figure imgf000071_0001
Figure imgf000071_0002
Toj oTj oTl oTj o'Tl oTj oTj oTj oTj oTj oTj o O ) > ) ) > ϊ υJ > j 2 rt 2 F
Figure imgf000071_0003
Figure imgf000071_0004
El ffi lm El ffi-hn, El CE^m
Br 2-Me-4-OCH2CF3 2-Me-4-OCH2CF3 OMe 2-Me-4-OCH2CF3
Br 2-Me-4-SCF3 2-Me-4-SCF3 OMe 2-Me-4-SCF3
Br 2-Me-4-SOCF3 2-Me-4-SOCF3 OMe 2-Me-4-SOCF3
Br 2-Me-4-S02CF3 2-Me-4-S02CF3 OMe 2-Me-4-S02CF3
Br 2-Me-4-SCF2H 2-Me-4-SCF2H OMe 2-Me-4-SCF2H
Br 2-Me-4-SOCF2H 2-Me-4-SOCF2H OMe 2-Me-4-SOCF2H
Br 2-Me-4-S02CF2H 2-Me-4-S02CF2H OMe 2-Me-4-S02CF2H
CF3 2-Me-4-CF3 N02 2-Me-4-CF3 SMe 2-Me-4-CF3
CF3 2-Me-4-OCF3 N02 2-Me-4-OCF3 SMe 2-Me-4-OCF3
CF3 2-Me-4-OCF2H N02 2-Me-4-OCF2H SMe 2-Me-4-OCF2H
CF3 2-Me-4-OCH2CF3 N02 2-Me-4-OCH2CF3 SMe 2-Me-4-OCH2CF3
CF3 2-Me-4-SCF3 N02 2-Me-4-SCF3 SMe 2-Me-4-SCF3
CF3 2-Me-4-SOCF3 N02 2-Me-4-SOCF3 SMe 2-Me-4-SOCF3
CF3 2-Me-4-S02CF3 N02 2-Me-4-S02CF3 SMe 2-Me-4-S02CF3
CF3 2-Me-4-SCF2H N02 2-Me-4-SCF2H SMe 2-Me-4-SCF2H
CF3 2-Me-4-SOCF2H N02 2-Me-4-SOCF2H SMe 2-Me-4-SOCF2H
CF3 2-Me-4-S02CF2H N02 2-Me-4-S02CF2H SMe 2-Me-4-S02CF2H Table 10
Figure imgf000072_0001
— CD CD CO CO CO CD CD CD -D -O CO TJ TJ O O O O O O O O O O O
Figure imgf000073_0001
Figure imgf000073_0002
--. CO CD CD CO CD -D CD CD CD CD CO Tl 0 0 0 0 0 0 0 0 0 0 0 2 2 2 P
Figure imgf000073_0003
— CD CD CD CD CD CD CO CO CD CD CO TJ TJ O O O O O O O O O O O 2 rt rt 2 rt 2
Figure imgf000073_0004
o o o o o O O O O O O O O O O o o o o O O O O O o o
Tl Tl TJ TJ TJ Tl Tl TJ τι Tl TJ Tl TJ TJ Tl TJ t to to to O CO O CO CO CO CO co O CO co r 2 2 ft 2r 2rt 2rt 2rt 2rt 2rt 2 ft 2t 2rt
X X X X X
Figure imgf000074_0001
oo oo oo oo oo o O o o o O O o o O O O O O O
TJ oTJ TJ o] o O O O O
TJ TJ TJ TJ TJ Tl TJ TJ TJ TJ Tl TJ o to to to t O O CO CO O CO CO CO O U- O r 2t 2rt 2rt 2rt 2 rt r 2t r 2t r 2t r 2t 2tt F
X X X X X rt 2
Figure imgf000074_0002
El -R- ι El ( -m El (E-lm
OCF2H 2-SCF3 OCF2H 3-SCF3 OCF2H 4-SCF3
OCF2H 2-SOCF3 OCF2H 3-SOCF3 OCF2H 4-SOCF3
OCF2H 2-S02CF3 OCF2H 3-S02CF3 OCF2H 4-S0 CF3
OCF2H 2-SCF2H OCF2H 3-SCF2H OCF2H 4-SCF2H
OCF2H 2-SOCF2H OCF2H 3-SOCF2H OCF2H 4-SOCF2H
OCF2H 2-S02CF2H OCF2H 3-S02CF2H OCF2H 4-S02CF2H
Me 2-Me-4-CF3 F 2-Me-4-CF3 CI 2-Me-4-CF3
Me 2-Me-4-OCF3 F 2-Me-4-OCF3 CI 2-Me-4-OCF3
Me 2-Me-4-OCF2H F 2-Me-4-OCF2H CI 2-Me-4-OCF2H
Me 2-Me-4-OCH2CF3 F 2-Me-4-OCH2CF3 CI 2-Me-4-OCH2CF3
Me 2-Me-4-SCF3 F 2-Me-4-SCF3 CI 2-Me-4-SCF3
Me 2-Me-4-SOCF3 F 2-Me-4-SOCF3 CI 2-Me-4-SOCF3
Me 2-Me-4-S02CF3 F 2-Me-4-S02CF3 CI 2-Me-4-S02CF3
Me 2-Me-4-SCF2H F 2-Me-4-SCF2H CI 2-Me-4-SCF2H
Me 2-Me-4-SOCF2H F 2-Me-4-SOCF2H CI 2-Me-4-SOCF2H
Me 2-Me-4-S02CF2H F 2-Me-4-S02CF2H CI 2-Me-4-S02CF2H
Br 2-Me-4-CF3 2-Me-4-CF3 OMe 2-Me-4-CF3
Br 2-Me-4-OCF3 2-Me-4-OCF3 OMe 2-Me-4-OCF3
Br 2-Me-4-OCF2H 2-Me-4-OCF2H OMe 2-Me-4-OCF2H
Br 2-Me-4-OCH2CF3 2-Me-4-OCH2CF3 OMe 2-Me-4-OCH2CF3
Br 2-Me-4-SCF3 2-Me-4-SCF3 OMe 2-Me-4-SCF3
Br 2-Me-4-SOCF3 2-Me-4-SOCF3 OMe 2-Me-4-SOCF3
Br 2_Me-4-S02CF3 2-Me-4-S02CF3 OMe 2-Me-4-S02CF3
Br 2-Me-4-SCF2H 2-Me-4-SCF2H OMe 2-Me-4-SCF2H
Br 2-Me-4-SOCF H 2-Me-4-S0CF2H OMe 2-Me-4-SOCF2H
Br 2-Me-4-S02CF2H 2-Me-4-S02CF2H OMe 2-Me-4-S02CF2H
CF3 2-Me-4-CF3 N02 2-Me-4-CF3 SMe 2-Me-4-CF3
CF3 2-Me-4-OCF3 N02 2-Me-4-OCF3 SMe 2-Me-4-0CF3
CF3 2-Me-4-OCF2H N02 2-Me-4-OCF2H SMe 2-Me-4-OCF2H
CF3 2-Me-4-OCH2CF3 N02 2-Me-4-OCH2CF3 SMe 2-Me-4-OCH2CF3
CF3 2-Me-4-SCF3 N02 2-Me-4-SCF3 SMe 2-Me-4-SCF3
CF3 2-Me-4-SOCF3 N02 2-Me-4-SOCF3 SMe 2-Me-4-SOCF3
CF3 2-Me-4-S02CF3 N02 2-Me-4-S02CF3 SMe 2-Me-4-S02CF3
CF3 2-Me-4-SCF2H N02 2-Me-4-SCF2H SMe 2-Me-4-SCF2H
CF3 2-Me-4-SOCF2H N02 2-Me-4-SOCF2H SMe 2-Me-4-SOCF2H
CF3 2-Me-4-S02CF2H N02 2-Me-4-S02CF2H SMe 2-Me-4-S02CF2H 7f
Table 11
Figure imgf000076_0001
Figure imgf000077_0001
Figure imgf000078_0001
O O O O O O O 0 O O O
TJ O O 0 O O 0 0 O O
T0l T0j 0j T0j 0 Tj 0 Tj 0 Tj 0 O 0 0 0
Tl Tl o o
Tl TJ TJ TJ TJ TJ Tl TJ TJ TJ Q T TJ TJ to to to to to to to to to to to CO CO co CO CO co CO co C O CO 2 2 P
X X X X
Figure imgf000078_0002
O O O O O O O O O O O
O O O . 0 0 0 0 0 0 0 0 0 0 0 0 0 0 j Tj Tj o o
2 2 2 o o o o o o o o 0 0 0 0 0 0 0 0 _ ^ Tj Tj Tj Tj Tl T Tl Tj T] Tj T to to to to t to to to to to to j oj w co TJ coTJ coTI coTI coTI coTJ cToJ coTJ 2 2
Figure imgf000078_0003
El (E^m El (Mhn . El iώm
Br 2-Me-4-OCH2CF3 2-Me-4-OCH2CF3 OMe 2-Me-4-OCH2CF3
Br 2-Me-4-SCF3 2-Me-4-SCF3 OMe 2-Me-4-SCF3
Br 2-Me-4-SOCF3 2-Me-4-SOCF3 OMe 2-Me-4-SOCF3
Br 2-Me-4-S02CF3 2-Me-4-S0 CF3 OMe 2-Me-4-S02CF3
Br 2-Me-4-SCF2H 2-Me-4-SCF2H OMe 2-Me-4-SCF2H
Br 2-Me-4-SOCF2H 2-Me-4-SOCF2H OMe 2-Me-4-SOCF2H
Br 2-Me-4-S02CF2H 2-Me-4-S0 CF2H OMe 2-Me-4-S0 CF2H
CF3 2-Me-4-CF3 N02 2-Me-4-CF3 SMe 2-Me-4-CF3
CF3 2-Me-4-OCF3 N02 2-Me-4-OCF3 SMe 2-Me-4-OCF3
CF3 2-Me-4-OCF2H N02 2-Me-4-OCF2H SMe 2-Me-4-OCF2H
CF3 2-Me-4-OCH2CF3 N02 2-Me-4-OCH2CF3 SMe 2-Me-4-OCH2CF3
CF3 2-Me-4-SCF3 N02 2-Me-4-SCF3 SMe 2-Me-4-SCF3
CF3 2-Me-4-SOCF3 N02 2-Me-4-SOCF3 SMe 2-Me-4-SOCF3
CF3 2-Me-4-S02CF3 N02 2-Me-4-S02CF3 SMe 2-Me-4-S02CF3
CF3 2-Me-4-SCF2H N02 2-Me-4-SCF2H SMe 2-Me-4-SCF2H
CF3 2-Me-4-SOCF2H N02 2-Me-4-SOCF2H SMe 2-Me-4-SOCF2H
CF3 2-Me-4-S02CF2H N02 2-Me-4-S02CF H SMe 2-Me-4-S02CF2H Table 12
Figure imgf000079_0002
4-CF3
4-OCF3
4-OCF2H
4-OCF2CF2H
4-OCH2CF3
4-SCF3
4-SOCF3
Figure imgf000079_0001
4-S02CF3
Figure imgf000080_0001
Figure imgf000081_0001
oTj oj oj oTl oTj oT o*τj o Tl Toj oTj oTj o O O o o o O O O O ) ) ) ) ) i > i > 2 2
Figure imgf000081_0002
rt 2 rt rt 2 ct 2 rt 2 rt 2 rt 2 rt 2 rt 2 rt
Figure imgf000081_0003
o O T o Tj o Tj o Tl o Tj o Tj oj o Tj o Tj o O Tj o Tj o o O o o o o o > ) Ϊ Uϊ U> ) ) > 2 rt 2 rt 2 2 r 2 2 rt 2 rt c 2 2 2
Figure imgf000081_0004
rt
Figure imgf000081_0005
El iStm El (*h El ffi- tn
OCF2H 2-SCF3 OCF2H 3-SCF3 OCF2H 4-SCF3
OCF2H 2-SOCF3 OCF2H 3-SOCF3 OCF2H 4-SOCF3
OCF2H 2-S02CF3 OCF2H 3-S02CF3 OCF2H 4-S02CF3
OCF2H 2-SCF2H OCF2H 3-SCF2H OCF2H 4-SCF2H
OCF2H 2-SOCF2H OCF2H 3-SOCF2H OCF2H 4-SOCF2H
OCF2H 2-S02CF2H OCF2H 3-S02CF2H OCF2H 4-S02CF2H
Me 2-Me-4-CF3 F 2-Me-4-CF3 CI 2-Me-4-CF3
Me 2-Me-4-OCF3 F 2-Me-4-OCF3 CI 2-Me-4-OCF3
Me 2-Me-4-OCF2H F 2-Me-4-OCF2H CI 2-Me-4-OCF2H
Me 2-Me-4-OCH2CF3 F 2-Me-4-OCH2CF3 CI 2-Me-4-OCH2CF3
Me 2-Me-4-SCF3 F 2-Me-4-SCF3 CI 2-Me-4-SCF3
Me -Me-4-SOCF3 F 2-Me-4-SOCF3 CI 2-Me-4-SOCF3
Me 2-Me-4-S02CF3 F 2-Me-4-S0 CF3 CI 2-Me-4-S02CF3
Me 2-Me-4-SCF2H F 2-Me-4-SCF2H CI 2-Me-4-SCF2H
Me 2-Me-4-SOCF2H F 2-Me-4-SOCF2H CI 2-Me-4-SOCF2H
Me 2-Me-4-S02CF2H F 2-Me-4-S02CF2H CI 2-Me-4-S02CF2H
Br 2-Me-4-CF3 2-Me-4-CF3 OMe 2-Me-4-CF3
Br 2-Me-4-OCF3 2-Me-4-OCF3 OMe 2-Me-4-OCF3
Br 2-Me-4-OCF2H 2-Me-4-OCF2H OMe 2-Me-4-OCF2H
Br 2-Me-4-OCH2CF3 2-Me-4-OCH2CF3 OMe 2-Me-4-OCH2CF3
Br 2-Me-4-SCF3 2-Me-4-SCF3 OMe 2-Me-4-SCF3
Br 2-Me-4-SOCF3 2-Me-4-SOCF3 OMe 2-Me-4-SOCF3
Br 2-Me-4-S02CF3 2-Me-4-S02CF3 OMe 2-Me-4-S02CF3
Br 2.Me-4-SCF2H 2-Me-4-SCF2H OMe 2-Me-4-SCF2H
Br 2-Me-4-SOCF2H 2-Me-4-SOCF2H OMe 2-Me-4-SOCF2H
Br 2-Me-4-S02CF2H 2-Me-4-S02CF2H OMe 2-Me-4-S0 CF2H
CF3 2-Me-4-CF3 N02 2-Me-4-CF3 SMe 2-Me-4-CF3
CF3 2-Me-4-OCF3 N02 2-Me-4-OCF3 SMe 2-Me-4-OCF3
CF3 2-Me-4-OCF2H N02 2-Me-4-OCF2H SMe 2-Me-4-OCF2H
CF3 2-Me-4-OCH2CF3 N02 2-Me-4-OCH2CF3 SMe 2-Me-4-OCH2CF3
CF3 2-Me-4-SCF3 N02 2-Me-4-SCF3 SMe 2-Me-4-SCF3
CF3 2_Me-4-SOCF3 N02 2-Me-4-SOCF3 SMe 2-Me-4-SOCF3
CF3 2-Me-4-S02CF3 N02 2-Me-4-S02CF3 SMe 2-Me-4-S02CF3
CF3 2-Me-4-SCF2H N02 2-Me-4-SCF2H SMe 2-Me-4-SCF2H
CF3 2-Me-4-SOCF2H N02 2-Me-4-SOCF2H SMe 2-Me-4-SOCF2H
CF3 2-Me-4-S02CF2H N02 2-Me-4-S02CF2H SMe 2-Me-4-S02CF2H 8: )
Table 13
Figure imgf000083_0001
Figure imgf000084_0001
El ffillm l (E^m El (E^m
OMe 2-SOCF2H OMe 3-SOCF2H OMe 4-SOCF2H
OMe 2-S02CF2H OMe 3-S02CF2H OMe 4-S02CF2H
CF3 2-CF3 CF3 3-CF3 CF3 4-CF3
CF3 2-OCF3 CF3 3-OCF3 CF3 4-OCF3
CF3 2-OCF2H CF3 3-OCF2H CF3 4-OCF2H
CF3 2-OCF2CF2H CF3 3-OCF2CF2H CF3 4-OCF2CF2H
CF3 2-OCH2CF3 CF3 3-OCH2CF3 CF3 4-OCH2CF3
CF3 2-SCF3 CF3 3-SCF3 CF3 4-SCF3
CF3 2-SOCF3 CF3 3-SOCF3 CF3 4-SOCF3
CF3 2-S02CF3 CF3 3-S02CF3 CF3 4-S02CF3
CF3 2-SCF2H CF3 3-SCF2H CF3 4-SCF2H
CF3 2-SOCF2H CF3 3-SOCF2H CF3 4-SOCF2H
CF3 2-S02CF2H CF3 3-S02CF2H CF3 4-S02CF2H
OCF2H 2-CF3 OCF2H 3-CF3 OCF2H 4-CF3
OCF2H 2-OCF3 OCF2H 3-OCF3 OCF2H 4-OCF3
OCF2H 2-OCF2H OCF2H 3-OCF2H OCF2H 4-OCF2H
OCF2H 2-OCF2CF2H OCF2H 3-OCF2CF2H OCF2H 4-OCF2CF2H
OCF2H 2-OCH2CF3 OCF2H 3-OCH2CF3 OCF2H 4-OCH2CF3
OCF2H 2-SCF3 OCF2H 3-SCF3 OCF2H 4-SCF3
OCF2H 2-SOCF3 OCF2H 3-SOCF3 OCF2H 4-SOCF3
OCF2H 2-S02CF3 OCF2H 3-S02CF3 OCF2H 4-S02CF3
OCF2H 2-SCF2H OCF2H 3-SCF2H OCF2H 4-SCF2H
OCF2H 2-SOCF2H OCF2H 3-SOCF2H OCF2H 4-S0CF2H
OCF2H 2-S02CF2H OCF2H 3-S02CF2H OCF2H 4-S02CF2H
Me 2-Me-4-CF3 F 2-Me-4-CF3 CI 2-Me-4-CF3
Me 2-Me-4-0CF3 F 2-Me-4-OCF3 CI 2-Me-4-OCF3
Me 2-Me-4-OCF2H F 2-Me-4-OCF2H CI 2-Me-4-OCF2H
Me 2-Me-4-OCH2CF3 F 2-Me-4-OCH2CF3 CI 2-Me-4-OCH2CF3
Me 2-Me-4-SCF3 F 2-Me-4-SCF3 CI 2-Me-4-SCF3
Me 2-Me-4-SOCF3 F 2-Me-4-SOCF3 CI 2-Me-4-SOCF3
Me 2-Me-4-S02CF3 F 2-Me-4-S02CF3 CI 2-Me-4-S02CF3
Me 2-Me-4-SCF2H F 2-Me-4-SCF2H CI 2-Me-4-SCF H
Me 2-Me-4-SOCF2H F 2-Me-4-SOCF2H CI 2-Me-4-SOCF2H
Me 2-Me-4-S02CF2H F 2-Me-4-S02CF2H CI 2-Me-4-S02CF2H
Br 2-Me-4-CF3 I 2-Me-4-CF3 OMe 2-Me-4-CF3
Br 2-Me-4-OCF3 I 2-Me-4-OCF3 OMe 2-Me-4-OCF3
Br 2-Me-4-OCF2H I 2-Me-4-OCF2H OMe 2-Me-4-OCF2H El (B m El ( m El ( ^m
Br 2-Me-4-OCH2CF3 2-Me-4-OCH2CF3 OMe 2-Me-4-OCH2CF3
Br 2-Me-4-SCF3 2-Me-4-SCF3 OMe 2-Me-4-SCF3
Br 2-Me-4-SOCF3 2-Me-4-SOCF3 OMe 2-Me-4-SOCF3
Br 2-Me-4-S02CF3 2-Me-4-S02CF3 OMe 2-Me-4-S02CF3
Br 2-Me-4-SCF2H 2-Me-4-SCF2H OMe 2-Me-4-SCF2H
Br 2-Me-4-SOCF2H 2-Me-4-SOCF2H OMe 2-Me-4-SOCF2H
Br 2-Me-4-S02CF2H 2-Me-4-S02CF2H OMe 2-Me-4-S02CF2H
CF3 2-Me-4-CF3 N02 2-Me-4-CF3 SMe 2-Me-4-CF3
CF3 2-Me-4-OCF3 N02 2-Me-4-OCF3 SMe 2-Me-4-OCF3
CF3 2-Me-4-OCF2H N02 2-Me-4-OCF2H SMe 2-Me-4-OCF2H
CF3 2-Me-4-OCH2CF3 N02 2-Me-4-OCH2CF3 SMe 2-Me-4-OCH2CF3
CF3 2-Me-4-SCF3 N02 2-Me-4-SCF3 SMe 2-Me-4-SCF3
CF3 2-Me-4-SOCF3 N02 2-Me-4-SOCF3 SMe 2-Me-4-SOCF3
CF3 2-Me-4-S0 CF3 N02 2-Me-4-S02CF3 SMe 2-Me-4-S0 CF3
CF3 2-Me-4-SCF2H N02 2-Me-4-SCF2H SMe 2.Me-4-SCF2H
CF3 2-Me-4-SOCF2H N02 2-Me-4-SOCF2H SMe 2-Me-4-SOCF2H
CF3 2-Me-4-S02CF2H N02 2-Me-4-S02CF2H SMe 2-Me-4-S02CF2H Table 14
Figure imgf000086_0001
El ffiS El £E!}m El &hm
Me 2-CF3 Me 3-CF3 Me 4-CF3
Me 2-OCF3 Me 3-OCF3 Me 4-OCF3
Me 2-OCF2H Me 3-OCF2H Me 4-OCF2H
Me 2-OCF2CF2H Me 3-OCF2CF2H Me 4-OCF2CF2H
Me 2-OCH2CF3 Me 3-OCH2CF3 Me 4-OCH2CF3
Me 2-SCF3 Me 3-SCF3 Me 4-SCF3
Me 2-SOCF3 Me 3-SOCF3 Me 4-SOCF3
Me 2-S02CF3
Figure imgf000086_0002
Me 3-S02CF3
Figure imgf000086_0003
Me 4-S02CF3 _ -θ D3 te ro co cσ ∑3 D -c co co o o o o o
Figure imgf000087_0001
»H 03 3 03 03 O3 O3 03 03 O3 C0 O3 TJ TJ TJ O O O O O
Figure imgf000087_0002
- CO CO CO CO CO CO CO CO CO C CO Tl J 0 0 0 0 0
Figure imgf000087_0003
o o o o o o o o o o o o O O O O O O o o o O o o o o O O O
Tl TJ Tl l Tl TJ TJ TJ Tl TJ TJ J TJ to Tl J o to to to co 2 rt 2 rt r 2t 2 rt 2 r 2 r 2 rt r 2t 2 rt 2 rt P
X X X X X
Figure imgf000088_0001
o o o o o o o o o o o o o o o O O O O
Tl T oj T oj T oj T oj T oj T oj o o o O O o C > > > > u 2 rt 2 rt 2 rt 2 rt 2 rt 2 rt 2 ct 2 ct 2 rt 2 r 2 rt FL
X X X X X
Figure imgf000088_0002
O O O O O O O O O O O O O O O O
Tj Tj Tj Tj j Tj Tj Tj Tj Tj Tj o o o O o O O O O O O O O
Tl o Tl Tl o τ o TJ tO t t tO ) > ) ) ) r 2t r 2t r 2t r 2t r 2t r 2t r 2t r 2t r 2t r 2t r 2t P
Figure imgf000088_0003
El Eirn El (E^m El ®hm
OCF2H 2-SCF3 OCF2H 3-SCF3 OCF2H 4-SCF3
OCF2H 2-SOCF3 OCF2H 3-SOCF3 OCF2H 4-SOCF3
OCF2H 2-S02CF3 OCF2H 3-S02CF3 OCF2H 4-S02CF3
OCF2H 2-SCF2H OCF2H 3-SCF2H OCF2H 4-SCF H
OCF2H 2-S0CF2H OCF2H 3-SOCF2H OCF2H 4-SOCF2H
OCF2H 2-S02CF2H OCF2H 3-S02CF2H OCF2H 4-S02CF2H
Me 2-Me-4-CF3 F 2-Me-4-CF3 CI 2-Me-4-CF3
Me 2-Me-4-OCF3 F 2-Me-4-OCF3 CI 2-Me-4-OCF3
Me 2-Me-4-OCF2H F 2-Me-4-OCF2H CI 2-Me-4-OCF2H
Me 2-Me-4-OCH2CF3 F 2-Me-4-OCH2CF3 CI 2-Me-4-OCH2CF3
Me 2-Me-4-SCF3 F 2-Me-4-SCF3 CI 2-Me-4-SCF3
Me 2-Me-4-SOCF3 F 2-Me-4-SOCF3 CI 2-Me-4-SOCF3
Me 2-Me-4-S02CF3 F 2-Me-4-S02CF3 CI 2-Me-4-S02CF3
Me 2-Me-4-SCF2H F 2-Me-4-SCF2H CI 2-Me-4-SCF2H
Me 2-Me-4-SOCF2H F 2-Me-4-S0CF2H CI 2-Me-4-SOCF2H
Me 2-Me-4-S02CF2H F 2-Me-4-S02CF2H CI 2-Me-4-S02CF2H
Br 2-Me-4-CF3 2-Me-4-CF3 OMe 2-Me-4-CF3
Br 2-Me-4-OCF3 2-Me-4-OCF3 OMe 2-Me-4-0CF3
Br 2-Me-4-OCF2H 2-Me-4-OCF2H OMe 2-Me-4-OCF2H
Br 2-Me-4-OCH2CF3 2-Me-4-OCH2CF3 OMe 2-Me-4-OCH2CF3
Br 2-Me-4-SCF3 2-Me-4-SCF3 OMe 2-Me-4-SCF3
Br 2-Me-4-SOCF3 2-Me-4-SOCF3 OMe 2-Me-4-SOCF3
Br 2-Me-4-S02CF3 2-Me-4-S02CF3 OMe 2-Me-4-S02CF3
Br 2-Me-4-SCF2H 2-Me-4-SCF2H OMe 2-Me-4-SCF2H
Br 2-Me-4-SOCF2H 2-Me-4-SOCF2H OMe 2-Me-4-SOCF2H
Br 2-Me-4-S02CF2H 2-Me-4-S02CF2H OMe 2-Me-4-S02CF2H
CF3 2-Me-4-CF3 N02 2-Me-4-CF3 SMe 2-Me-4-CF3
CF3 2-Me-4-OCF3 N02 2-Me-4-OCF3 SMe 2-Me-4-OCF
CF3 2-Me-4-OCF2H N02 2-Me-4-OCF2H SMe 2-Me-4-OCF2H
CF3 2-Me-4-OCH2CF3 N02 2-Me-4-OCH2CF3 SMe 2-Me-4-OCH2CF3
CF3 2-Me-4-SCF3 N02 2-Me-4-SCF3 SMe 2-Me-4-SCF3
CF3 2-Me-4-SOCF3 N02 2-Me-4-SOCF3 SMe 2-Me-4-SOCF3
CF3 2-Me-4-S02CF3 N02 2-Me-4-S02CF3 SMe 2-Me-4-S02CF3
CF3 2-Me-4-SCF2H N02 2-Me-4-SCF2H SMe 2-Me-4-SCF2H
CF3 2-Me-4-SOCF2H N02 2-Me-4-SOCF2H SMe 2-Me-4-SOCF2H
CF3 2-Me-4-S02CF2H N02 2-Me-4-S02CF2H SMe 2-Me-4-S02CF2H NI υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ
>\ X X X X X X X X X X X X X υ o υ υ υ υ υ υ υ o o υ υ Z Z Z Z Z Z Z Z Z Z Z Z Z
Figure imgf000090_0001
Figure imgf000090_0002
m
90 T
© r~- --. r- °° 00 OO © 0 --' --' rn m _ ι__ oo oo T 00 00 — <— < en en
© CN CS m m rn m en en i --. ,—. — en m m en en en CN Wl CN CN
© « ^ ^ J i_-j !_4 ^ -. A £ --* π fc t- ^
IΛ
©
NI X X X X X X X X X X U PC MN HM ϊ HH HM H X H 3H πt-I MM H--» M υ υ υ υ z z z z z z z z l-C W U »- υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ o υ υ H α.
H Z Z Z υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ ^ Z £ Z Z Z Z Z Z Z Z
XI υ υ υ υ υ υ υ υ υ υ υ υ z z z z z z z z z z z z U U U O O O O J U U O
<υ u ω u ω u to u ϋ u ω U fu α u υ cu υ 1 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 ' υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ
en en en en en en en en en en en en en en en en en en en en m rn rn en en en m en en en en en en en rn m oil C_, ^ U< CL, _-, C-< fc fc fc fc fc fc l--1 fc fc υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ b υ υt-4 pυ_, Cυ4 Uυ-l fcυ fcυ fcυ fcυ fcυ fcυ fcυ fcυ fcυ fcυ fcυ fcυ fcυ fcυ fcυ tυ-l
ε :ι _ α> to α , , α> ω ,__ α> , <u — . 0) υ 2 υ 2 2 υ 2 υ 2 υ 2 υ υ s s 2 oi T T T fc T ^J- -i </ι fN CN ^O KO ■* «* , rt 2 9 2 9 2 υ υ cή >Λ CS o 4 ^r 2 rf 9 "* fc 2 42 9 "* ι 2A 9 ""> tN
3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3
^1 m m m ffl ffl ffl m m pQ CQ i-q C0 p. α n co si n CQ CQ pa pa pa
Figure imgf000091_0001
O CO O o O CO to CO CO CO CO CO CO to to CO
CO CO © © 00 00 4- ∞ OO CO co o © 00 oo -fc- CO L*
Figure imgf000092_0001
TJ l TJ TJ TJ ύ U ύ t U ClI BI tE D tS O iJ CD w ^, c c c c c c c c c c c c c c 1
Figure imgf000092_0002
2 r o
Figure imgf000092_0003
o o o o o o o o o o o o o o o o o o o o o o o o o .^, χ oχ χo oχ oχ oχ oχ oχ oχ oχ Ω2 Ω2 Q2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 1^
z z z z z z z z z z z z z z z z z z z z z z z g g g g g g g g g g g g g gix
o o o o g o o o o o o o o o o o o o o o o o o o o o o o o o o z z z Z Z Z
o X oX oX oX oX oX oX oX oX oX oX oX oX oX oX oX oX oX oX oX oX oX oX z z z z z z z o o o o o o IN
75 75 75 75 75 75 75 7 co CO LO CO CO O to .5 7.5 7.5 ^ 7! ^ ^ κ co LO ^-> --> o o oo
7? Ti 7s 75 75 75 75 O 75 75 o O to J I— — — ' ' o 00 00 *- OO 00 I
J -? I I*c.
2 ft o 2 tt 2 rt o 2 r o 2 ft |3 π
Figure imgf000093_0001
Figure imgf000093_0002
o o o o o o o o o o o o o Z Z Z IX
Z Z Z Z Z Z Z Z Z
Figure imgf000093_0003
o o o o o o o o o H ?H ^ X HH --i li---H HH IN
Z Z Z Z Z Z Z Z Z Z Z Z Z O O O x x x IN
75 75 75 75 75 75 75 t _- _. _ 75 75 75 7 75 5 75 75 75 7 7 75 75 75 75 75 75 75 75 75 75 75 75 75
C CO LO LO LO to LO CO CO CO O CO . . . 75 75 co co co 175
00 4-. OO 00 CO LO 1— © © 00 00 4-. 00 00 -^ CO O -— © © 00 00 4-. 00 00 co co ►—
71 to fc f> r 4-- -. • σi Os to t tiϊ'
2 2 O O rt ft 2 rt o 2 o ό — 2 rt o 2 ft 0 — 2 rt 2 r o 2 ft o — o o 2 r o 2 r Q 2 o 2 0 2 2 0 2 'fc ct a 1—' ct 1 ' rt 13
Figure imgf000094_0001
o o 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 0 0 0 0 0 0 0 0 0 0 0 0 0 O O O Ε K Ε IΕ S Ε K WH MH I-^ H H 2 2 2 IX
Z Z Z Z Z Z Z ZΪ Z Z Z Z Z Z Z Z Z Z Z Z Z Z Z Z Z Z Z Z Z Z Z Z Z Z Z
Figure imgf000094_0002
CN
90 IΛ
SO ©_
CS
©
& Nl Xυ Xυ X υ υX υX υ g15 Q5 g'5 g'3 g*2 g^: g: g! g g'S υ 2 2υ 2υ 2υ 2υ 2υ 2υ 2υ υ2 2υ 2υ 2υ υ2 υ2 υ2 2υ υ fc
H Z Z Z Z Z Z Z Z Z Z Z Z Z Z Z Z Z Z Z X X X X X X X X X X X X υ υ υ υ υ υ υ υ υ υ υ υ υ
XI 2 2 2 2 2 ^ X X X X X X X X |>--H H υ υ υ υ υ 2 l- ϊ W υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ z z z z z z z z z z z z
.22 en m m s cs CN cs cs cs oi fc en en en m n en en en cs fc m fc fc fc fc e fc m en en en en fc fc n fc fc fc en fc fc en fc b fc e fc fc fc fc fc fc fc fc fc fc u. fc fc υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ X X X X X X X X X X X X
OI £. CN fN CN cs cs CN CN cs s cs cs cs cs s fN CN CN fN CN υ υ υ υ υ υ υ υ υ υ υ υ υ
X X X X X X X X X X X X X X X X X X X cs cs cs cs cs tN fN fc fc cs cs υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ fc fc fc cs fc fc fc fc z z z z z z z z z z z z z z z z z z z z υ υ υ υ υ cT fc fc υ υ υ υ υ υ υ υ z z z z z z z z z z z z z
ci e_> . | ___, _ — <υ , cu ω _ cu ω — . <u _ cu __ cu _ 1 υ 2 υ 2 υ 2 υ υ 2 9 2 2 9 2 υ 2 υ 2 υ 2 u 2 9 2 2 9 2 9 2 2 9 el T in v> ( s vθ so 4 ^ 4 ^ « «r CN cs O so T ^r ■T ^ — T ^ <n "> cs so O
m
90 00 © © en OO -T 00 00 © © --. en en 00 00 00 00 © © --• en m T en — — 1 — CS s m rn en en m en cs cs en en en en en © fc-51 cs rn rn en en en CI — , _ OO r~- ^ i _-*i fc^-5 i^4 ^ ^ ^ ^ i-, ^
©_
CN
©
75 75 75 75 75 75 75 75 *; * 75 75 75 7! 75 75 75 75 75 75 75 w w 75 75 75 75 75 75 75 75 75 75
CO to to CO LO CO CO CO t O CO CO O co co to to ■ fc ■ fc ■ fc ,!_ _ E I7X
— © © 00 oo CO CO — © © 00 CO CO —' —- © © 00
2 ft o 2 tt o 2 c o o o 2 tt o 2 O 2 ό 2 2 ό 2 ό 2 rt ό 2 o 2 c ό 2 o — r ≤t 2 o 2 o ft 13
Figure imgf000096_0001
Z Z Z Z Z Z Z Z Z Z Z Z Z Z Z Z Z Z Z Z Z Z Z Z Z Z Z Z Z Z Z Z Z Z Z Z
o X oX oX oX oX oX oX oX oX oX Gfc Gfc Gfc Gfc Gfc Gfc Gfc Gfc Gfc Gfc Gfc Gfc Gfc ox ox ox ox ox ox ox ox ox ox ox ox ox IN
CU ι--i rj
Figure imgf000097_0001
H Z Z Z Z Z Z Z Z Z Z Z Z Z Z Z Z Z Z Z Z Z Z Z Z *7 '7 '7 '7 fc X X X X X
^ ^ ^ ^ υ υ υ
XI i '5 '5 '5 '5 ' i 5 >S ^ '5 '-> ^ '5 '5 'S ^ X X X X X X X X X r^ rl ^ Z Z υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ u υ υ υ υ υ υ υ υ υ o
Figure imgf000097_0002
— « α — — <_> _ <u — <u _ υ s υ 9 2 2 υ υ υ 2 9 2 9 2 9 2 2 9 2 vo 4 ■<-■ -5- fc 4 > 4 ^ T ^r ~ -* 2 9 2 υ υ 2 9 2 2 so -* >A "^ 4 -5- 4 4
m
90 —i en en r_l ,_ OO 00 T OO 00 © © — en 00 © © ^- — , cs en en m en f> — , _ 00 00 T 00 rn , , _, _-, _. CN t*1 n „ _, J- oo T m m en CN m en en en m m i i — - CN
© - r~- X u u W &-! s i4 ^ ^ i i4 i4 ^ ^ ώ W W ^ ϊi-5 tϊ -l H-C HH HH >-S ύ-l ύ-ϊ 5*5 i-J Ϊ t-d ^ ^
©
© O
l 2 2 2 2 fc fc fc fc υ υ υ υ co cQ co co υ
Figure imgf000098_0001
Figure imgf000098_0002
CI CD —
9 2 2
. X X X X X X X X X X X X X X X X X xi υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ
m
90 © © en m T m m rn m m m
© l-.il ^--.1 W K t-H K l-C K C | --i ϊ i-X-t fc- HM H l-C - r~- « -5 -^ « H- -< >l υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ
©
© o Ml i_-! ^ ^ ^ ^ -«, i ^ --i ^ ^ l--; --i fc- t- --i
7 I5 7 I5 7 I5 7 I5 7 (5 7 I5 7 I5 7 I5 7 I5 7 I5 7 I5 7 I: 7 I5 7 I5 715 : π* 75 75 75 75 75 75 75 75 75 75 75 75 75 75 75 75 75 75 75 75 75 75
00 00 00 00 00 00 00 00 00 00 00 00 00 00 00 '—
Figure imgf000099_0001
O O O O O O O O O O O O O O O O 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 o b-u S t-C 3- 3--! Ϊ-C X X Ε X 1Ε S X X X X X X X X X X X
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 o 0 0 0 0 0 0 0 0 0 0 0
X X X X X X X X X X X X
O O O O O O O O O O O O O O O Z Z Z Z Z Z Z z z z z z z z z Z z Z z Z O O 0
X X X s O
Figure imgf000099_0002
4-. fc ό 2 2 ό o 2 2 o ό 2 2 rt ό — ό •— 2 2 o ό 2 2 a ό — ό — 2 2 o 2 2 ό o 2 2 o ό 2 2 o o 2
0 TJ 0Tj 0Tj 0Tj 0J 0j 0j 0Tj 0Tj 0Tj 0Tj 0j 0j 0j 0Tj 0Tj 0Tj 0Tj 0Tj 0Tj 0j 0Tj 0Tj 0Tj 0Tj 0Tj 0j 0Tj 0Tj 0j 0Tj 0Tj 0T] 0j 0Tj 0Tj 0Tj 0Tj
03 D0 03 O O O O "1 >I1 2 ct 2rt 2ft 2ft
Figure imgf000099_0003
Figure imgf000099_0004
K-l 8 CH CH CH CH t-Bu 4-C1 CF3 Br
K-18 CH CH CH CH /-Pr 4-Me CF3 CN
K-l 8 CH CH CH CH t-Bu 4-Me CF3 CN
K-18 CH CH CH CH z'-Pr 4-C1 CF3 CN
K-18 CH CH CH CH t-Bu 4-C1 CF3 CN
K-18 CH CH CH N /-Pr 4-Me CF3 Me
K-18 CH CH CH N f-Bu 4-Me CF3 Me
K-18 CH CH CH N /-Pr 4-C1 CF3 Me
K-18 CH CH CH N f-Bu 4-C1 CF3 Me
K-18 CH CH CH N /-Pr 4-Me CF3 F
K-18 CH CH CH N f-Bu 4-Me CF3 F
K-18 CH CH CH N /-Pr 4-C1 CF3 F
K-18 CH CH CH N t-Bu 4-C1 CF3 F
K-18 CH CH CH N /-Pr 4-Me CF3 CI
K-18 CH CH CH N t-Bu 4-Me CF3 CI
K-18 CH CH CH N /-Pr 4-C1 CF3 CI
K-18 CH CH CH N t-Bu 4-C1 CF3 CI
K-18 CH CH CH N /-Pr 4-Me CF3 Br
K-18 CH CH CH N f-Bu 4-Me CF3 Br
K-18 CH CH CH N /-Pr 4-C1 CF3 Br
K-18 CH CH CH N t-Bu 4-C1 CF3 Br
K-18 CH CH CH N /-Pr 4-Me CF3 CN
K-18 CH CH CH N t-Bu 4-Me CF3 CN
K-18 CH CH CH N /-Pr 4-C1 CF3 CN
K-18 CH CH CH N t-Bu 4-C1 CF3 CN
K-14 CH CH CH CH /-Pr 1-Me CF3 Me
K-14 CH CH CH CH t-Bu 1-Me CF3 Me
K-14 CH CH CH CH /-Pr 1-Me CF3 F
K-14 CH CH CH CH t-Bu 1-Me CF3 F
K-14 CH CH CH CH /-Pr 1-Me CF3 CI
K-14 CH CH CH CH t-Bu 1-Me CF3 CI
K-14 CH CH CH CH /-Pr 1-Me CF3 Br
K-14 CH CH CH CH t-Bu 1-Me CF3 Br
K-14 CH CH CH CH /-Pr 1-Me CF3 CN
K-14 CH CH CH CH t-Bu 1-Me CF3 CN
K-14 CH CH CH N /-Pr 1-Me CF3 Me
K-14 CH CH CH N f-Bu 1-Me CF3 Me
K-14 CH CH CH N /-Pr 1-Me CF3 F K-14 CH CH CH N f-Bu 1-Me CF3 F
K-14 CH CH CH N /-Pr 1-Me CF3 CI
K-14 CH CH CH N f-Bu 1-Me CF3 CI
K-14 CH CH CH N /-Pr 1-Me CF3 Br
K-14 CH CH CH N f-Bu 1-Me CF3 Br
K-14 CH CH CH N /-Pr 1-Me CF3 CN
K-14 CH CH CH N f-Bu 1-Me CF3 CN
K-28 CH CH CH CH /-Pr 4-Me CF3 Me
K-28 CH CH CH CH f-Bu 4-Me CF3 Me
K-28 CH CH CH CH /-Pr 4-C1 CF3 Me
K-28 CH CH CH CH f-Bu 4-C1 CF3 Me
K-28 CH CH CH CH /-Pr 4-Me CF3 F
K-28 CH CH CH CH f-Bu 4-Me CF3 F
K-28 CH CH CH CH /-Pr 4-C1 CF3 F
K-28 CH CH CH CH f-Bu 4-C1 CF3 F
K-28 CH CH CH CH /-Pr 4-Me CF3 CI
K-28 CH CH CH CH f-Bu 4-Me CF3 CI
K-28 CH CH CH CH /-Pr 4-C1 CF3 CI
K-28 CH CH CH CH f-Bu 4-C1 CF3 CI
K-28 CH CH CH CH /-Pr 4-Me CF3 Br
K-28 CH CH CH CH f-Bu 4-Me CF3 Br
K-28 CH CH CH CH /-Pr 4-C1 CF3 Br
K-28 CH CH CH CH f-Bu 4-C1 CF3 Br
K-28 CH CH CH CH /-Pr 4-Me CF3 CN
K-28 CH CH CH CH f-Bu 4-Me CF3 CN
K-28 CH CH CH CH /-Pr 4-C1 CF3 CN
K-28 CH CH CH CH f-Bu 4-C1 CF3 CN
K-28 CH CH CH N /-Pr 4-Me CF3 Me
K-28 CH CH CH N f-Bu 4-Me CF3 Me
K-28 CH CH CH N /-Pr 4-C1 CF3 Me
K-28 CH CH CH N f-Bu 4-C1 CF3 Me
K-28 CH CH CH N /-Pr 4-Me CF3 F
K-28 CH CH CH N f-Bu 4-Me CF3 F
K-28 CH CH CH N /-Pr 4-C1 CF3 F
K-28 CH CH CH N f-Bu 4-C1 CF3 F
K-28 CH CH CH N /-Pr 4-Me CF3 CI
K-28 CH CH CH N f-Bu 4-Me CF3 CI
K-28 CH CH CH N /-Pr 4-C1 CF3 CI 75 75 7^ 7^ 75 75 75 75 75 75 75 75 75 75 75 75 75 7^ 7^ 75 7^ 7^ 75 75 75 75 75 75 75 75 75 75 75 75 75 75 75 75 co co co co co to to to to to to to to
© © © © © © © © © © © © © © ©
O O O O O O O O O O O O O O O O O O O O O O O O O O O o o o o o o o o o o o
H-H HH <U t--H M--J 3- ≠C H MM MM W MM MM MM MM S MM ϊ M MM X X X X X X X X X X X
O X OX O O O O O O O O O O O O O OX OX OX OX OX OX OX OX OX OX OX O 0 0 0 0 0 0 0 o o o o X X X X X X X X X X X X X X X X X X
0 0 0 0 0 0 0 0 o o 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
X X X HU X H X C 3- ϊ C ^C X HC H-- X 7-t X XX iJU X-l JM •£ X u X 3 «-E M J-
z z z z z z z z z o o o o o o o o o o o o o o o o o o o z z z z z z z z z
X X i-C X X t-M H X X 3- ^-C 3-ϊ «-C X X X X X X X
Tj 03 TJ ro TJ no TJ ID TJ J TJ ID TJ m TJ m 3 03 03 TJ 03 DO 3> 03 c c c c c c c 3 co 3 TJ 03 DO TJ 03 J DO 0 c c -1 C "• c c c c ^ c
~ CΛ n ™ ™ n cft ^ ^ Cn cn - --- Λ Cn --, „ n LΛ --, ;--, LΛ t-n _, ;_ LΛ LΛ . 4- 4-. ≤ ^ Λ ? ? Λ 5
^ Ω Ω ^ ^ G Ω « ^ Ω Ω « ^ Ω Ω ^ « Ω Ω « ^ Ω Ω ^ ^ Ω Ω " ^ Ω Ω | | Ω Ω 2 Ω
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
O "D τι τj τi 2 2 2 2 O O 03 D0 03 03 O O O O ,D I τι τi 2; 2' 2: 2 O O O D0 D0 03 C0 O
- t tt n ' z z -' -' ,-, -' -- ~ ~ s, S' f' f z z z; ", -, - '1 -
K-30 CH CH CH N f-Bu Me CF3 CI
K-30 CH CH CH N /-Pr 5-C1 CF3 CI
K-30 CH CH CH N f-Bu 5-C1 CF3 CI
K-30 CH CH CH N /-Pr Me CF3 Br
K-30 CH CH CH N f-Bu Me CF3 Br
K-30 CH CH CH N /-Pr 5-C1 CF3 Br
K-30 CH CH CH N f-Bu 5-C1 CF3 Br
K-30 CH CH CH N /-Pr Me CF3 CN
K-30 CH CH CH N f-Bu Me CF3 CN
K-30 CH CH CH N /-Pr 5-C1 CF3 CN
K-30 CH CH CH N f-Bu 5-C1 CF3 CN
K-30 CH CH CH CH /-Pr Me CF3 Me
K-30 CH CH CH CH f-Bu Me CF3 Me
K-30 CH CH CH CH /-Pr 5-C1 CF3 Me
K-30 CH CH CH CH f-Bu 5-C1 CF3 Me
K-30 CH CH CH CH /-Pr Me CF3 F
K-30 CH CH CH CH f-Bu Me CF3 F
K-30 CH CH CH CH /-Pr 5-C1 CF3 F
K-30 CH CH CH CH f-Bu 5-C1 CF3 F
K-30 CH CH CH CH -Pr Me CF3 CI
K-30 CH CH CH CH f-Bu Me CF3 CI
K-30 CH CH CH CH /-Pr 5-C1 CF3 CI
K-30 CH CH CH CH f-Bu 5-C1 CF3 CI
K-30 CH CH CH CH /-Pr Me CF3 Br
K-30 CH CH CH CH f-Bu Me CF3 Br
K-30 CH CH CH CH /-Pr 5-C1 CF3 Br
K-30 CH CH CH CH f-Bu 5-C1 CF3 Br
K-30 CH CH CH CH /-Pr Me CF3 CN
K-30 CH CH CH CH f-Bu Me CF3 CN
K-30 CH CH CH CH /-Pr 5-C1 CF3 CN
K-30 CH CH CH CH f-Bu 5-C1 CF3 CN
K-30 CH CH CH N /-Pr Me CF3 Me
K-30 CH CH CH N f-Bu Me CF3 Me
K-30 CH CH CH N /-Pr 5-C1 CF3 Me
K-30 CH CH CH N f-Bu 5-C1 CF3 Me
K-30 CH CH CH N /-Pr Me CF3 F
K-30 CH CH CH N f-Bu Me CF3 F
K-30 CH CH CH N /-Pr 5-Cl CF3 F 90 IΛ
©
CΛ -. -> i- Z Z Z Z Z Z Z ^ ^ ^ JJ fc υ υ υ υ co oa αa pa υ υ υ υ 2 2 2 fc υ υ υ υ co co co co U υ υ υ 2 2 2 2
H υ fc fc fc fc fc Cu CL. fc fc fc fc fc u. fc fc fc fc fc fc fc fc fc fc fc (j-. l-U l--. _-. lJ-. --. C c fc υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ-. υt-. υ--. υl-_, fc fc f υ υ υ υ
Figure imgf000104_0001
3 c v- 3 3 3 _. 3 3 3 3 3 3 3 3 3 3 3 3 3 -. 3 CO fc CO fc CO cα CO fc cu fc CO fc CD fc co α. CO fc CO fc CO fc OU fc u fc cu fc cu CO fc CO on
z z z z z z z z z z z z Xυ ^υ^ Xυ υJ, υM υM υMM υMM υM Xυ υU Xυ υX Xυ Xυ Xυ Xυ Xυ Xυ υX z z z z
υ υ υ υ υ υ υ υ υ υ υ υ x x x x x x x x x x x x x x x x x x x x x x x x x υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ
υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ
m
90 T
© -Lt S c fcυ fcυ υ--5 υfc υHH
© υ υ υf fcυ lυ-H fcυ fc r~- υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ υ Xυ
© © © © © © © © —I o © © © © © © m m m en m en en en m en en en en en en en en en en en en en en en en en en en m
;-< _ --, ^ ;-<l --i -^ _- --i ^ ^ ^ ^ --i -- _4 --, ^
75 75 75 75 75 75 75 75 75 75 75 75 75 75 75 75 75 75 75 75 75 75 75 75 75 75 75 75 75 75 75 75 75 75 75 75 75 75 co co co co co co co co CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO CO co co co co co co co co co co co
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 fc fc _-H -M fc -I. M --. -^ HH fc^ fc^ fc fc fc 34 fc fc H fc X nC X X X X X X X X fc X X fc fc fc 33 fc
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
HM H M HX M HM MM HM M H M X HM HM HM HM HM S H^
O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 0 0 0 0 0
X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X o 0
X X X X X X X
z z Z Q o o o o o o o o o o o o o o o o o o o z z z z z z z z z z z z z z z
4
03 03 03 03 DO 03 DO 03 03 3 J DO J 03 J DO c DO _? DO 0 c c c c c c c -? » 03 TJ 03 c c 0 c3 y "« c c ~* c c "• c "* c "* c
I W I M M N M M M W M | | M W M 10 I W M W M W M M N M M | W W
O 2 2 ό ό 2 2 ό o 2 2 o ό 2 2 o ό 2 2 ό ό 2 2 2 2 ό ό 2 2 ό ό 2 2 ό ό 2
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Tj Tj Mrj Mrj Tj Tj Tj Tj Tj Tj Tj Tj Tj Tj T^ T^ Tj Tl Tj Tj Tj T Tj Mrl Tj Mη Tj
2 2 2 Ω Ω Ω π ω c0 t:0 ro o o o o >τl > , hτ r1 2 2 2 2 θ θ 03 03 03 03 θ θ θ o Tl Tl TJ tt r r Z Z Z Z rt ft ft ft Z Z Z Z
75 75 75 75 75 75 75 75 75 75 75 75 75 75 75 75 75 75 71 75 75 75 75 75 75 75 75 75 75 75 75 7^ 75 75 75 75 75 75
LO CO O CO O CO co CO CO O CO CO CO CO O O O CO LO LO LO O O O O O co CO CO CO CO co O O co CO CO CO co CO O CO CO CO LO LO
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O O O
UZ UZ X X UZ UZ t--M UZ X X t-L^ UZ ≠E UZ t-E UZ UZ X X X MM MM MM M M I U * X X X X X X H X X X
O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 0 0 0 0 0 0
K K MM ^ HM 3H M ; HM E iT E K My MM! .--- ffi
O O O O O O O O O O O O O O 0 0 0 0 o o o o o o o o o o o o o o o o o o o
H^ HM H H HM HM ---M >-I-) HH H Mπ MM MM M o
X X X X X UZ UZ M X HM MM X MM MM UZ MM UZ UZ ffi M U X X X
Z O O O O O O O O O O O O O O O O O O o o z z z z z z z z z z z z z z z z z
UZ UZ UZ UZ UZ UZ MM ^Z >-- X UZ i-^ UZ UZ ^ UZ UZ MM X X
Figure imgf000106_0001
* -*• * * *r*
DO DO 03 03 J CO J CO TJ 03 00 TJ 03 DO DO 03 J 03 03 DO 3s 03 DO DO 03 c c c c -1 c "« C *" c c c c c C ^ C C c "• c c c c
? oi (Λ * » o\ t> ? * α » » ?' ^ 1 ? oι θ\ ^ ^ t. κ) M W M M w ιo M l ι ιo lo w w M M
Λ 2 o'"-' όl~~' ro2 ro2 ό— o**—' ro2 ro2 ό^~ o—* ro2 ro2 ό— o— ro2 ro2 o— ό— π2> 2ro o— ό-— TO2 ro2 o•—• ό^-^ ro2 2ro ό*— o'—' 2ro 2ro o•— όι—' 2ro 2o o^~
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Tj Tj Tj Tj Tj Tj Tj Tj Mrj Mrj Tj M-^ Tj Tj Tj Tj Tj Tj Tj Tj MEl Tj Tj T^
2 O O O O D3 03 C0 03 O O O D τi τj τj 2 2 2 2 ) O D0 D0 03 03 O O O O ,D TJ TI τι
S, Z Z Z - -, -, -, - - - ~ t Λ o o Z Z Z ^ '1 "1 "' - - '- -"
K-33 CH CH CH N f-Bu 6-Me CF3 Me
K-33 CH CH CH N /-Pr 6-C1 CF3 Me
K-33 CH CH CH N f-Bu 6-C1 CF3 Me
K-33 CH CH CH N /-Pr 6-Me CF3 F
K-33 CH CH CH N f-Bu 6-Me CF3 F
K-33 CH CH CH N /-Pr 6-C1 CF3 F
K-33 CH CH CH N f-Bu 6-C1 CF3 F
K-33 CH CH CH N /-Pr 6-Me CF3 CI
K-33 CH CH CH N f-Bu 6-Me CF3 CI
K-33 CH CH CH N /-Pr 6-C1 CF3 CI
K-33 CH CH CH N f-Bu 6-C1 CF3 CI
K-33 CH CH CH N /-Pr 6-Me CF3 Br
K-33 CH CH CH N f-Bu 6-Me CF3 Br
K-33 CH CH CH N /-Pr 6-C1 CF3 Br
K-33 CH CH CH N f-Bu 6-C1 CF3 Br
K-33 CH CH CH N /-Pr 6-Me CF3 CN
K-33 CH CH CH N f-Bu 6-Me CF3 CN
K-33 CH CH CH N /-Pr 6-C1 CF3 CN
K-33 CH CH CH N f-Bu 6-C1 CF3 CN
K-33 CH CH CH CH /-Pr 6-Me CF3 Me
K-33 CH CH CH CH f-Bu 6-Me CF3 Me
K-33 CH CH CH CH /-Pr 6-C1 CF3 Me
K-33 CH CH CH CH f-Bu 6-C1 CF3 Me
K-33 CH CH CH CH /-Pr 6-Me CF3 F
K-33 CH CH CH CH f-Bu 6-Me CF3 F
K-33 CH CH CH CH /-Pr 6-C1 CF3 F
K-33 CH CH CH CH f-Bu 6-C1 CF3 F
K-33 CH CH CH CH /-Pr 6-Me CF3 CI
K-33 CH CH CH CH f-Bu 6-Me CF3 CI
K-33 CH CH CH CH /-Pr 6-C1 CF3 CI
K-33 CH CH CH CH f-Bu 6-C1 CF3 CI
K-33 CH CH CH CH /-Pr 6-Me CF3 Br
K-33 CH CH CH CH f-Bu 6-Me CF3 Br
K-33 CH CH CH CH /-Pr 6-C1 CF3 Br
K-33 CH CH CH CH f-Bu 6-C1 CF3 Br
K-33 CH CH CH CH /-Pr 6-Me CF3 CN
K-33 CH CH CH CH f-Bu 6-Me CF3 CN
K-33 CH CH CH CH /-Pr 6-C1 CF3 CN 75 75 75 75 75 75 75 75 75 75 75 75 75 75 75 75 75 75 75 75 75
CO CO CO LO CO CO CO co CO CO CO CO CO CO CO CO LO LO LO LO CO
CO O CO O O CO CO co CO CO CO CO CO CO O LO LO LO LO CO CO
Figure imgf000108_0001
R5 , s Cl
R2 is H. R3 s Me R2 is H. R3 is Et R2 is H. R3 s /-Pr R2 is Me. R3 is Me
R4a R4b R6 R4a R4b R6 R4a R4b R6 R4a R4b R6
CH3 F CI CH3 F CI CH3 F CI CH3 F CI
CH3 F Br CH3 F Br CH3 F Br CH3 F Br
CH3 CF3 CI CH3 CF3 CI CH3 CF3 CI CH3 CF3 CI
CH3 CF3 Br CH3 CF3 Br CH3 CF3 Br CH3 CF3 Br
CH3 Br CI CH3 Br CI CH3 Br CI CH3 Br CI
CH3 Br Br CH3 Br Br CH3 Br Br CH3 Br Br
CH3 CI CI CH3 CI CI CH3 CI CI CH3 CI CI
CH3 CI Br CH3 CI Br CH3 CI Br CH3 CI Br
CI H CI CI H CI CI H CI CI H CI
CI H Br CI H Br CI H Br CI H Br
CI I CI CI I CI CI I CI CI I CI
CI I Br CI I Br CI I Br CI I Br
CI F CI CI F CI CI F CI CI F CI
CI F Br CI F Br CI F Br CI F Br
CI CF3 CI CI CF3 CI CI CF3 CI CI CF3 CI
CI CF3 Br CI CF3 Br CI CF3 Br CI CF3 Br
CI Br CI CI Br CI CI Br CI CI Br CI
CI Br Br CI Br Br CI Br Br CI Br Br
CI CI CI CI CI CI CI CI CI CI CI CI
CI CI Br CI CI Br CI CI Br CI CI Br
Br H CI Br H CI Br H CI Br H CI
Br H Br Br H Br Br H Br Br H Br
Br I CI Br I CI Br I CI Br I CI
Br I Br Br I Br Br I Br Br I Br
Br F CI Br F CI Br F CI Br F CI
Br F Br Br F Br Br F Br Br F Br
Br CF3 CI Br CF3 CI Br CF3 CI Br CF3 CI
Br CF3 Br Br CF3 Br Br CF3 Br Br CF3 Br
Br Br CI Br Br CI Br Br CI Br Br CI
Br Br Br Br Br Br Br Br Br Br Br Br
Br CI CI Br CI CI Br CI CI Br CI CI
Br CI Br Br CI Br Br CI Br Br CI Br R5 is Br
R2 is H. R3 is Me R2 is H. R3 is Et R2 is H. R3 s /-Pr R2 is Me. R3 is Me
R4a R4b R6 R4a R4b R6 R4a R4b R6 R4a R4b R6
CH3 H CI CH3 H CI CH3 H CI CH3 H CI
CH3 H Br CH3 H Br CH3 H Br CH3 H Br
CH3 I CI CH3 I CI CH3 I CI CH3 I CI
CH3 I Br CH3 I Br CH3 I Br CH3 I Br
CH3 F CI CH3 F CI CH3 F CI CH3 F CI
CH3 F Br CH3 F Br CH3 F Br CH3 F Br
CH3 CF3 CI CH3 CF3 CI CH3 CF3 CI CH3 CF3 CI
CH3 CF3 Br CH3 CF3 Br CH3 CF3 Br CH3 CF3 Br
CH3 Br CI CH3 Br CI CH3 Br CI CH3 Br CI
CH3 Br Br CH3 Br Br CH3 Br Br CH3 Br Br
CH3 CI CI CH3 CI CI CH3 CI CI CH3 CI CI
CH3 CI Br CH3 CI Br CH3 CI Br CH3 CI Br
CI H CI CI H CI CI H CI CI H CI
CI H Br CI H Br CI H Br CI H Br
CI I CI CI I CI CI I CI CI I CI
CI I Br CI I Br CI I Br CI I Br
CI F CI CI F CI CI F CI CI F CI
CI F Br CI F Br CI F Br CI F Br
CI CF3 CI CI CF3 CI CI CF3 CI CI CF3 CI
CI CF3 Br CI CF3 Br CI CF3 Br CI CF3 Br
CI Br CI CI Br CI CI Br CI CI Br CI
CI Br Br CI Br Br CI Br Br CI Br Br
CI CI CI CI CI CI CI CI CI CI CI CI
CI CI Br CI CI Br CI CI Br CI CI Br
Br H CI Br H CI Br H CI Br H CI
Br H Br Br H Br Br H Br Br H Br
Br I CI Br I CI Br I CI Br I CI
Br I Br Br I Br Br I Br Br I Br
Br F CI Br F CI Br F CI Br F CI
Br F Br Br F Br Br F Br Br F Br
Br CF3 CI Br CF3 CI Br CF3 CI Br CF3 CI
Br CF3 Br Br CF3 Br Br CF3 Br Br CF3 Br
Br Br CI Br Br CI Br Br CI Br Br CI
Br Br Br Br Br Br Br Br Br Br Br Br
Br CI CI Br CI CI Br CI CI Br CI CI
Figure imgf000111_0001
o P '73
DO
Figure imgf000111_0002
Figure imgf000111_0003
Figure imgf000112_0001
co υ cQ υ pa υ cQ υ cQ
- fc fc fc' fc ≤ r.a ζj ζj
υ υ υ υ υ υ υ υ υ
Figure imgf000112_0002
o
Figure imgf000113_0001
Figure imgf000114_0001
RD is CHOCFT
R2 is H. R3 is Me R2 is H, R3 is Et R2 is H. R3 s /'-Pr R2 is Me. R3 is Me
R4a R4b R6 R a R4b R6 R4 ic-4b R6 R4* R4 ≠
CH3 Br CI CH3 Br CI CH3 Br CI CH3 Br CI
CH3 Br Br CH3 Br Br CH3 Br Br CH3 Br Br
CH3 CI CI CH3 CI CI CH3 CI CI CH3 CI CI
CH3 CI Br CH3 CI Br CH3 CI Br CH3 CI Br
CI H CI CI H CI CI H CI CI H CI
CI H Br CI H Br CI H Br CI H Br
CI I CI CI I CI CI I CI CI I CI
CI I Br CI I Br CI I Br CI I Br
CI F CI CI F CI CI F CI CI F CI
CI F Br CI F Br CI F Br CI F Br
CI CF3 CI CI CF3 CI CI CF3 CI CI CF3 CI
CI CF3 Br CI CF3 Br CI CF3 Br CI CF3 Br
CI Br CI CI Br CI CI Br CI CI Br CI
CI Br Br CI Br Br CI Br Br CI Br Br
CI CI CI CI CI CI CI CI CI CI CI CI
CI CI Br CI CI Br CI CI Br CI CI Br
Br H CI Br H CI Br H CI Br H CI
Br H Br Br H Br Br H Br Br H Br
Br I CI Br I CI Br I CI Br I CI
Br I Br Br I Br Br I Br Br I Br
Br F CI Br F CI Br F CI Br F CI
Br F Br Br F Br Br F Br Br F Br
Br CF3 CI Br CF3 CI Br CF3 CI Br CF3 CI
Br CF3 Br Br CF3 Br Br CF3 Br Br CF3 Br
Br Br CI Br Br CI Br Br CI Br Br CI
Br Br Br Br Br Br Br Br Br Br Br Br
Br CI CI Br CI CI Br CI CI Br CI CI
Br CI Br Br CI Br Br CI Br Br CI Br
Figure imgf000115_0001
R5 is CF2CHF2
R2 is H. R3 is Me R2 is H. R3 is Et R2 is H. R3 s /'-Pr R2 is Me. R3 is Me
R4a R4b 6 R4a R4b R6 R4a R4b R6 R4a R4b R6
CH3 I Br CH3 I Br CH3 I Br CH3 I Br
CH3 F CI CH3 F CI CH3 F CI CH3 F CI
CH3 F Br CH3 F Br CH3 F Br CH3 F Br
CH3 CF3 CI CH3 CF3 CI CH3 CF3 CI CH3 CF3 CI
CH3 CF3 Br CH3 CF3 Br CH3 CF3 Br CH3 CF3 Br
CH3 Br CI CH3 Br CI CH3 Br CI CH3 Br CI
CH3 Br Br CH3 Br Br CH3 Br Br CH3 Br Br
CH3 CI CI CH3 CI CI CH3 CI CI CH3 CI CI
CH3 CI Br CH3 CI Br CH3 CI Br CH3 CI Br
CI H CI CI H CI CI H CI CI H CI
CI H Br CI H Br CI H Br CI H Br
CI I CI CI I CI CI I CI CI I CI
CI I Br CI I Br CI I Br CI I Br
CI F CI Ct F CI CI F CI CI F CI
CI F Br CI F Br CI F Br CI F Br
CI CF3 CI CI CF3 CI CI CF3 CI CI CF3 CI
CI CF3 Br CI CF3 Br CI CF3 Br CI CF3 Br
CI Br CI CI Br CI CI Br CI CI Br CI
CI Br Br CI Br Br CI Br Br CI Br Br
CI CI CI CI CI CI CI CI CI CI CI CI
CI CI Br CI CI Br CI CI Br CI CI Br
Br H CI Br H CI Br H CI Br H CI
Br H Br Br H Br Br H Br Br H Br
Br I CI Br I CI Br I CI Br I CI
Br I Br Br I Br Br I Br Br I Br
Br F CI Br F CI Br F CI Br F CI
Br F Br Br F Br Br F Br Br F Br
Br CF3 CI Br CF3 CI Br CF3 CI Br CF3 CI
Br CF3 Br Br CF3 Br Br CF3 Br Br CF3 Br
Br Br CI Br Br CI Br Br CI Br Br CI
Br Br Br Br Br Br Br Br Br Br Br Br
Br CI CI Br CI CI Br CI CI Br CI CI
Br CI Br Br CI Br Br CI Br Br CI Br
Figure imgf000117_0001
Figure imgf000118_0001
0 03 0
0 — ' | I?«
Figure imgf000118_0002
Figure imgf000118_0003
Figure imgf000119_0001
R5 is CF3
R2 is H. R3 is Me R2 is H. R3 is Et R2 is H. R3 is z'-Pr R2 is Me. R
R4a R4b R6 R4a R4b R6 R4a R4b R6 R4a R4b
CI F CI CI F CI CI F CI CI F CI
CI F Br CI F Br CI F Br CI F Br
CI CF3 CI CI CF3 CI CI CF3 CI CI CF3 CI
CI CF3 Br CI CF3 Br CI CF3 Br CI CF3 Br
CI Br CI CI Br CI CI Br CI CI Br CI
CI Br Br CI Br Br CI Br Br CI Br Br
CI CI CI CI CI CI CI CI CI CI CI CI
CI CI Br CI CI Br CI CI Br CI CI Br
Br H CI Br H CI Br H CI Br H CI
Br H Br Br H Br Br H Br Br H Br
Br I CI Br I CI Br I CI Br I CI
Br I Br Br I Br Br I Br Br I Br
Br F CI Br F CI Br F CI Br F CI
Br F Br Br F Br Br F Br Br F Br
Br CF3 CI Br CF3 CI Br CF3 CI Br CF3 CI
Br CF3 Br Br CF3 Br Br CF3 Br Br CF3 Br
Br Br CI Br Br CI Br Br CI Br Br CI
Br Br Br Br Br Br Br Br Br Br Br Br
Br CI CI Br CI CI Br CI, CI Br CI CI
Br CI Br Br CI Br Br CI Br Br CI Br
R5 is OCHoCF3
R2 is H. R3 s Me R2 is H. R3 is Et R2 is H. R3 s -Pr R2 is l Me. R3 is Me
R4a R4b R6 R4a R4b R6 R4a R4b R6 R4a R4b R6
CH3 H CI CH3 H CI CH3 H CI CH3 H CI
CH3 H Br CH3 H Br CH3 H Br CH3 H Br
CH3 I CI CH3 I CI CH3 I CI CH3 I CI
CH3 I Br CH3 I Br CH3 I Br CH3 I Br
CH3 F CI CH3 F CI CH3 F CI CH3 F CI
CH3 F Br CH3 F Br CH3 F Br CH3 F Br
CH3 CF3 CI CH3 CF3 CI CH3 CF3 CI CH3 CF3 CI
CH3 CF3 Br CH3 CF3 Br CH3 CF3 Br CH3 CF3 Br
CH3 Br CI CH3 Br CI CH3 Br CI CH3 Br CI
CH3 Br Br CH3 Br Br CH3 Br Br CH3 Br Br
CH3 CI CI CH3 CI CI CH3 CI CI CH3 CI CI
Figure imgf000121_0001
fN
90 IΛ
© o
H υ fc
Figure imgf000122_0001
Figure imgf000122_0002
O
Figure imgf000123_0001
G Q G Ω Ω τι -H - a
O 03 O 00 O
Figure imgf000124_0001
Figure imgf000124_0002
03 |?0
03 |?0
Figure imgf000125_0001
R5 is CI
R2 is H. R3 is Me R2 is H. R3 is Et R2 is H. R3 s .-Pr R2 is Me. R3 is Me
R4a R4b R6 R4a R4b R6 R4a R4b R6 R4a R4b R6
CH3 I Br CH3 I Br CH3 I Br CH3 I Br
CH3 F CI CH3 F CI CH3 F CI CH3 F CI
CH3 F Br CH3 F Br CH3 F Br CH3 F Br
CH3 CF3 CI CH3 CF3 CI CH3 CF3 CI CH3 CF3 CI
CH3 CF3 Br CH3 CF3 Br CH3 CF3 Br CH3 CF3 Br
CH3 Br CI CH3 Br CI CH3 Br CI CH3 Br CI
CH3 Br Br CH3 Br Br CH3 Br Br CH3 Br Br
CH3 CI CI CH3 CI CI CH3 CI CI CH3 CI CI
CH3 CI Br CH3 CI Br CH3 CI Br CH3 CI Br
CI H CI CI H CI CI H CI CI H CI
CI H Br CI H Br CI H Br CI H Br
CI I CI CI I CI CI I CI CI I CI
CI I Br CI I Br CI I Br CI I Br
CI F CI CI F CI CI F CI CI F CI
CI F Br CI F Br CI F Br CI F Br
CI CF3 CI CI CF3 CI CI CF3 CI CI CF3 CI
CI CF3 Br CI CF3 Br CI CF3 Br CI CF3 Br
CI Br CI CI Br CI CI Br CI CI Br CI
CI Br Br CI Br Br CI Br Br CI Br Br
CI CI CI CI CI CI CI CI CI CI CI CI
CI CI Br CI CI Br CI CI Br CI CI Br
Br H CI Br H CI Br H CI Br H CI
Br H Br Br H Br Br H Br Br H Br
Br I CI Br I CI Br I CI Br I CI
Br I Br Br I Br Br I Br Br I Br
Br F CI Br F CI Br F CI Br F CI
Br F Br Br F Br Br F Br Br F Br
Br CF3 CI Br CF3 CI Br CF3 CI Br CF3 CI
Br CF3 Br Br CF3 Br Br CF3 Br Br CF3 Br
Br Br CI Br Br CI Br Br CI Br Br CI
Br Br Br Br Br Br Br Br Br Br Br Br
Br CI CI Br CI CI Br CI CI Br CI CI
Br CI Br Br CI Br Br CI Br Br CI Br 03 O3 O3 C0 O3 O3 CO 0O CO H- — — — — — _ — — - — — - - O O O O O O O O O O O O
_? _? Ω Ω Ω ' Ω Ω "" Ω Ω ' Ω Ω Ω Ω Ω "" cox cox cox cox cox cxo cox cxo cxo cox cox cox I to «fc
O CO C? Ω Ω TI Tl — X X Q Q _? Ω ri >n - « X Ω -? 5, ι Ω τi HH - c j ^ co co ft I cr S-
O 53 O 03 O D0 O 03 O 00 O 03 O 03 O 03 O D0 O 00 O 03 O 03 O CD O D0 O D0 O 00 O 03 O
I I? O3s
03 O 03 O 03 O
Figure imgf000127_0001
I Oκ
Figure imgf000127_0002
Figure imgf000128_0001
Figure imgf000129_0001
Figure imgf000130_0001
Figure imgf000131_0001
Figure imgf000131_0002
Figure imgf000132_0001
R5 is CFoCHFo
R2 is H. R3 is Me R2 is H. R3 is Et R2 is H, R3 is -Pr R2 is Me. R3 is Me
R4 R4b R6 R4a R4b R6 R4a R4b R6 R4a R4b R6
CH3 H CI CH3 H CI CH3 H CI CH3 H CI
CH3 H Br CH3 H Br CH3 H Br CH3 H Br
CH3 I CI CH3 I CI CH3 I CI CH3 I CI R5 is CFoCHFo
R2 is H. R3 s Me R2 is H. R3 is Et R2 is H. R3 s /'-Pr R2 is Me. R3 is Me
R4a R4b R6 R4a R4b R6 R4a R4b R6 R4a R4b R6
CH3 I Br CH3 I Br CH3 I Br CH3 I Br
CH3 F CI CH3 F CI CH3 F CI CH3 F CI
CH3 F Br CH3 F Br CH3 F Br CH3 F Br
CH3 CF3 CI CH3 CF3 CI CH3 CF3 CI CH3 CF3 CI
CH3 CF3 Br CH3 CF3 Br CH3 CF3 Br CH3 CF3 Br
CH3 Br CI CH3 Br CI CH3 Br CI CH3 Br CI
CH3 Br Br CH3 Br Br CH3 Br Br CH3 Br Br
CH3 CI CI CH3 CI CI CH3 CI CI CH3 CI CI
CH3 CI Br CH3 CI Br CH3 CI Br CH3 CI Br
CI H CI CI H CI CI H CI CI H CI
CI H Br CI H Br CI H Br CI H Br
CI I CI CI I CI CI I CI CI I CI
CI I Br CI I Br CI I Br CI I Br
CI F CI CI F CI CI F CI CI F CI
CI F Br CI F Br CI F Br CI F Br
CI CF3 CI CI CF3 CI CI CF3 CI CI CF3 CI
CI CF3 Br CI CF3 Br CI CF3 Br CI CF3 Br
CI Br CI CI Br CI CI Br CI CI Br CI
CI Br Br CI Br Br CI Br Br CI Br Br
CI CI CI CI CI CI CI CI CI CI CI CI
CI CI Br CI CI Br CI CI Br CI CI Br
Br H CI Br H CI Br H CI Br H CI
Br H Br Br H Br Br H Br Br H Br
Br I CI Br I CI Br I CI Br I CI
Br I Br Br I Br Br I Br Br I Br
Br F CI Br F CI Br F CI Br F CI
Br F Br Br F Br Br F Br Br F Br
Br CF3 CI Br CF3 CI Br CF3 CI Br CF3 CI
Br CF3 Br Br CF3 Br Br CF3 Br Br CF3 Br
Br Br CI Br Br CI Br Br CI Br Br CI
Br Br Br Br Br Br Br Br Br Br Br Br
Br CI CI Br CI CI Br CI CI Br CI CI
Br CI Br Br CI Br Br CI Br Br CI Br
Figure imgf000134_0001
Figure imgf000135_0001
O 00 O D0 O D0 O PS,
CO O 03 O 00 O 03 O DO O [7
Figure imgf000135_0002
Figure imgf000135_0003
Figure imgf000136_0001
Figure imgf000136_0002
Figure imgf000137_0001
Figure imgf000138_0001
Figure imgf000139_0001
Figure imgf000140_0001
XI υ
CO
Figure imgf000140_0002
Figure imgf000140_0003
Figure imgf000141_0001
Figure imgf000141_0002
.--. fc fc fc fc fc fc fc fc fc ro υ fN υ υ υ υ υ υ υ υ
X X £ CO CQ CQ υ ϋ" υ fc fc fc fN υ υ υ X X c
X pa CO CQ υ υ υ fc fc f υ υ υ X CQ υ υ Ό fc
X υ υ υ υ υ υ υ B CQ CQ υ? X υ υ o o o o o o o o o fc l fl fl fl fl fl fl fl fl f fl fl o -- l f
CQ CQ pa co co CQ pa CQ CQ oa CQ CQ X X c fc fl fl fl fc fc fc fl fl cl -- -- -- -- f fc fc -i- f υ υ υ υ υ υ X υ X υ X X X υ υ υ X f υ X υ X υ X X υ υ υ υ υ υ υ υ
Figure imgf000141_0003
Figure imgf000142_0001
Figure imgf000142_0002
Figure imgf000142_0003
Figure imgf000143_0001
- t
Figure imgf000143_0002
Figure imgf000143_0003
Figure imgf000144_0001
o O O o O O o O o o O o
X X X X X X X X X X X X ro 00 00 w 03 DO CO DO 00 00 03 03 o o o o O o o o o o o eo co co eo Ifc to o o o o o o o o o o o o o o o
X O O O o o o o o
X o 2
O o o 03 03 03 rt o to X to Tj Tj Tl O O o 03 00 03 to X to X to X Tj Tj Tj to X to X o to X Tj o •n o Tj o o o ω ro o o o co o o o co o o O co co F
Tl Tl Tl TJ J Tl fc o co co co
O 00 O O a O Q 03 o O 00 o O 03 O Q DO O o 03 o o DD o o z z z 00 O O z 00 o o z ro o o z DO [73 2 z z Z Z z Z 1 os
Figure imgf000145_0001
Figure imgf000146_0001
U -5 rj U £- § u l_i
μ, — — — fl fl oa αa « υ υ υ £, £,
fc fl fcfl fcfl fcfl fcfl fcfl fcfl fcfl
Figure imgf000146_0002
υ υ υ υ υ υ υ υ
Figure imgf000147_0001
O
Figure imgf000147_0002
Figure imgf000147_0003
Figure imgf000148_0001
Figure imgf000149_0001
° Tj Ω X o o o o o o O o o o o
X X X X 00 DO DO 00 03 03 co co co X X X co x cox co X ro ro ro ro ro ω o o o o o o o o o o Ifc Ix 0
'fc
O o O O O O O O o o
O O O O O O O o
00 O O to X to X to X Tj T TJ O u O O DO 00 DO X to to X to X o Tl TJ o Tl o o o 00 03 CO o co co to X to X X O to Tj Tj Tl O O O 00 [73 o I en
O o O O O F
Tj Tl o
Tj Tl Tl Tl Tl LO co o Ω ■Z ro o g z ro - Ω § » Ω § « δ DO o δ w o δ 03 Ω δ w Q δ DO Ω g ro o g ro o o F I Ov
Figure imgf000149_0002
Figure imgf000150_0001
Figure imgf000150_0002
Figure imgf000150_0003
Figure imgf000151_0001
C
Figure imgf000151_0002
Figure imgf000151_0003
Figure imgf000152_0001
Figure imgf000153_0001
Figure imgf000154_0001
Figure imgf000155_0001
Figure imgf000156_0001
Figure imgf000157_0001
Figure imgf000158_0001
Figure imgf000159_0001
Figure imgf000160_0001
Figure imgf000161_0001
Figure imgf000162_0001
Figure imgf000163_0001
Ω ro
o
Figure imgf000164_0001
Figure imgf000164_0002
Figure imgf000165_0001
Figure imgf000165_0002
Figure imgf000166_0001
00 00 03 03 00 DO 00 DO DO ro S? S? Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω x Ifc fc o o ω ro o Tl oTj Tj — — x x Ω Ω S? S? Ω Ω τι -rι - - χ χ Ω fc I σ* 70 ro o ro o ro o ro o ro o ro o ro o ro o ro o ro o ro o ro o ro [73 I Oi Irt
Figure imgf000167_0001
Figure imgf000168_0001
Figure imgf000169_0001
Figure imgf000170_0001
Figure imgf000171_0001
Figure imgf000172_0001
Formulation/Utility
Compounds of this invention will generally be used as a formulation or composition with an agriculturally suitable carrier comprising at least one of a liquid diluent, a solid diluent or a surfactant. The formulation or composition ingredients are selected to be consistent with the physical properties of the active ingredient, mode of application and environmental factors such as soil type, moisture and temperature. Useful formulations include liquids such as solutions (including emulsifiable concentrates), suspensions, emulsions (including microemulsions and/or suspoemulsions) and the like which optionally can be thickened into gels. Useful formulations further include solids such as dusts, powders, granules, pellets, tablets, films, and the like which can be water-dispersible ("wettable") or water-soluble. Active ingredient can be (micro)encapsulated and further formed into a suspension or solid formulation; alternatively the entire formulation of active ingredient can be encapsulated (or "overcoated"). Encapsulation can control or delay release of the active ingredient. Sprayable formulations can be extended in suitable media and used at spray volumes from about one to several hundred liters per hectare. High-strength compositions are primarily used as intermediates for further formulation.
The formulations will typically contain effective amounts of active ingredient, diluent and surfactant within the following approximate ranges that add up to 100 percent by weight.
Weight Percent
Active Ingredient Diluent Surfactant
Water-Dispersible and Water-soluble 5-90 0-94 1-15 Granules, Tablets and Powders.
Suspensions, Emulsions, Solutions 5-50 40-95 0-15 (including Emulsifiable Concentrates)
Dusts 1-25 70-99 0-5
Granules and Pellets 0.01-99 5-99.99 0-15
High Strength Compositions 90-99 0-10 0-2 Typical solid diluents are described in Watkins, et al., Handbook of Insecticide Dust
Diluents and Carriers, 2nd Ed., Dorland Books, Caldwell, New Jersey. Typical liquid diluents are described in Marsden, Solvents Guide, 2nd Ed., Interscience, New York, 1950. McCutcheon 's Detergents and Emulsifiers Annual, Allured Publ. Corp., Ridgewood, New Jersey, as well as Sisely and Wood, Encyclopedia of Surface Active Agents, Chemical Publ. Co., Inc., New York, 1964, list surfactants and recommended uses. All formulations can contain minor amounts of additives to reduce foam, caking, corrosion, microbiological growth and the like, or thickeners to increase viscosity.
Surfactants include, for example, polyethoxylated alcohols, polyethoxylated alkylphenols, polyethoxylated sorbitan fatty acid esters, dialkyl sulfosuccinates, alkyl sulfates, alkylbenzene sulfonates, organosilicones, NN-dialkyltaurates, lignin sulfonates, naphthalene sulfonate formaldehyde condensates, polycarboxylates, and polyoxyethylene/polyoxypropylene block copolymers. Solid diluents include, for example, clays such as bentonite, montmorillonite, attapulgite and kaolin, starch, sugar, silica, talc, diatomaceous earth, urea, calcium carbonate, sodium carbonate and bicarbonate, and sodium sulfate. Liquid diluents include, for example, water, N,N-dimethylformamide, dimethyl sulfoxide, N-alkylpyrrolidone, ethylene glycol, polypropylene glycol, paraffins, alkylbenzenes, alkylnaphthalenes, oils of olive, castor, linseed, tung, sesame, corn, peanut, cotton-seed, soybean, rape-seed and coconut, fatty acid esters, ketones such as cyclohexanone, 2-heptanone, isophorone and 4-hydroxy-4-methyl-2-pentanone, and alcohols such as methanol, cyclohexanol, decanol and tetrahydrofurfuryl alcohol.
Solutions, including emulsifiable concentrates, can be prepared by simply mixing the ingredients. Dusts and powders can be prepared by blending and, usually, grinding as in a hammer mill or fluid-energy mill. Suspensions are usually prepared by wet-milling; see, for example, U.S. 3,060,084. Granules and pellets can be prepared by spraying the active material upon preformed granular carriers or by agglomeration techniques. See Browning, "Agglomeration", Chemical Engineering, December 4, 1967, pp 147-48, Perry's Chemical Engineer's Handbook, 4th Ed., McGraw-Hill, New York, 1963, pages 8-57 and following, and PCT Publication WO 91/13546. Pellets can be prepared as described in U.S. 4,172,714. Water-dispersible and water-soluble granules can be prepared as taught in U.S. 4,144,050, U.S. 3,920,442 and DE 3,246,493. Tablets can be prepared as taught in U.S. 5,180,587, U.S. 5,232,701 and U.S. 5,208,030. Films can be prepared as taught in GB 2,095,558 and U.S. 3,299,566. For further information regarding the art of formulation, see T. S. Woods, "The
Formulator's Toolbox - Product Forms for Modern Agriculture" in Pesticide Chemistry and Bioscience, The Food-Environment Challenge, T. Brooks and T. R. Roberts, Eds., Proceedings of the 9th International Congress on Pesticide Chemistry, The Royal Society of Chemistry, Cambridge, 1999, pp. 120-133. See also U.S. 3,235,361, Col. 6, line 16 through Col. 7, line 19 and Examples 10-41; U.S. 3,309,192, Col. 5, line 43 through Col. 7, line 62 and Examples 8, 12, 15, 39, 41, 52, 53, 58, 132, 138-140, 162-164, 166, 167 and 169-182; U.S. 2,891,855, Col. 3, line 66 through Col. 5, line 17 and Examples 1-4; Klingman, Weed Control as a Science, John Wiley and Sons, Inc., New York, 1961, pp 81-96; and Hance et al., Weed Control Handbook, 8th Ed., Blackwell Scientific Publications, Oxford, 1989. In the following Examples, all percentages are by weight and all formulations are prepared in conventional ways. Compound numbers refer to compounds in Index Table A.
Example A Wettable Powder
Compound 1 65.0% dodecylphenol polyethylene glycol ether 2.0% sodium ligninsulfonate 4.0% sodium silicoaluminate 6.0% montmorillonite (calcined) 23.0%. Example B
Granule
Compound 1 10.0% attapulgite granules (low volatile matter,
0.71/0.30 mm; U.S.S. No. 25-50 sieves) 90.0%.
Example C
Extruded Pellet
Compound 1 25.0% anhydrous sodium sulfate 10.0% crude calcium ligninsulfonate 5.0% sodium alkylnaphthalenesulfonate 1.0% calcium/magnesium bentonite 59.0%.
Example D
Emulsifiable Concentrate
Compound 1 20.0% blend of oil soluble sulfonates and polyoxyethylene ethers 10.0% isophorone 70.0%.
Example E
Granule
Compound 1 0.5% cellulose 2.5% lactose 4.0% cornmeal 93.0%. Compounds of this invention are characterized by favorable metabolic and/or soil residual patterns and exhibit activity controlling a spectrum of agronomic and non- agronomic invertebrate pests. (In the context of this disclosure "invertebrate pest control" means inhibition of invertebrate pest development (including mortality) that causes significant reduction in feeding or other injury or damage caused by the pest; related expressions are defined analogously.) As referred to in this disclosure, the term
"invertebrate pest" includes arthropods, gastropods and nematodes of economic importance as pests. The term "arthropod" includes insects, mites, spiders, scorpions, centipedes, millipedes, pill bugs and symphylans. The term "gastropod" includes snails, slugs and other Stylommatophora. The term "nematode" includes all of the helminths, such as: roundworms, heartworms, and phytophagous nematodes (Nematoda), flukes (Tematoda), Acanthocephala, and tapeworms (Cestoda). Those skilled in the art will recognize that not all compounds are equally effective against all pests. Compounds of this invention display activity against economically important agronomic and nonagronomic pests. The term "agronomic" refers to the production of field crops such as for food and fiber and includes the growth of cereal crops (e.g., wheat, oats, barley, rye, rice, maize), soybeans, vegetable crops (e.g., lettuce, cabbage, tomatoes, beans), potatoes, sweet potatoes, grapes, cotton, and tree fruits (e.g., pome fruits, stone fruits and citrus fruits). The term "nonagronomic" refers to other horticultural (e.g., forest, greenhouse, nursery or ornamental plants not grown in a field), public (human) and animal health, domestic and commercial structure, household, and stored product applications or pests. For reason of invertebrate pest control spectrum and economic importance, protection (from damage or injury caused by invertebrate pests) of agronomic crops of cotton, maize, soybeans, rice, vegetable crops, potato, sweet potato, grapes and tree fruit by controlling invertebrate pests are preferred embodiments of the invention. Agronomic or nonagronomic pests include larvae of the order Lepidoptera, such as armyworms, cutworms, loopers, and heliothines in the family Noctuidae (e.g., fall armyworm (Spodoptera fugiperda J. E. Smith), beet armyworm (Spodoptera exigua Hϋbner), black cutworm (Agrotis ipsilon Hufhagel), cabbage looper (Tήchoplusia ni
Hubner), tobacco budworm (Heliothis virescens Fabricius)); borers, casebearers, webworms, coneworms, cabbageworms and skeletonizers from the family Pyralidae (e.g., European corn borer (Ostrinia nubilalis Hubner), navel orangeworm (Amyelois transitella Walker), corn root webworm (Crambus caliginosellus Clemens), sod webworm (Herpetogramma licarsisalis Walker)); leafrollers, budworms, seed worms, and fruit worms in the family Tortricidae (e.g., codling moth (Cydia pomonella Linnaeus), grape berry moth (Endopiza viteana Clemens), oriental fruit moth (Grapholita molesta Busck)); and many other economically important lepidoptera (e.g., diamondback moth (Plutella xylostella Linnaeus), pink bollworm (Pectinophora gossypiella Saunders), gypsy moth (Lymantria dispar Linnaeus)); nymphs and adults of the order Blattodea including cockroaches from the families Blattellidae and Blattidae (e.g., oriental cockroach (Blatta orientalis Linnaeus), Asian cockroach (Blatella asahinai Mizukubo), German cockroach (Blattella germanica Linnaeus), brownbanded cockroach (Supella longipalpa Fabricius), American cockroach (Periplaneta americana Linnaeus), brown cockroach (Periplaneta brunnea Burmeister), Madeira cockroach (Leucophaea maderae Fabricius)); foliar feeding larvae and adults of the order Coleoptera including weevils from the families Anthribidae, Bruchidae, and Curculionidae (e.g., boll weevil (Anthonomus grandis Boheman), rice water weevil (Lissorhoptrus oryzophilus Kuschel), granary weevil (Sitophilus granarius Linnaeus), rice weevil (Sitophilus oryzae Linnaeus)); flea beetles, cucumber beetles, rootworms, leaf beetles, potato beetles, and leafminers in the family Chrysomelidae (e.g., Colorado potato beetle (Leptinotarsa decemlineata Say), western corn rootworm (Diabrotica virgifera virgifera LeConte)); chafers and other beetles from the family Scaribaeidae (e.g., Japanese beetle (Popillia japonica Newman) and European chafer (Rhizotrogus majalis Razoumowsky)); carpet beetles from the family Dermestidae; wireworms from the family Elateridae; bark beetles from the family Scolytidae and flour beetles from the family Tenebrionidae. In addition agronomic and nonagronomic pests include: adults and larvae of the order Dermaptera including earwigs from the family Forficulidae (e.g., European earwig (Forficula auricularia Linnaeus), black earwig (Chelisoches morio Fabricius)); adults and nymphs of the orders Hemiptera and Homoptera such as, plant bugs from the family Miridae, cicadas from the family Cicadidae, leafhoppers (e.g. Empoasca spp.) from the family Cicadellidae, planthoppers from the families Fulgoroidae and Delphacidae, treehoppers from the family Membracidae, psyllids from the family Psyllidae, whiteflies from the family Aleyrodidae, aphids from the family Aphididae, phylloxera from the family Phylloxeridae, mealybugs from the family Pseudococcidae, scales from the families Coccidae, Diaspididae and Margarodidae, lace bugs from the family Tingidae, stink bugs from the family Pentatomidae, cinch bugs (e.g., Blissus spp.) and other seed bugs from the family Lygaeidae, spittlebugs from the family Cercopidae squash bugs from the family Coreidae, and red bugs and cotton stainers from the family Pyrrhocoridae. Also included are adults and larvae of the order Acari (mites) such as spider mites and red mites in the family Tetranychidae (e.g., European red mite (Panonychus ulmi Koch), two spotted spider mite (Tetranychus urticae Koch), McDaniel mite (Tetranychus mcdanieli McGregor)), flat mites in the family Tenuipalpidae (e.g., citrus flat mite (Brevipalpus lewisi McGregor)), rust and bud mites in the family Eriophyidae and other foliar feeding mites and mites important in human and animal health, i.e. dust mites in the family Epidermoptidae, follicle mites in the family Demodicidae, grain mites in the family Glycyphagidae, ticks in the order Ixodidae (e.g., deer tick (Ixodes scapularis Say), Australian paralysis tick (Ixodes holocyclus Neumann), American dog tick (Dermacentor variabilis Say), lone star tick (Amblyomma americanum Linnaeus) and scab and itch mites in the families Psoroptidae, Pyemotidae, and Sarcoptidae; adults and immatures of the order Orthoptera including grasshoppers, locusts and crickets (e.g., migratory grasshoppers (e.g., Melanoplus sanguinipes Fabricius, M. differ entialis Thomas), American grasshoppers (e.g., Schistocerca americana Drury), desert locust (Schistocerca gregaria Forskal), migratory locust (Locusta migratoria Linnaeus), house cricket (Acheta domesticus Linnaeus), mole crickets (Gryllotalpa spp.)); adults and immatures of the order Diptera including leafminers, midges, fruit flies (Tephritidae), frit flies (e.g., Oscinella frit Linnaeus), soil maggots, house flies (e.g., Musca domestica Linnaeus), lesser house flies (e.g., Fannia caniculaήs Linnaeus, F. femoralis Stein), stable flies (e.g., Stomoxys calcitrans Linnaeus), face flies, horn flies, blow flies (e.g., Chrysomya spp., Phormia spp.), and other muscoid fly pests, horse flies (e.g., Tabanus spp.), bot flies (e.g., Gastrophilus spp., Oestrus spp.), cattle grubs (e.g., Hypoderma spp.), deer flies (e.g., Chrysops spp.), keds (e.g., Melophagus ovinus Linnaeus) and other Brachycera, mosquitoes (e.g., Aedes spp., Anopheles spp., Culex spp.), black flies (e.g., Prosimulium spp., Simulium spp.), biting midges, sand flies, sciarids, and other Nematocera; adults and immatures of the order Thysanoptera including onion thrips (Thrips tabaci Lindeman) and other foliar feeding thrips; insect pests of the order Hymenoptera including ants (e.g., red carpenter ant (Camponotus ferrugineus Fabricius), black carpenter ant (Camponotus pennsylvanicus De Geer), Pharaoh ant (Monomorium pharaonis Linnaeus), little fire ant (Wasmannia auropunctata Roger), fire ant (Solenopsis geminata Fabricius), red imported fire ant (Solenopsis invicta Buren), Argentine ant (Iridomyrmex humilis Mayr), crazy ant (Paratrechina longicornis Latreille), pavement ant (Tetramorium caespitum Linnaeus), cornfield ant (Lasius alienus Forster), odorous house ant (Tapinoma sessile Say)), bees (including carpenter bees), hornets, yellow jackets and wasps; insect pests of the order
Isoptera including the eastern subterranean termite (Reticulitermes flavipes Kollar), western subterranean termite (Reticulitermes hesperus Banks), Formosan subterranean termite (Coptotermes formosanus Shiraki), West Indian drywood termite (Incisitermes immigrans Snyder) and other termites of economic importance; insect pests of the order Thysanura such as silverfish (Lepisma saccha na Linnaeus) and firebrat (Thermobia domestica Packard); insect pests of the order Mallophaga and including the head louse (Pediculus humanus capitis De Geer), body louse (Pediculus humanus humanus Linnaeus), chicken body louse (Menacanthus stramineus Nitszch), dog biting louse (Trichodectes canis De Geer), fluff louse (Goniocotes gallinae De Geer), sheep body louse (Bovicola ovis Schrank), short-nosed cattle louse (Haematopinus eurysternus Nitzsch), long-nosed cattle louse (Linognathus vituli Linnaeus) and other sucking and chewing parasitic lice that attack man and animals; insect pests of the order Siphonoptera including the oriental rat flea (Xenopsylla cheopis Rothschild), cat flea (Ctenocephalides felis Bouche), dog flea (Ctenocephalides canis Curtis), hen flea (Ceratophyllus gallinae Schrank), sticktight flea (Echidnophaga gallinacea Westwood), human flea (Pulex irritans Linnaeus) and other fleas afflicting mammals and birds. Additional arthropod pests covered include: spiders in the order Araneae such as the brown recluse spider (Loxosceles reclusa Gertsch & Mulaik) and the black widow spider (Latrodectus mactans Fabricius), and centipedes in the order Scutigeromorpha such as the house centipede (Scutigera coleoptrata Linnaeus). Compounds of the present invention also have activity on members of the Classes Nematoda, Cestoda, Trematoda, and
Acanthocephala including economically important members of the orders Strongylida, Ascaridida, Oxyurida, Rhabditida, Spirurida, and Enoplida such as but not limited to economically important agricultural pests (i.e. root knot nematodes in the genus Meloidogyne, lesion nematodes in the genus Pratylenchus, stubby root nematodes in the genus Trichodorus, etc.) and animal and human health pests (i.e. all economically important flukes, tapeworms, and roundworms, such as Strongylus vulgaris in horses, Toxocara canis in dogs, Haemonchus contortus in sheep, Dirofilaria immitis Leidy in dogs, Anoplocephala perfoliata in horses, Fasciola hepatica Linnaeus in ruminants, etc.). Compounds of the invention show particularly high activity against pests in the order Lepidoptera (e.g., Alabama argillacea Hubner (cotton leaf worm), Archips argyrospila Walker (fruit tree leaf roller), A. rosana Linnaeus (European leaf roller) and other Archips species, Chilo suppressalis Walker (rice stem borer), Cnaphalocrosis medinalis Guenee (rice leaf roller), Cr ambus caliginosellus Clemens (corn root webworm), Cr ambus teterrellus Zincken (bluegrass webworm), Cydia pomonella Linnaeus (codling moth), Earias insulana Boisduval (spiny bollworm), Earias vittella Fabricius (spotted bollworm), Helicoverpa armigera Hubner (American bollworm), Helicoverpa zea Boddie (corn earworm), Heliothis virescens Fabricius (tobacco budworm), Herpetogramma licarsisalis Walker (sod webworm), Lobesia botrana Denis & Schiffermuller (grape berry moth), Pectinophora gossypiella Saunders (pink bollworm), Phyllocnistis citrella Stainton (citrus leafminer), Pieris brassicae Linnaeus (large white butterfly), Pieris rapae Linnaeus (small white butterfly), Plutella xylostella Linnaeus (diamondback moth), Spodoptera exigua Hubner (beet armyworm), Spodoptera litura Fabricius (tobacco cutworm, cluster caterpillar), Spodoptera frugiperda J. E. Smith (fall armyworm), Trichoplusia ni Hubner (cabbage looper) and Tuta absoluta Meyrick (tomato leafminer)). Compounds of the invention also have commercially significant activity on members from the order Homoptera including: Acyrthisiphon pisum Harris (pea aphid), Aphis craccivora Koch (cowpea aphid), Aphis fabae Scopoli (black bean aphid), Aphis gossypii Glover (cotton aphid, melon aphid), Aphis pomi De Geer (apple aphid), Aphis spiraecola Patch (spirea aphid), Aulacorthum solani Kaltenbach (foxglove aphid), Chaetosiphon fragaefolii Cockerell (strawberry aphid), Diuraphis noxia Kurdjumov/Mordvilko (Russian wheat aphid), Dysaphis plantaginea Paaserini (rosy apple aphid), Eriosoma lanigerum Hausmann (woolly apple aphid), Hyalopterus pruni Geoffroy (mealy plum aphid), Lipaphis erysimi Kaltenbach (turnip aphid), Metopolophium dirrhodum Walker (cereal aphid), Macrosipum euphorbiae Thomas (potato aphid), Myzus persicae Sulzer (peach-potato aphid, green peach aphid), Nasonovia ribisnigri Mosley (lettuce aphid), Pemphigus spp. (root aphids and gall aphids), Rhopalosiphum maidis Fitch (corn leaf aphid), Rhopalosiphum padi Linnaeus (bird cherry- oat aphid), Schizaphis graminum Rondani (greenbug), Sitobion avenae Fabricius (English grain aphid), Therioaphis maculata Buckton (spotted alfalfa aphid), Toxoptera aurantii
Boyer de Fonscolombe (black citrus aphid), and Toxoptera citricida Kirkaldy (brown citrus aphid); Adelges spp. (adelgids); Phylloxera devastatrix Pergande (pecan phylloxera); Bemisia tabaci Gennadius (tobacco whitefly, sweetpotato whitefly), Bemisia argentifolii Bellows & Perring (silverleaf whitefly), Dialeurodes citri Ashmead (citrus whitefly) and Trialeurodes vaporariorum Westwood (greenhouse whitefly); Empoasca fabae Harris
(potato leafhopper), Laodelphax striatellus Fallen (smaller brown planthopper), Macrolestes quadrilineatus Forbes (aster leafhopper), Nephotettix cinticeps Uhler (green leafhopper), Nephotettix nigropictus St&l (rice leafhopper), Nilaparvata lugens Stal (brown planthopper), Peregrinus maidis Ashmead (corn planthopper), Sogatellafurcifera Horvath (white-backed planthopper), Sogatodes orizicola Muir (rice delphacid), Typhlocyba pomaria McAtee white apple leafhopper, Erythroneoura spp. (grape leafhoppers); Magicidada septendecim Linnaeus (periodical cicada); Icerya purchasi Maskell (cottony cushion scale), Quadraspidiotus perniciosus Comstock (San Jose scale); Planococcus citri Risso (citrus mealybug); Pseudococcus spp. (other mealybug complex); Cacopsylla pyricola Foerster (pear psylla), Trioza diospyri Ashmead (persimmon psylla). These compounds also have activity on members from the order Hemiptera including: Acrosternum hilare Say (green stink bug), Anasa tristis De Geer (squash bug), Blissus leucopterus leucopterus Say (chinch bug), Corythuca gossypii Fabricius (cotton lace bug), Cyrtopeltis modesta Distant (tomato bug), Dysdercus suturellus Herrich-Schaffer (cotton stainer), Euchistus servus Say (brown stink bug), Euchistus variolarius Palisot de Beauvois (one-spotted stink bug), Graptosthetus spp. (complex of seed bugs), Leptoglossus corculus Say (leaf-footed pine seed bug), Lygus lineolaris Palisot de Beauvois (tarnished plant bug), Nezara viridula Linnaeus (southern green stink bug), Oebalus pugnax Fabricius (rice stink bug), Oncopeltus fasciatus Dallas (large milkweed bug), Pseudatomoscelis seriatus Reuter (cotton fleahopper). Other insect orders controlled by compounds of the invention include Thysanoptera (e.g., Frankliniella occidentalis Pergande (western flower thrip), Scirthothrips citri Moulton (citrus thrip), Sericothrips variabilis Beach (soybean thrip), and Thrips tabaci Lindeman (onion thrip); and the order Coleoptera (e.g., Leptinotarsa decemlineata Say (Colorado potato beetle),
Epilachna varivestis Mulsant (Mexican bean beetle) and wireworms of the genera Agriotes, Athous or Limonius).
Compounds of this invention can also be mixed with one or more other biologically active compounds or agents including insecticides, fungicides, nematocides, bactericides, acaricides, growth regulators such as rooting stimulants, chemosterilants, semiochemicals, repellents, attractants, pheromones, feeding stimulants, other biologically active compounds or entomopathogenic bacteria, virus or fungi to form a multi-component pesticide giving an even broader spectrum of agricultural utility. Thus compositions of the present invention can further comprise a biologically effective amount of at least one additional biologically active compound or agent. Examples of such biologically active compounds or agents with which compounds of this invention can be formulated are: insecticides such as abamectin, acephate, acetamiprid, avermectin, azadirachtin, azinphos-methyl, bifenthrin, binfenazate, buprofezin, carbofuran, chlorfenapyr, chlorfluazuron, chlorpyrifos, chlorpyrifos-methyl, chromafenozide, clothianidin, cyfluthrin, beta-cyfluthrin, cyhalothrin, lambda-cyhalothrin, cypermethrin, cyromazine, deltamethrin, diafenthiuron, diazinon, diflubenzuron, dimethoate, diofenolan, emamectin, endosulfan, esfenvalerate, ethiprole, fenothicarb, fenoxycarb, fenpropathrin, fenproximate, fenvalerate, fipronil, flonicamid, flucythrinate, tau-fluvalinate, flufenoxuron, fonophos, halofenozide, hexaflumuron, imidacloprid, indoxacarb, isofenphos, lufenuron, malathion, metaldehyde, methamidophos, methidathion, methomyl, methoprene, methoxychlor, monocrotophos, methoxyfenozide, nithiazin, novaluron, oxamyl, parathion, parathion-methyl, permethrin, phorate, phosalone, phosmet, phosphamidon, pirimicarb, profenofos, pymetrozine, pyridalyl, pyriproxyfen, rotenone, spinosad, sulprofos, tebufenozide, teflubenzuron, tefluthrin, terbufos, tetrachlorvinphos, thiacloprid, thiamethoxam, thiodicarb, thiosultap-sodium, tralomethrin, trichlorfon and triflumuron; fungicides such as acibenzolar, azoxystrobin, benomyl, blasticidin-S, Bordeaux mixture (tribasic copper sulfate), bromuconazole, carpropamid, captafol, captan, carbendazim, chloroneb, chlorothalonil, copper oxychloride, copper salts, cyflufenamid, cymoxanil, cyproconazole, cyprodinil, (S)-3,5-dichloro-N-(3-chloro-l-ethyl-l-methyl-2-oxopropyl)-4- methylbenzamide (RH 7281), diclocymet (S-2900), diclomezine, dicloran, difenoconazole, (S)-3,5-dihydro-5-methyl-2-(methylthio)-5-phenyl-3-(phenylamino)-4H-imidazol-4-one (RP 407213), dimethomorph, dimoxystrobin, diniconazole, diniconazole-M, dodine, edifenphos, epoxiconazole, famoxadone, fenamidone, fenarimol, fenbuconazole, fencaramid (SZX0722), fenpiclonil, fenpropidin, fenpropimorph, fentin acetate, fentin hydroxide, fluazinam, fludioxonil, flumetover (RPA 403397), fluquinconazole, flusilazole, flutolanil, flutriafol, folpet, fosetyl-aluminum, furalaxyl, furametapyr (S-82658), hexaconazole, ipconazole, iprobenfos, iprodione, isoprothiolane, kasugamycin, kresoxim-methyl, mancozeb, maneb, mefenoxam, mepronil, metalaxyl, metconazole, metomino- strobin/fenominostrobin (SSF-126), myclobutanil, neo-asozin (ferric methanearsonate), oxadixyl, penconazole, pencycuron, probenazole, prochloraz, propamocarb, propiconazole, pyrifenox, pyraclostrobin, pyrimethanil, pyroquilon, quinoxyfen, spiroxamine, sulfur, tebuconazole, tetraconazole, thiabendazole, thifluzamide, thiophanate-methyl, thiram, tiadinil, triadimefon, triadimenol, tricyclazole, trifloxystrobin, triticonazole, validamycin and vinclozolin; nematocides such as aldicarb, oxamyl and fenamiphos; bactericides such as streptomycin; acaricides such as amitraz, chinomethionat, chlorobenzilate, cyhexatin, dicofol, dienochlor, etoxazole, fenazaquin, fenbutatin oxide, fenpropathrin, fenpyroximate, hexythiazox, propargite, pyridaben and tebufenpyrad; and biological agents such as Bacillus thuringiensis including ssp. aizawai and kurstaki, Bacillus thuringiensis delta endotoxin, baculovirus, and entomopathogenic bacteria, virus and fungi. Compounds of this invention and compositions thereof may be applied to plants genetically transformed to express proteins toxic to invertebrate pests (such as Bacillus thuringiensis toxin). The effect of the exogenous invertebrate pest control compounds and compositions may be synergistic with the expressed toxin proteins. A general reference for these agricultural protectants is The Pesticide Manual, 12th
Edition, C. D. S. Tomlin, Ed., British Crop Protection Council, Farnham, Surrey, U.K., 2000. Preferred insecticides and acaricides for mixing with compounds of this invention include pyrethroids such as cypermethrin, cyhalothrin, cyfluthrin, beta-cyfluthrin, esfenvalerate, fenvalerate and tralomethrin; carbamates such as fenothicarb, methomyl, oxamyl and thiodicarb; neonicotinoids such as clothianidin, imidacloprid and thiacloprid; neuronal sodium channel blockers such as indoxacarb; insecticidal macrocyclic lactones such as spinosad, abamectin, avermectin and emamectin; γ-aminobutyric acid (GABA) antagonists such as endosulfan, ethiprole and fipronil; insecticidal ureas such as flufenoxuron and triflumuron; juvenile hormone mimics such as diofenolan and pyriproxyfen; pymetrozine; and amitraz. Preferred biological agents for mixing with compounds of this invention include Bacillus thuringiensis and Bacillus thuringiensis delta endotoxin as well as naturally occurring and genetically modified viral insecticides including members of the family Baculoviridae as well as entomophagous fungi.
Most preferred mixtures include a mixture of a compound of this invention with cyhalothrin; a mixture of a compound of this invention with beta-cyfluthrin; a mixture of a compound of this invention with esfenvalerate; a mixture of a compound of this invention with methomyl; a mixture of a compound of this invention with imidacloprid; a mixture of a compound of this invention with thiacloprid; a mixture of a compound of this invention with indoxacarb; a mixture of a compound of this invention with abamectin; a mixture of a compound of this invention with endosulfan; a mixture of a compound of this invention with ethiprole; a mixture of a compound of this invention with fipronil; a mixture of a compound of this invention with flufenoxuron; a mixture of a compound of this invention with pyriproxyfen; a mixture of a compound of this invention with pymetrozine; a mixture of a compound of this invention with amitraz; a mixture of a compound of this invention with Bacillus thuringiensis and a mixture of a compound of this invention with Bacillus thuringiensis delta endotoxin.
In certain instances, combinations with other invertebrate pest control compounds or agents having a similar spectrum of control but a different mode of action will be particularly advantageous for resistance management. Thus, compositions of the present invention can further comprise a biologically effective amount of at least one additional invertebrate pest control compound or agent having a similar spectrum of control but a different mode of action. Contacting a plant genetically modified to express a plant protection compound (e.g., protein) or the locus of the plant with a biologically effective amount of a compound of invention can also provide a broader spectrum of plant protection and be advantageous for resistance management. Invertebrate pests are controlled in agronomic and nonagronomic applications by applying one or more of the compounds of this invention, in an effective amount, to the environment of the pests including the agronomic and/or nonagronomic locus of infestation, to the area to be protected, or directly on the pests to be controlled. Thus, the present invention further comprises a method for the control of invertebrates in agronomic and/or nonagronomic applications, comprising contacting the invertebrates or their environment with a biologically effective amount of one or more of the compounds of the invention, or with a composition comprising at least one such compound or a composition comprising at least one such compound and an effective amount of at least one additional biologically active compound or agent. Examples of suitable compositions comprising a compound of the invention and an effective amount of at least one additional biologically active compound or agent include granular compositions wherein the additional biologically active compound is present on the same granule as the compound of the invention or on granules separate from those of the compound of this invention.
A preferred method of contact is by spraying. Alternatively, a granular composition comprising a compound of the invention can be applied to the plant foliage or the soil. Compounds of this invention are also effectively delivered through plant uptake by contacting the plant with a composition comprising a compound of this invention applied as a soil drench of a liquid formulation, a granular formulation to the soil, a nursery box treatment or a dip of transplants. Compounds are also effective by topical application of a composition comprising a compound of this invention to the locus of infestation. Other methods of contact include application of a compound or a composition of the invention by direct and residual sprays, aerial sprays, gels, seed coatings, microencapsulations, systemic uptake, baits, eartags, boluses, foggers, fumigants, aerosols, dusts and many others. The compounds of this invention may also be impregnated into materials for fabricating invertebrate control devices (e.g. insect netting).
The compounds of this invention can be incorporated into baits that are consumed by the invertebrates or within devices such as traps and the like. Granules or baits comprising between 0.01-5% active ingredient, 0.05-10% moisture retaining agent(s) and 40-99% vegetable flour are effective in controlling soil insects at very low application rates, particularly at doses of active ingredient that are lethal by ingestion rather than by direct contact.
The compounds of this invention can be applied in their pure state, but most often application will be of a formulation comprising one or more compounds with suitable carriers, diluents, and surfactants and possibly in combination with a food depending on the contemplated end use. A preferred method of application involves spraying a water dispersion or refined oil solution of the compounds. Combinations with spray oils, spray oil concentrations, spreader stickers, adjuvants, other solvents, and synergists such as piperonyl butoxide often enhance compound efficacy.
The rate of application required for effective control (i.e. "biologically effective amount") will depend on such factors as the species of invertebrate to be controlled, the pest's life cycle, life stage, its size, location, time of year, host crop or animal, feeding behavior, mating behavior, ambient moisture, temperature, and the like. Under normal circumstances, application rates of about 0.01 to 2 kg of active ingredient per hectare are sufficient to control pests in agronomic ecosystems, but as little as 0.0001 kg/hectare may be sufficient or as much as 8 kg/hectare may be required. For nonagronomic applications, effective use rates will range from about 1.0 to 50 mg/square meter but as little as 0.1 mg/square meter may be sufficient or as much as 150 mg/square meter may be required. One skilled in the art can easily determine the biologically effective amount necessary for the desired level of invertebrate pest control.
The following TESTS demonstrates the control efficacy of compounds of this invention on specific pests. "Control efficacy" represents inhibition of invertebrate pest development (including mortality) that causes significantly reduced feeding. The pest control protection afforded by the compounds is not limited, however, to these species. See Index Tables A through K and L for compound descriptions. The following abbreviations are used in the Index Tables which follow: t is tertiary, n is normal, i is iso, c is cyclo, s is secondary, Me is methyl, Et is ethyl, Pr is propyl, i-Pr is isopropyl, c-Pr is cyclopropyl, Bu is butyl, s-Bu is secondary butyl, Pent is pentyl, OMe is methoxy, OEt is ethoxy, SMe is methylthio, SEt is ethylthio, CN is cyano, and NO2 is nitro. The abbreviation "Ex." stands for "Example" and is followed by a number indicating in which example the compound is prepared.
INDEX TABLE A
Figure imgf000184_0001
Compound 2 El ffl- n J m.p. °C.
1 (Ex. 3) H /-Pr 4-Me 4-CF3-Ph *
2 H t-Bu 4-Me 4-CF3-Ph *
Figure imgf000184_0002
4 H /-Pr 4-Me 2-Me,4-SCHF2-Ph *
5 H f-Bu 4-Me 2-Me,4-SCHF2-Ph *
6 H t-Bu 4-Me 4-OCF3-Ph *
7 H /-Pr 4-Me 2-Me,4-S02CHF2-Ph *
8 H /-Pr 4-Me 2-Me,4-SOCF3-Ph * Compound R2 R! Gώn m.p. °C.
9 H t-Bu 4-Me 2-Me,4-S02CHF2-Ph
10 H t-Bu 4-Me 2-Me,4-SOCHF2-Ph
11 H i-Pr 4-Me 4-SCHF2-Ph
12 H t-Bu 4-Me 4-SCHF2-Ph
13 H i-Pr 4-Me 2-Me,4-CF3-Ph
14 H /-Pr 4-Me 2-Me,4-OCF3-Ph
15 H t-Bu 4-Me 2-Me,4-CF3-Ph
16 H t-Bu 4-Me 2-Me,4-OCF3-Ph
17 H /-Pr 4-Me 2-Me,4-Cl-Ph 222.5-225
18 H t-Bu 4-Me 2-Me,4-Cl-Ph 214-215
19 H i-Pr 4-Me 2-Me-6-CF3 -3 -pyridiny 1
20 H f-Bu 4-Me 2-Me-6-CF3-3-pyridinyl
21 H i-Pr 4-Me 1 -Ph-3 -Me-5 -pyrazolyl
22 H f-Bu 4-Me 1 -Ph-3-Me-5-pyrazolyl
23 H /-Pr 4-Me 2-Me-6-Cl-3-pyridinyl
24 H f-Bu 4-Me 2-Me-6-Cl-3 -pyridiny 1
25 H CH2CH NMe2 4,5-Me2 Ph
26 -CH2CH2CH2CH2- H Ph
27 H c-hexyl H Ph
28 H c-propyl H Ph
29 H H 4-f-Bu-Ph 3,5-Cl2-Ph
30 H Me 4-Me l-(2-CI-3-pyridinyl)-3-Br-5-pyrazolyl 214-215
31 H /-Pr 4-Me l-(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl 159-161
32 H /-Pr 4-Me l-(2-Cl-Ph)-3-CF3-5-pyrazolyl 198-202
33 H Me 4-Me l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl 188-190
34 H /-Pr 4-Me 1 -(2-C1-3 -pyridiny l)-3 -CF3 -5 -pyrazolyl 170-174
35 H Me 4-Me 1 -(2-Cl-Ph)-3-CF3-5-pyrazolyl 201-203
36 H Me 4.5-C-2 1 -(2-Cl-Ph)-3-CF3-5-pyrazolyl 238-240
37 H /-Pr 4.5-C.2 1 -(2-Cl-Ph)-3-CF3-5-pyrazolyl 240
38 H /-Pr 4.5-C.2 1 -(2-C1-3 -pyridiny l)-3 -Br-5 -pyrazolyl 208-210
39 H Me 4.5-C.2 l-(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl 208
40 H /-Pr 4-Me-5-Cl l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl 234-236
41 H Me 4-Me-5-Cl l-(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl 229-231
42 H /-Pr 4-Me-5-Cl l-(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl 222-223
43 H Me 4-Me-5-Cl l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl 226-228
* See Index Table L for lR NMR data. INDEX TABLE B
Figure imgf000186_0001
Compound R£ m.p. °C.
Bl i-Pr 2-Me,4-SCHF2-Ph 178.5-180.5
B2 i-Pr 2-Me,4-S02CHF2-Ph 207-210
B3 /-Pr 2-Me,4-SOCF3-Ph 175-180
B4 i-Pr 2-Me,4-CF3-Ph . 201 -203
B5 i-Pr 2-Me-6-CF3-3-pyridinyl 221-5-222.5
B6 /-Pr 1 -Ph-3 -Me-5 -pyrazolyl
B7 f-Bu 1 -Ph-3-Me-5-pyrazolyl
B8 f-Bu 2-Me-6-CF -3-pyridinyl
B9 z-Pr 2-Me-5-Cl-3-thienyl *
BIO Me l-(2-Cl-Ph)-3-CF3-5-pyrazolyl 266-270
Bl l /-Pr 1 -(2-Cl-Ph)-3-CF3-5-pyrazolyl 232-236
B12 Me l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl 233-236
B13 i-Pr l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl 220-222
B14 Me l-(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl 235-238
B15 /-Pr l-(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl 198-200
* See Index Table L for ] H NMR data.
INDEX TABLE C
Figure imgf000186_0002
Compound 2 El Rl J m.p. °C.
CI H i-Pr Me 4-F-Ph *
Figure imgf000186_0003
Compound B? E^ El J m.p. °C.
Figure imgf000187_0001
C5 H i-Pr Me 3-Cl-Ph
C6 H i-Pr Me 4-CN-Ph
C7 H i-Pr Me 4-CF3-Ph
C8 H /-Pr Me 2-Me-4-SOCF3-Ph *
C9 Ex. 2) H /-Pr Me 4-OCF3-Ph 68-75
CIO H f-Pr Me 2-Me-4-Br-Ph *
Cl l Pr Pr Ph 3-F-Ph
C12 -(CH2)5- Ph 2-thienyl
C13 -(CH2)2NMe(CH2)2- Ph 4-N02-Ph
C14 H /-Pr Me 3-pyridinyl
C15 H c-hexyl Ph 2-thienyl
C16 allyl allyl Ph 2-Me-Ph
C17 Et Et Ph Ph
C18 H allyl Ph Ph
C19 H (CH2)2Ph Ph Ph
C20 Me Me Ph 4-Me-Ph
C21 -(CH2)2NMe(CH2) - Ph 4-Br-Ph
C22 -1 H2)20(CH2)2- Ph Ph
C23 H Et Me l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl 253-255
C24 H /-Pr Me l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl 214-216
C25 H Me Me l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl 230-232
C26 H Me Me l-(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl 234-236
C27 H /-Pr Me 1 -(2-Cl-Ph)-3-CF3-5-pyrazolyl 218-220
C28 H /-Pr Me 1 -(2-Cl-Ph)-3-Br-5-pyrazolyl 170-173
C29 H CH2-2-furanyl Ph 3-Me-Ph
C30 H Et CH2CF3 l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl 236-238
C31 H /-Pr CH2CF3 1 -(2-C1-3 -pyridinyl)-3-CF3 -5 -pyrazolyl 216-218
C32 H Me Et l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl 238-240
C33 H Et Et ]-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl 216-218
C34 H /-Pr Et l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl 198-201
C35 H Me CH2CF3 l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl 260-262
C36 H Me CH2CF3 l-(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl 253-256
C37 H Et CH2CF3 l-(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl 220-223
C38 H /-Pr CH2CF3 l-(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl 188-190
C39 H Me Et l-(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl 221-223 Compound R2 El i J m.p. °C.
C40 H Et Et l-(2-Cl-3- •pyridiny l)-3 -Br-5 -pyrazolyl 182-184
C41 H /-Pr Et l-(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl 172-175
C42 -(CH2)6- Ph 4-Br-Ph
C43 -(CH2)4- Ph 4-Me-Ph
C44 -(CH2)5- Ph 3-F-Ph
C45 -(CH2)4- Ph 3-F-Ph
C46 H CH2Ph Ph 2-F-Ph
C47 H CH2-2-furanyl Ph 3-F-Ph
C48 -(CH2)6- Ph 4-Me-Ph
C49 CH2)20(CH2)2- Ph 2-Me-Ph
* See Index Table L for lR NMR data.
INDEX TABLE D
Figure imgf000188_0001
Compound El El gl J m.p. °C.
Dl H /-Pr 2-Me 4-CF3-Ph 223-225
D2 H f-Bu 2-Me 4-CF3-Ph 260-261
D3 (Ex. 1) H i-Pr 2-Me 4-OCF3-Ph 202-204
D4 H i-Pr 2-Me 2-Me,4-CF3-Ph 235-236
D5 H i-Pr 2-Me 2-Me,4-OCF3-Ph 198-200
D6 H /-Pr 2-Me 2-Me-6-CF3-3-pyridinyl 240-243
D7 H i-Pr 2-Me l-Ph-3-CF3-5-pyrazolyl 215-220 (dec/
D8 H i-Pr 2-Me 1 -(2-Cl-Ph)-3-CF3-5-pyrazolyl 140-144
D9 H i-Pr 2-Me 2-Me-3-Cl-Ph 260-261
D10 H /-Pr 2-Me l-(2-CI-3-pyridinyl)-3-CF3-5-pyrazolyI 207-209*
Dl l Me Me 2-Me 1 -(2-Cl-Ph)-3-CF3-5-pyrazolyl 172-175
D12 H Me 2-Me l-(2-Cl-Ph)-3-CF3-5-pyrazolyl 193-195
D13 H t-Pr 2-Cl l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl 175-179
D14 H /-Pr 2-Me l-(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl 156-158
D15 H /-Pr 2-Cl 1 -(2-C1-3 -pyridiny l)-3 -Br-5 -pyrazolyl 160-165 Compound El El El J m.p. °C.
D16 H Me 2-Cl l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl 178-180
D17 H Me 2-Cl l-(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl 118-125
D18 H Me 2-Me l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl 207-209
D19 H Me 2-Me l-(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl 216-218
D20 H allyl Me l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazoly] 187
D21 H allyl Me l-(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl 199-201
* See Index Table L for lR NMR data.
INDEX TABLE E
Figure imgf000189_0001
Compound El R £E- J m.p. °C.
Figure imgf000189_0002
E4 H /'-Pr H 2-Me,3-Cl-Ph *
E5 H /'-Pr 2-Me l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl 138-140
E6 H /-Pr 2-Me 1 -(2-Cl-Ph)-3-CF3-5-pyrazolyl 170-173
E7 H /-Pr 2-Me 1 -(2-Cl-Ph)-3-Br-5-pyrazolyl *
E8 H /'-Pr 2-Me l-(2-Cl-3-pyridinyl)-3-CN-5-pyrazolyl *
E9 H /-Pr 2-Me 1 -(2-C1-3 -pyridiny l)-3 -Br-5 -pyrazolyl 1 12-115
E10 H Et 2,6-Cl2 1 -(2-C1-3 -pyridinyl)-3-Br-5-pyrazolyl 147-150
El l H Me 2,6-Cl2 1 -(2-C1-3 -pyridiny l)-3 -Br-5 -pyrazolyl 223-224
E12 H i-Pr 2,6-Cl2 l-(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl 142-145
E13 H Me 2,6-Cl2 1 -(2-C1-3 -pyridiny l)-3-CF3 -5 -pyrazolyl 238-240
E14 H Et 2,6-Cl2 l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl 207-209
El 5 (Ex. 5) H /'-Pr 2,6-Cl2 l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl 240-242
E16 Me Me 2,6-Cl2 l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl 153-155
E17 Me Me 2,6-Cl2 l-(2-Cl-3-pyridinyl)-3-Cl-5-pyrazolyl 224-226
E18 Me Me 2,6-Br2 2,6-Br2-3-NH2-4-pyridinyl 208-210
E19 H Et 2,6-Br2 l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl 223-225 Compound El El J m.p. °C. E20 H /-Pr 2,6-Br2 l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl >240 E21 Et Et 2.6-C-2 l-(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl 231-233 E22 H i-Pr 2-Cl-6-Br l-(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl 224-226 E23 H NMe2 2,6-Br2 l-(2-Cl-3-pyridinyl)-3-Cl-5-pyrazolyl E24 H H 2,6-Cl2 l -(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl E25 H NMe2 2.6-C-2 l-(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl E26 Me Me 2-CU6-NMe2 l-(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl E27 H Me 2,6-Br2 l-(2-Cl-Ph)-3-CF3-5-pyrazolyl E28 H Et 2,6-Br2 1 -(2-Cl-Ph)-3-CF3-5-pyrazolyl E29 H Me 2,6-Br2 l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl E30 H Et 2,6-Br2 l-(2-Cl-3-pyridinyl)-3-Cl-5-pyrazolyl E31 H Me 2,6-Br2 l-(2-Cl-3-pyridinyl)-3-Cl-5-pyrazolyl E32 H /-Pr 2,6-Br2 l-(2-Cl-3-pyridinyl)-3-Cl-5-pyrazolyl E33 H NMe2 2,6-Cl2 l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl E34 H /-Pr 2,6-Br2 l-(2-Cl-Ph)-3-CF3-5-pyrazolyl E35 H NMe2 2,6-Cl2 2,6-Cl2-3-NH2-4-pyridinyl E36 Et Et 2,6-Cl2 2,6-Cl2-3 -NH2-4-pyridinyl
* See Index Table L for !H NMR data.
INDEX TABLE F
Figure imgf000190_0001
Compound R! £R--}n J m.p. °C.
Fl /-Pr H 4-CF3-Ph
F2 f-Bu H 4-CF3-Ph 199-200
F3 /-Pr 6-Me 4-CF3-Ph 218-220
F4 /-Pr 4,6-Me2 4-CF3-Ph 235-237
F5 /-Pr 6-Me 2-Me-4-Cl-Ph 172-174
F6 f-Bu H 2-Me-3-Cl-Ph 218-220
F7 /-Pr H 2-Me-3-Cl-Ph
* See Index Table L for lR NMR data. INDEX TABLE G
Figure imgf000191_0001
Compound El El ffi- n I m.p. °C. Gl H i-Pr 4-Me 4-CF3-Ph 121-123* G2 H /-Pr 4-Me l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl 183-184 G3 H S-CH(Ph)Me H 3-pyridinyl G4 H i-Pr 4-Me l-(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl 172-175 G5 H /-Pr 4-Me 1-(2-Cl-3-Ph)-3-Br-5-pyrazolyl G6 H /-Pr 4-Me-6-Cl l-(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl 175-177 G7 H Me 4-Me-6-Cl l-(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl 230-235 G8 Me Me 4,6-Cl2 l-(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl 225-227 G9 H NMe2 4,6-Cl2 l-(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl 125-130 G10 H H 4,6-Cl2 l-(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl 130-135 Gi l H Me 4,6-Cl2 l-(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl 214-216 G12 H Et 4,6-Cl2 l-(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl 210-212 G13 H /-Pr 4,6-Cl2 l-(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl 208-210 G14 H NMe2 4,6-Cl2 4,6-Cl2-3-NH2-2-pyridinyl 192-194 G15 Me Me 4,6-Cl2 4,6-Cl2-3-NH2-2-pyridinyl 171-172 G16 H H 4,6-Br2 l-(2-Cl-3-pyridinyl)-3-Cl-5-pyrazolyl >240 G17 H Me 4,6-Cl2 l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl G18 H Et 4,6-Cl l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl G19 H /-Pr 4,6-Cl2 l-(2-Cl-3-pyridinyl)-3-CF-5~-pyrazolyl G20 H H 4,6-Cl2 l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl G21 Et Et 4,6-Cl2 l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyI G22 H Me 4,6-Cl2 1-(2-Cl-3-pyridinyl)-3-Cl-5-pyrazolyl G23 H Et 4,6-Cl2 l-(2-Cl-3-pyridinyl)-3-Cl-5-pyrazolyl G24 H /-Pr 4,6-Cl2 1-(2-Cl-3-pyridinyl)-3-Cl-5-pyrazolyl G25 H NMe2 4,6-Cl2 l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl G26 Me Me 4,6-Cl2 l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl G27 Me Me 4,6-Cl2 l-(2-Cl-3-pyridinyl)-3-Cl-5-pyrazolyl G28 H H 4,6-Cl2 1-(2-Cl-3-pyridinyl)-3-Cl-5-pyrazolyl Compound El El -El)n m.p. °C.
G29 H NMe2 4,6-Cl2 l-(2-Cl-3-pyridinyl)-3-Cl-5-pyrazolyl
G30 Et Et 4,6-Cl2 l-(2-Cl-3-pyridinyl)-3-Cl-5-pyrazolyl
G31 H Me 4,5,6-Cl3 l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl
G32 H Et 4,5,6-Cl3 l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl
G33 H CH2CH2SMe 4,6-Cl2 l-(2-Cl-3-pyridinyl)-3-Cl-5-pyrazolyl
* See Index Table L for JH NMR data.
INDEX TABLE H
Figure imgf000192_0001
Compound J m.p. °C.
HI 2-Me-4-Br-Ph *
See Index Table J for ]H NMR data.
INDEX TABLE I
Figure imgf000192_0002
Compound El El -E_hn I m.p. °C.
II Me Me 4,6-Me2 l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazoIyI 244-245*
12 H /-Pr 4,6-Me2 1 -(2-C1-3 -pyridiny l)-3 -CF3 -5 -pyrazolyl
13 H Me 4,6-Me2 l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl 195-197
14 Me Me, 4,6-Me2 l-(2-Cl-3-pyridinyl)-3-Br-5-pyrazoIyI 243-244
15 H Me 4,6-Me2 l-(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl 202-204 16 (Ex. 4) Me Me 4-Me l-(2-Cl-3-pyridinyl)-3-Cl-5-pyrazolyl 232-236
17 H i-Pr 4-Me l-(2-Cl-3-pyridinyl)-3-Cl-5-pyrazolyl 87-90
18 H i-Pr 4,6-Me2 l-(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl 81-83
19 H Me 4-Me l-(2-Cl-3-pyridinyl)-3-Cl-5-pyrazolyl 205-207
* See Index Table L for lR NMR data. INDEX TABLE J
Figure imgf000193_0001
Compound El El El m.p. °C.
Jl H i-Pr Me l-(2-Cl-Ph)-3-CF3-5-pyrazolyl 174-176*
J2 H /-Pr Me l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl 206-208
J3 H Me Me 1 -(2-Cl-Ph)-3-CF3-5-pyrazolyl 166-168
J4 H Me Me l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl 176-178
J5 H Me Me l-(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl 227-229
J8 H /-Pr Me l-(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl 172-174
* See Index Table L for lR NMR data.
INDEX TABLE K
Figure imgf000193_0002
Compound Rl El El m.p. °C.
Kl H Me Me l-(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl 224-226*
K2 H /-Pr Me l-(2-Cl-3-pyridinyl)-3-Br-5-pyrazolyl 168-172
K3 H Me Me 1 -(2-Cl-Ph)-3-CF3-5-pyrazolyl 185-190
K4 H /-Pr Me 1 -(2-Cl-Ph)-3-CF3-5-pyrazolyl 160-162
K5 H Me Me l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl 176-179
K6 H /-Pr Me l-(2-Cl-3-pyridinyl)-3-CF3-5-pyrazolyl 180-182
* See Index Table L for l H NMR data. INDEX TABLE L Compd. No. *H NMR Partial Spectrum Data (CDC13 solution unless indicated otherwise)3
1 10.63 (s,lH), 5.58 (d,lH)
2 10.55 (s,lH), 5.60 (s,lH)
3 10.55 (s,lH), 5.58 (d,lH)
4 9.80 (s,lH), 5.60 (d,lH)
5 9.68 (s,lH), 5.60 (s,lH)
6 10.45 (s,l H). 5.60 (d,lH)
7 9.93 (s.lH), 5.60 (d,lH)
8 9.90 (s,lH), 5.59 (d,lH)
9 9.83 (s H), 5.60 (s,lH)
10 9.78 (s,lH). 5.60 (s,lH)
11 10.57 (s,lH), 5.58 (d,lH)
12 10.46 (s,l H), 5.60 (s,lH)
13 9.85 (s,lH), 5.60 (d, lH)
14 9.82 (s,lH), 5.58 (d,lH)
15 9.76 (s,lH), 5.62 (s,lH)
16 9.68 (s,lH), 5.60 (s,lH) CI 10.19 (s,lH), 5J2 (d,lH) C2 10.23 (s,lH), 5Jl (d,lH) C3 10.23 (s,lH), 5.66 (s,lH) C4 9.50 (s,lH), 5.62 (d,lH) C5 10.18 (s,lH), 5.67 (s, lH) C6 10.41 (s,lH), 5.62 (S,1H) C7 10.36 (s,lH), 5.66 (s,lH) C8 9.56 (s.lH), 5.54 (d,lH)
CIO 9.56 (s,lH), 5.53 (d,lH)
D10 12.2 (brs.lH), 6.0 (s,lH)
El 10.10 (s,lH), 6.24 (s,lH)
E2 10.08 (s,lH), 6.30 (s,lH)
E3 8.36 (m,3H), 7.94 (d,lH), 7.79 (d,2H), 4.36 (m,lH), 1.32 (d,6H)
E4 10.05, IH), 6.16 (d,lH)
E7 7.75 (d,lH), 7.67 (s,lH)
E8 8.23 (s,lH), 7.77 (d,lH)
E23 (DMSO-- ) 10.8 (m,lH), 9.5 (s,lH)
E24 (DMSO-c ) 10.5 (s,lH)
E25 (DMSO-ay 10.9 (s,lH)
E26 (DMSO-β ) 13.4 (brs, 1 H) E27 9.0 (s,lH), 6.2 (m,lH)
E28 9.25 (s,lH), 6.18 (m,lH)
E29 (DMSO-d6) 10.9 (s, 1 H), 8.55 ( , 1 H)
E30 9.3 (s,lH), 6.25 (t,lH)
E31 (DMSO-_ ) 10.75 (s,lH), 8.55 (m,lH)
E32 (Σ>MSO-d6) 13.5 (brs,lH)
E33 (OMSO-d6) 10.9 (m,lH), 9.6 (s,lH)
E34 9.5 (brs,lH), 6.05 (d,lH)
E35 (DMSO-_fø> 10.9 (s,lH), 6.66 (m,lH)
E36 10.3 (s,lH)
Fl 11.56 (s,lH), 8.41 (d,lH)
Gl 11.97 (s,lH)
HI 5.56 (d,lH) a ^H NMR data are in ppm downfield from tetramethylsilane. Couplings are designated by (s)-singlet, (d)-doublet, (t)-triplet, (q)-quartet, (m)-multiplet, (dd)-doublet of doublets, (dt)-doublet of triplets, (br s)-broad singlet.
BIOLOGICAL EXAMPLES OF THE INVENTION
TEST A For evaluating control of diamondback moth (Plutella xylostella) the test unit consisted of a small open container with a 12-14-day-old radish plant inside. This was pre-infested with 10-15 neonate larvae on a piece of insect diet by use of a core sampler to remove a plug from a sheet of hardened insect diet having many larvae growing on it and transfer the plug containing larvae and diet to the test unit. The larvae moved onto the test plant as the diet plug dried out.
Test compounds were formulated using a solution containing 10% acetone, 90% water and 300 ppm X-77® Spreader Lo-Foam Formula non-ionic surfactant containing alkylarylpolyoxyethylene, free fatty acids, glycols and isopropanol (Loveland Industries, Inc.), unless otherwise indicated. The formulated compounds were applied in 1 mL of liquid through a SUJ2 atomizer nozzle with 1/8 JJ custom body (Spraying Systems Co.) positioned 1.27 cm (0.5 inches) above the top of each test unit. All experimental compounds in these tests were sprayed at 250 ppm and replicated three times. After spraying of the formulated test compound, each test unit was allowed to dry for 1 hour and then a black, screened cap was placed on top. The test units were held for 6 days in a growth chamber at 25 °C and 70% relative humidity. Plant feeding damage was then visually assessed based on foliage consumed.
Of the compounds tested the following provided very good to excellent levels of plant protection (ratings of 0-1, 10% or less feeding damage): 1, 2, 3, 4, 5, 6, 7, 8, 9, 12, 13, 15, 16, 19, 20, 21, 22, 23, 24, 30, 31, 32, 33, 34, 36, 37, 38, Bl, B3, B5, Bl l, B12, B15, CI, C2, C3, C7, C9, C24, Dl, D3, D4, D5, D6, D7, D8, D10, Dl l, D12, D13, D14, D18, D19, D20, D21, E5, E6, E7, E8, E9, ElO, El l, E12, E13, E14, E15, E16, E17, E19, E20, E21, E22, Gl, G2, G4, G5, G6, G7, G8, G9, G10, Gl 1, G12, G13, J6, Kl and K2. TEST B
For evaluating control of fall armyworm (Spodoptera frugiperda) the test unit consisted of a small open container with a 4-5-day-old corn (maize) plant inside. This was pre-infested (using a core sampler) with 10-15 1 -day-old larvae on a piece of insect diet. Test compounds were formulated and sprayed at 250 ppm as described for Test A. The applications were replicated three times. After spraying, the test units were maintained in a growth chamber and then visually rated as described for Test A.
Of the compounds tested, the following provided excellent levels of plant protection (10% or less feeding damage): 30, 31, 32, 33, 34, 35, 36, B10, Bll, B12, B13, B14, Dl, D3, D7,D8, D10,D11, D14, D15, E5, E6, E7, E9, ElO, El l, E12, E13, E22, G2, G4, G5, G6, G7, G9, G10, Gl l, G12, G13, J6 and K2.
TEST C For evaluating control of tobacco budworm (Heliothis virescens) the test unit consisted of a small open container with a 6-7 day old cotton plant inside. This was pre- infested (using a core sampler) with 8 2-day-old larvae on a piece of insect diet. Test compounds were formulated and sprayed at 250 ppm as described for Test A.
The applications were replicated three times. After spraying, the test units were maintained in a growth chamber and then visually rated as described for Test A.
Of the compounds tested, the following provided very good to excellent levels of plant protection (20% or less feeding damage): 31, 32, 33, 34, 35, 36, 37, B12, B13, B14, B15, Dl, D4, D5, D6, D8, D10, Dl 1, D12, D13, D14, D15, D18, D19, D20, D21, E5, E6, E7, E9, ElO, E12, E15, E20, E21, E22, G2, G5, G6, G7, G8, G9, G10, Gi l, G12, and G13.
TEST D For evaluating control of beet armyworm (Spodoptera exigua) the test unit consisted of a small open container with a 4-5-day-old corn plant inside. This was pre-infested (using a core sampler) with 10-15 1 -day-old larvae on a piece of insect diet.
Test compounds were formulated and sprayed at 250 ppm as described for Test A. The applications were replicated three times. After spraying, the test units were maintained in a growth chamber and then visually rated as described for Test A.
Of the compounds tested, the following provided very good to excellent levels of plant protection (20% or less feeding damage): 31, 32, 34, B13, B15, Dl, D3, D4, D7, D8, D10, Dl 1, D14, D19, E5, E6, E7, E9, ElO, E15, E22, Gl, G2, G4, G5, G6, G7, G9, G10, Gl 1, G12, G13, D20, J6 and K2. TEST E For evaluating control of green peach aphid (Myzus persicae) through contact and/or systemic means, the test unit consisted of a small open container with a 12-15-day-old radish plant inside. This was pre-infested (using the cut leaf method) with 30-40 insects on each piece of leaf, and the soil was covered with a layer of sand.
Test compounds were formulated and sprayed at 250 ppm as described for Test A. The applications were replicated three times. After spraying, the test units were maintained in a growth chamber and then visually assessed for insect mortality.
Of the compounds tested, the following resulted in at least 80% mortality: C48, E13, E14, E16, G4, G9,G10,Gl l and G13.
TEST F For evaluating control of cotton melon aphid (Aphis gossypiϊ) through contact and/or systemic means, the test unit consisted of a small open container with a 6-7-day-old cotton plant inside. This was pre-infested (using the cut leaf method) with 30-40 insects on each piece of leaf, and the soil was covered with a layer of sand.
Test compounds were formulated and sprayed at 250 ppm as described for Test A. The applications were replicated three times. After spraying, the test units were maintained in a growth chamber and then visually rated as described for Test E.
Of the compounds tested, the following resulted in at least 80% mortality: E9.

Claims

CLAIMS What is claimed is: 1. A compound of Formula I, an N-oxide thereof or suitable salt thereof
Figure imgf000198_0001
wherein
A and B are independently O or S; each J is independently a phenyl ring, a naphthyl ring system, a 5- or 6-membered heteroaromatic ring or an aromatic 8-, 9- or 10-membered fused heterobicyclic ring system wherein each ring or ring system is optionally substituted with 1 to 4 R5;
K is, together with the two contiguous linking carbon atoms, a 5- or 6-membered heteroaromatic ring optionally substituted with 1 to 3 R4; n is 1 to 3;
R1 is H; or C C6 alkyl, C2-C6 alkenyl, C2-Cg alkynyl or C3-C6 cycloalkyl each optionally substituted with one or more substituents selected from the group consisting of halogen, CN, NO2, hydroxy, Cj-C-j alkoxy, C1-C4 alkylthio, C1-C4 alkylsulfinyl, C]-C4 alkylsulfonyl, C2-C4 alkoxycarbonyl, Cj-C4 alkylamino, C2-Cg dialkylamino and C3-C^ cycloalkylamino; or R1 is C2-C6 alkylcarbonyl, C2-C6 alkoxycarbonyl, C2-Cβ alkylaminocarbonyl, C3-C8 dialkylaminocarbonyl or C(=A)J;
R2 is H, CrC6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, CrC4 alkoxy, C1-C4 alkylamino, C2-Cg dialkylamino, C3-C6 cycloalkylamino, C -Cg alkoxycarbonyl or C2-Cg alkylcarbonyl; R3 is H; G; or C,-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, each optionally substituted with one or more substituents selected from the group consisting of G, halogen, CN, NO2, hydroxy, C1-C4 alkoxy, -C4 haloalkoxy, CrC4 alkylthio, CrC4 alkylsulfinyl, CrC4 alkylsulfonyl, C2-C6 alkoxycarbonyl, C2-C6 alkylcarbonyl, C3-C6 trialkylsilyl, or a phenyl, phenoxy or 5- or 6-membered heteroaromatic ring, each ring optionally substituted with one to three substituents independently selected from R6; or R2 and R3 can be taken together with the nitrogen to which they are attached to form a ring containing 2 to 6 atoms of carbon and optionally one additional atom of nitrogen, sulfur or oxygen, and said ring may be optionally substituted with one to four substituents selected from R12; and G is a 5- or 6-membered nonaromatic carbocyclic or heterocyclic ring, optionally including one or two ring members selected from the group consisting of C(=O), SO or S(O)2 and optionally substituted with one to four substituents selected
Figure imgf000199_0001
each R4 is independently H, Cι-C6 alkyl, C2-Cg alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C -C6 haloalkyl, C2-C6 haloalkenyl, C2-C6 haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, NO , hydroxy, Cι-C alkoxy, Cι-C haloalkoxy, CrC4 alkylthio, C!-C alkylsulfinyl, CrC4 alkylsulfonyl, CrC haloalkylthio, Cj-C4 haloalkylsulfinyl, C1-C4 haloalkylsulfonyl, C1-C4 alkylamino, C2-Cg dialkylamino, C -Cg cycloalkylamino, C1-C4 alkoxyalkyl, C1-C4 hydroxyalkyl, C(O)R10, CO2R!0, C(O)NR10R11, NR10Rli, N(R1l)CO2R10; or each R4 is independently a phenyl, benzyl, phenoxy or 5- or 6-membered heteroaromatic ring, each ring optionally substituted with one to three substituents independently selected from R6; each R5 is independently H, Cj-Cg alkyl, C2-Cg alkenyl, C2-Cg alkynyl, C3-Cg cycloalkyl, C, -C6 haloalkyl, C2-C6 haloalkenyl, C2-C6 haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, CO2H, CONH2, NO2, hydroxy, CrC4 alkoxy, C1-C4 haloalkoxy, C1-C4 alkylthio, C1-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, C1-C4 haloalkylthio, C--C4 haloalkylsulfinyl, C1-C4 haloalkylsulfonyl, C1-C4 alkylamino, C2-Cg dialkylamino, C3-Cg cycloalkylamino, C2-Cg alkylcarbonyl, 2-C6 alkoxycarbonyl, C -Cg alkylaminocarbonyl, C3-Cg dialkylaminocarbonyl,
C -Cg trialkylsilyl; or each R5 is independently a phenyl, benzyl, benzoyl, phenoxy, 5- or 6-membered heteroaromatic ring or an aromatic 8-, 9- or 10-membered fused heterobicyclic ring system, each ring or ring system optionally substituted with one to three substituents independently selected from R6; or
(R5)2 when attached to adjacent carbon atoms can be taken together as -OCF2O-,
-CF2CF2O-, or -OCF2CF2O-; and each R6 is independently C!-C alkyl, C2-C alkenyl, C2-C4 alkynyl, C3-Cg cycloalkyl, CrC4 haloalkyl, C2-C4 haloalkenyl, C2-C4 haloalkynyl, C3-CG halocycloalkyl, halogen, CN, NO2, C ] -C4 alkoxy, C \ -C haloalkoxy, C 1 -C4 alkylthio, CrC4 alkylsulfinyl, C C4 alkylsulfonyl, C1-C4 alkylamino, C2-C8 dialkylamino, C3-C6 cycloalkylamino, C3-C6 (alkyl)cycloalkylamino, C -C4 alkylcarbonyl, C2-Cg alkoxycarbonyl, C2-C6 alkylaminocarbonyl, C3-Cg dialkylaminocarbonyl or C3-C6 trialkylsilyl; each R10 is independently H, C!-C4 alkyl or C1-C4 haloalkyl; each R1 ! is independently H or C1-C4 alkyl; and each R12 is independently C 1 -C alkyl, halogen, CN, NO2 or C - -C alkoxy.
2. The compound of Claim 1 wherein A and B are both O and J is a phenyl ring optionally substituted with 1 to 4 R5.
3. The compound of Claim 2 wherein each R4 is independently CrC4 alkyl, C1-C4 haloalkyl, halogen, CN, NO2 or C C alkoxy, and one R4 group is attached to the K ring at the atom adjacent to either the NR!C(=A)J moiety or the C(=B)NR2R3 moiety; and each R5 is independently H, halogen, C1-C4 alkyl, Cι-C2 alkoxy, C1-C4 haloalkyl, CN, NO2, CrC4 haloalkoxy, CrC4 alkylthio, C,-C4 alkylsulfinyl, CrC4 alkylsulfonyl, C1-C4 haloalkylthio, C1-C4 haloalkylsulfinyl, C1-C4 haloalkylsulfonyl or C2-C alkoxycarbonyl; or each R5 is independently a phenyl or a 5- or 6-membered heteroaromatic ring, each ring optionally substituted with one to three substituents independently selected
Figure imgf000200_0001
(R5)2 when attached to adjacent carbon atoms can be taken together as -OCF2O-, -CF2CF2O- or -OCF2CF2O-.
4. The compound of Claim 3 wherein Rl is H;
R2 is H or CH3;
R3 is C1-C4 alkyl optionally substituted with one or more substituents independently selected from halogen, CN, OCH3 or S(O)pCH3; each R4 is independently CH3, CF3, CN or halogen, and one R4 group is attached to the K ring at the atom adjacent to the NR!C(=A)J moiety; each R5 is independently H, halogen, methyl, CF3, OCF3, OCHF2, S(O)pCF3,
S(O)pCHF2, OCH2CF3, OCF2CHF2, S(O)pCH2CF3 or S(O)pCF2CHF2; or a phenyl, pyrazole, imidazole, triazole, pyridine or pyrimidine ring, each ring optionally substituted with one to three substituents independently selected from
C1-C4 alkyl, C1-C4 haloalkyl, halogen or CN; and p is 0, 1 or 2.
5. The compound of Claim 4 wherein R3 is CrC4 alkyl.
6. The compound of Claim 1 wherein
A and B are both O;
J is a 5- or 6-membered heteroaromatic ring selected from the group consisting of J-l, J-2, J-3, J-4 and J-5, each J optionally substituted with 1 to 3 R5
Figure imgf000201_0001
J-l J-2 J-3 J-4 J-5
Q is O, S or NR5; and
W, X, Y and Z are independently N or CR5, provided that in J-4 and J-5 at least one of W, X, Y or Z is N.
7. The compound of Claim 6 wherein each R4 is independently Cι-C alkyl, Cj-04 haloalkyl, halogen, CN, NO2 or C1-C4 alkoxy, and one R4 group is attached to the K ring at the atom adjacent to either the NR*C(=A)J moiety or the C(=B)NR2R3 moiety; and each R5 is independently H, Cj-C alkyl, C1-C4 haloalkyl, halogen, CN, NO2, C!-C4 haloalkoxy, CJ-C4 alkylthio, C1-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, C1-C4 haloalkylthio, C1-C4 haloalkylsulfinyl, C1-C4 haloalkylsulfonyl or C2-C4 alkoxycarbonyl; or a phenyl or a 5- or 6-membered heteroaromatic ring, each ring optionally substituted with R6.
8. The compound of Claim 7 wherein
J substituted with 1 to 3 R5 is selected from the group consisting of J-6, J-7, J-8, J-9, J-10, J-l L J-12 and J-13
Figure imgf000201_0002
Figure imgf000201_0003
R5 is H, CrC4 alkyl, CrC4 haloalkyl, or
Figure imgf000202_0001
V is N, CH, CF, CC1, CBr or CI; each R6 and R7 is independently H, Cj-Cg alkyl, C3-C6 cycloalkyl, -Cg, haloalkyl, halogen, CN, CrC4 alkoxy, Cj-C4 haloalkoxy or Cι-C4 haloalkylthio; and R is H, C ! -C6 alkyl, C l -C6 haloalkyl, C3-C6 alkenyl, C3-C6 haloalkenyl, C3-C6 alkynyl or C3-Cg haloalkynyl; provided R7 and R9 are not both H.
9. The compound of Claim 8 wherein V is N.
10. The compound of Claim 8 wherein V is CH, CF, CC1 or CBr.
11. The compound of Claim 9 or Claim 10 wherein RMs H;
R is H or CH3;
R3 is Cj-C4 alkyl optionally substituted with one or more substituents independently selected from halogen, CN, OCH3 or S(O)pCH3; each R4 is independently CH3, CF3, CN or halogen, and one R4 group is attached to the K ring at the atom adjacent to the NR!C(=A)J moiety;
R6 is CΓC4 alkyl, CrC4 haloalkyl, halogen or CN; R7 is H, CH3, CF3, OCH2CF3, OCHF2 or halogen; and p is 0, 1 or 2.
12. The compound of Claim 11 wherein R3 is C1-C4 alkyl; one R4 group is independently CH3, CI, Br or I and is attached to the K ring at the atom adjacent to the
NR}C(=A)J moiety; and a second optional R4 is H, F, CI, Br, I or CF3.
13. The compound of Claim 12 wherein J substituted with 1 to 3 R5 is J-6; R6 is CI or Br; and R7 is halogen, OCH2CF3 or CF3.
14. The compound of Claim 13 wherein V is N; R3 is methyl, ethyl, isopropyl, tertiary butyl or N(CH3)2; and R7 is Br, CI, OCH2CF3, or CF3.
15. The compound of Claim 12 wherein J substituted with 1 to 3 R5 is J-7; R6 is CI or Br; and R9 is CF3, CHF2, CH2CF3 or CF2CHF2.
16. The compound of Claim 12 wherein J substituted with 1 to 3 R5 is J-8; R6 is CI or Br; and R7 is halogen, OCH2CF3 or CF3.
17. The compound of Claim 12 wherein J substituted with 1 to 3 R5 is J-9; R6 is CI or Br; and R7 is OCH2CF3 or CF3.
18. The compound of Claim 12 wherein J substituted with 1 to 3 R5 is J-10; R6 is CI or Br; and R is CF3, CHF2, CH2CF3 or CF2CHF2.
19. The compound of Claim 12 wherein J substituted with 1 to 3 R5 is J-l 1 ; R6 is CI or Br; and R7 is halogen, OCH2CF3 or CF3.
20. The compound of Claim 12 wherein J substituted with 1 to 3 R5 is J-l 2; R6 is CI or Br; R7 is H, halogen or CF3, and R is H, CF3, CHF2, CH2CF3, or CF2CHF2.
21. The compound of Claim 12 wherein J substituted with 1 to 3 R5 is J- 13 ; R6 is CI or Br; R7 is H, halogen or CF3, and R9 is H, CF3, CHF2, CH2CF3 or CF2CHF2.
22. The compound of Claim 1 selected from the group consisting of: 4-[[[l-(2-Chlorophenyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]carbonyl]amino]-5- methyl-N- 1 -methylethyl)-3 -pyridincarboxamide, 4-Methyl-N-(l -methylethyl)-3-[[2-methyl-4-(trifluoromethyl)benzoyl]amino]-2- thiophencarboxamide, l-Methyl-N-(l-methylethyl)-5-[[4-(trifluoromethyl)benzoyl]amino]-lH-pyrazole-4- carboxamide;
4-[[[3-Bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]carbonyl]amino]-5-chloro- N-methyl-3 -pyridinecarboxamide;
3-[[[3-Bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]carbonyl]amino]-2,6- dichloro-N-methyl-4-pyridinecarboxamide;
2,6-dichloro-3-[[[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5- yl] carbonyl] amino] -N-(l -methylethyl)- 4-pyridinecarboxamide; 3-[[[3-Bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]carbonyl]amino]-6-chloro-
N,4-dimethyl-2 -pyridinecarboxamide;
3-[[[3-Bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]carbonyl]amino]-4,6- dichloro-N-methyl-2 -pyridinecarboxamide;
5 - [ [[3 -Chloro- 1 -(3 -chloro-2-pyridinyl)- 1 H-pyrazol-5 -yl] carbonyl] amino] -N,6- dimethyl-4-pyrimidinecarboxamide; and
5-[[[3-Bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]carbonyl]amino]-NN,2,6- tetramethyl-4-pyridinecarboxamide.
23. A method for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of a compound of Claim 1.
24. The method of Claim 23 further comprising a biologically effective amount of at least one additional compound or agent for controlling invertebrate pests.
25. A composition for controlling an invertebrate pest comprising a biologically effective amount of a compound of Claim 1 and at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents.
26. The composition of Claim 25 further comprising a biologically effective amount of at least one additional compound or agent for controlling invertebrate pests.
PCT/US2002/006582 2001-03-05 2002-02-28 Heterocyclic diamide invertebrate pest control agents WO2002070483A1 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
IL15699402A IL156994A0 (en) 2001-03-05 2002-02-28 Heterocyclic diamide invertebrate pest control agent
KR1020037011596A KR100874324B1 (en) 2001-03-05 2002-02-28 Heterocyclic Diamide Invertebrate Pest Control
HU0303183A HUP0303183A2 (en) 2001-03-05 2002-02-28 Heterocyclic diamide invertebrate pest control agents, compositions containing them and use thereof
US10/469,263 US20040102324A1 (en) 2002-02-28 2002-02-28 Heterocyclic diamide invertebrate pest control agents
AT02723322T ATE509913T1 (en) 2001-03-05 2002-02-28 HETEROCYCLIC DIAMIDES FOR CONTROLLING INVERTEBRATE PESTS
CA002437840A CA2437840A1 (en) 2001-03-05 2002-02-28 Heterocyclic diamide invertebrate pest control agents
JP2002569803A JP4370098B2 (en) 2001-03-05 2002-02-28 Heterocyclic diamide invertebrate pest control agent
PL02364660A PL364660A1 (en) 2001-03-05 2002-02-28 Heterocyclic diamide invertebrate pest control agents
MXPA03007935A MXPA03007935A (en) 2001-03-05 2002-02-28 Heterocyclic diamide invertebrate pest control agents.
EP02723322A EP1373210B1 (en) 2001-03-05 2002-02-28 Heterocyclic diamide invertebrate pest control agents
BR0207996-8A BR0207996A (en) 2001-03-05 2002-02-28 Compost, invertebrate pest control method and composition for pest control
AU2002254107A AU2002254107B2 (en) 2001-03-05 2002-02-28 Heterocyclic diamide invertebrate pest control agents
US11/158,200 US7560564B2 (en) 2001-03-05 2005-06-21 Heterocyclic diamide invertebrate pest control agents

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27347401P 2001-03-05 2001-03-05
US60/273,474 2001-03-05

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US10469263 A-371-Of-International 2002-02-28
US11/158,200 Continuation US7560564B2 (en) 2001-03-05 2005-06-21 Heterocyclic diamide invertebrate pest control agents

Publications (1)

Publication Number Publication Date
WO2002070483A1 true WO2002070483A1 (en) 2002-09-12

Family

ID=23044092

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/006582 WO2002070483A1 (en) 2001-03-05 2002-02-28 Heterocyclic diamide invertebrate pest control agents

Country Status (18)

Country Link
EP (1) EP1373210B1 (en)
JP (1) JP4370098B2 (en)
KR (1) KR100874324B1 (en)
CN (1) CN100352808C (en)
AR (1) AR035763A1 (en)
AT (1) ATE509913T1 (en)
AU (1) AU2002254107B2 (en)
BR (1) BR0207996A (en)
CA (1) CA2437840A1 (en)
ES (1) ES2364550T3 (en)
HU (1) HUP0303183A2 (en)
IL (1) IL156994A0 (en)
MX (1) MXPA03007935A (en)
PL (1) PL364660A1 (en)
RU (1) RU2003129504A (en)
TW (1) TWI234561B (en)
WO (1) WO2002070483A1 (en)
ZA (1) ZA200305582B (en)

Cited By (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003015519A1 (en) * 2001-08-13 2003-02-27 E.I. Du Pont De Nemours And Company Arthropodicidal anthranilamides
WO2004046129A2 (en) * 2002-11-15 2004-06-03 E.I. Du Pont De Nemours And Company Novel anthranilamide insecticides
WO2005115986A1 (en) * 2004-05-25 2005-12-08 Astrazeneca Ab Therapeutic compounds: pyridine as scaffold
WO2006040113A3 (en) * 2004-10-11 2006-09-14 Syngenta Participations Ag Heterocyclic diamide insecticidal agents
US7205307B2 (en) * 2002-02-14 2007-04-17 Icagen, Inc. Pyrimidines as novel openers of potassium ion channels
WO2008064891A1 (en) * 2006-12-01 2008-06-05 Syngenta Participations Ag N-cyanoalkylanthranilamides as insecticides
US7385059B2 (en) 2003-07-22 2008-06-10 Astex Therapeutics Limited 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
WO2008130021A3 (en) * 2007-04-12 2009-01-22 Sumitomo Chemical Co Heterocyclic hydrazide compound and pesticidal use of the same
US7696232B2 (en) 2001-09-21 2010-04-13 E. I. Du Pont De Nemours And Company Anthranilamide arthropodicide treatment
US7696233B2 (en) 2001-08-13 2010-04-13 E. I. Du Pont De Nemours And Company Method for controlling particular insect pests by applying anthranilamide compounds
WO2010034738A3 (en) * 2008-09-24 2010-10-07 Basf Se Pyrazole compounds for controlling invertebrate pests
US8013163B2 (en) 2005-01-21 2011-09-06 Astex Therapeutics Limited 4-(2,6-dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide acid addition salts as kinase inhibitors
JP4865695B2 (en) * 2004-03-03 2012-02-01 シンジェンタ パーティシペーションズ アクチェンゲゼルシャフト New insecticide
WO2012034959A2 (en) 2010-09-13 2012-03-22 Basf Se Pyridine compounds for controlling invertebrate pests iii
WO2012076704A2 (en) 2010-12-10 2012-06-14 Basf Se Pyrazole compounds for controlling invertebrate pests
WO2013024005A1 (en) 2011-08-12 2013-02-21 Basf Se Anthranilamide compounds and their use as pesticides
WO2013024006A1 (en) 2011-08-12 2013-02-21 Basf Se Anthranilamide compounds and their use as pesticides
US8404718B2 (en) 2005-01-21 2013-03-26 Astex Therapeutics Limited Combinations of pyrazole kinase inhibitors
WO2013076092A1 (en) 2011-11-21 2013-05-30 Basf Se Process for preparing n-substituted 1h-pyrazole-5-carboxylate compounds and derivatives thereof
US8642597B2 (en) 2007-08-27 2014-02-04 Basf Se Pyrazole compounds for controlling invertebrate pests
WO2014060381A1 (en) 2012-10-18 2014-04-24 Bayer Cropscience Ag Heterocyclic compounds as pesticides
US8710056B2 (en) 2009-07-06 2014-04-29 Basf Se Pyridazine compounds for controlling invertebrate pests
US8729083B2 (en) 2008-09-24 2014-05-20 Basf Se Pyrazole compounds for controlling invertebrate pests
US8921567B2 (en) 2011-08-12 2014-12-30 Basf Se Process for preparing N-substituted 1H-pyrazole-5-carbonylchloride compounds
US9029639B2 (en) 2009-07-06 2015-05-12 Basf Se Pyridazine compounds for controlling invertebrate pests
US9044016B2 (en) 2011-08-12 2015-06-02 Basf Se N-thio-anthranilamide compounds and their use as pesticides
US9056853B2 (en) 2005-07-07 2015-06-16 Basf Se N-Thio-anthranilamid compounds and their use as pesticides
US9125414B2 (en) 2009-07-24 2015-09-08 Basf Se Pyridine derivatives compounds for controlling invertebrate pests
US9126944B2 (en) 2013-02-28 2015-09-08 Bristol-Myers Squibb Company Phenylpyrazole derivatives as potent ROCK1 and ROCK2 inhibitors
EP2865667A4 (en) * 2012-06-26 2015-12-16 Sumitomo Chemical Co Amide compound and use thereof for pest control
US9533968B2 (en) 2012-05-24 2017-01-03 Basf Se N-thio-anthranilamide compounds and their use as pesticides
WO2017137319A1 (en) * 2016-02-11 2017-08-17 Bayer Cropscience Aktiengesellschaft Substituted -oxyimidazolyl-carboxamides as pest control agents
WO2017137337A1 (en) * 2016-02-11 2017-08-17 Bayer Cropscience Aktiengesellschaft Substituted imidazolyl-carboxamides as pest control agents
WO2017137339A1 (en) * 2016-02-11 2017-08-17 Bayer Cropscience Aktiengesellschaft Substituted 2-oxyimidazolyl-carboxamides as pest control agents
WO2017137338A1 (en) * 2016-02-11 2017-08-17 Bayer Cropscience Aktiengesellschaft Substituierted 2-(het)aryl-imidazolyl-carboxyamides as pest control agents
US9828345B2 (en) 2013-02-28 2017-11-28 Bristol-Myers Squibb Company Phenylpyrazole derivatives as potent ROCK1 and ROCK2 inhibitors
WO2018199175A1 (en) 2017-04-27 2018-11-01 石原産業株式会社 N-(4-pyridyl) nicotinamide compound or salt thereof
WO2019128872A1 (en) 2017-12-29 2019-07-04 江苏中旗科技股份有限公司 Pyrazole amide compound having pesticidal activity and use thereof
WO2019128871A1 (en) 2017-12-29 2019-07-04 江苏中旗科技股份有限公司 N-alkyl-n-cyanoalkylbenzamide compound and use thereof
US10647661B2 (en) 2017-07-11 2020-05-12 Vertex Pharmaceuticals Incorporated Carboxamides as modulators of sodium channels
US11390602B2 (en) 2017-12-29 2022-07-19 Jiangsu Flag Chemical Industry Co., Ltd. N-alkyl-N-cyanoalkylbenzamide compound and use thereof
WO2023012081A1 (en) 2021-08-05 2023-02-09 Syngenta Crop Protection Ag Method for controlling diamide resistant pests & compounds therefor
EP4197333A1 (en) 2021-12-15 2023-06-21 Syngenta Crop Protection AG Method for controlling diamide resistant pests & compounds therefor
US11827627B2 (en) 2021-06-04 2023-11-28 Vertex Pharmaceuticals Incorporated N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels
US11834441B2 (en) 2019-12-06 2023-12-05 Vertex Pharmaceuticals Incorporated Substituted tetrahydrofurans as modulators of sodium channels

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2013069771A1 (en) * 2011-11-11 2015-04-02 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 Anthranilic acid derivatives and pest control agents
CN103288771B (en) * 2012-02-29 2014-12-03 中国中化股份有限公司 Isothiazole compound and use thereof as fungicide
AR096393A1 (en) * 2013-05-23 2015-12-30 Bayer Cropscience Ag PESTICIDE HETEROCYCLIC COMPOUNDS
KR102401408B1 (en) * 2014-07-28 2022-05-23 스미또모 가가꾸 가부시끼가이샤 Amide compound and use of same for noxious arthropod control
JP2019131470A (en) * 2016-05-20 2019-08-08 石原産業株式会社 Pest control agent containing n-(4-pyridyl) benzamide compound or salt thereof as active ingredient
JP2019142776A (en) * 2016-06-24 2019-08-29 石原産業株式会社 Pest control agent containing n-(4-pyridyl) benzamide compound or salt thereof as active ingredient
US20200339578A1 (en) * 2017-12-20 2020-10-29 Pi Industries Ltd. Pyrazolopyridine-diamides, their use as insecticide and processes for preparing the same

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4565875A (en) * 1984-06-27 1986-01-21 Fmc Corporation Imidazole plant growth regulators
EP0289879A1 (en) * 1987-04-24 1988-11-09 Mitsubishi Kasei Corporation Pyrazole derivative, insecticidal or miticidal composition containing the same as the effective ingredient
JPH05230016A (en) * 1991-10-14 1993-09-07 Takeda Chem Ind Ltd Amide derivative, its production and fungicide
US5538939A (en) * 1993-08-24 1996-07-23 Basf Aktiengesellschaft Acylamino-substituted isoxazole or isothiazole derivatives, their preparation and their use
WO2001070671A2 (en) * 2000-03-22 2001-09-27 E.I. Du Pont De Nemours And Company Insecticidal anthranilamides

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US456875A (en) * 1891-07-28 Micrometer-gage
NL6507580A (en) * 1964-06-22 1965-12-23
DE3046871A1 (en) * 1980-12-12 1982-07-22 Dr. Karl Thomae Gmbh, 7950 Biberach 2-Amino:alkoxy-phenyl-quinazolin-4-one derivs. - and -pyrido-pyrimidin-4-one derivs. prepd. by reaction of e.g. halo-alkoxy or epoxy-alkoxy cpds. with amine(s)
DE68908786T2 (en) * 1988-06-16 1994-03-17 Smith Kline French Lab Condensed pyrimidine derivatives, processes and intermediates for their preparation and pharmaceutical preparations containing them.
GB9121028D0 (en) * 1991-10-03 1991-11-13 Pfizer Ltd Therapeutic agents
JPH0687835A (en) * 1992-07-17 1994-03-29 Rohm & Haas Co Herbicidal 2-aryl-5,6-condensed-ring pyrimidine
GB9218322D0 (en) * 1992-08-28 1992-10-14 Pfizer Ltd Therapeutic agents
DE19603576A1 (en) * 1996-02-01 1997-08-07 Bayer Ag Acylated 4-amino and 4-hydrazinopyrimidines
DE19623744A1 (en) * 1996-06-14 1997-12-18 Bayer Ag Aminophthalic acid derivatives
JP3735159B2 (en) * 1996-06-17 2006-01-18 ローヌ−プーラン・アグロシミ New pesticide
WO1999003858A1 (en) * 1997-07-15 1999-01-28 Japan Energy Corporation Novel purine derivatives and medicinal use thereof
JP2000169461A (en) * 1998-09-28 2000-06-20 Nippon Nohyaku Co Ltd Insecticide and microbicide composition and its production

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4565875A (en) * 1984-06-27 1986-01-21 Fmc Corporation Imidazole plant growth regulators
EP0289879A1 (en) * 1987-04-24 1988-11-09 Mitsubishi Kasei Corporation Pyrazole derivative, insecticidal or miticidal composition containing the same as the effective ingredient
JPH05230016A (en) * 1991-10-14 1993-09-07 Takeda Chem Ind Ltd Amide derivative, its production and fungicide
US5538939A (en) * 1993-08-24 1996-07-23 Basf Aktiengesellschaft Acylamino-substituted isoxazole or isothiazole derivatives, their preparation and their use
WO2001070671A2 (en) * 2000-03-22 2001-09-27 E.I. Du Pont De Nemours And Company Insecticidal anthranilamides

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
COPPOLA, SYNTHESIS, 1980, pages 505
FABIS ET AL., TETRAHEDRON, 1998, pages 10789
JAKOBSEN ET AL., BIORGANIC AND MEDICINAL CHEMISTRY, vol. 8, 2000, pages 2803 - 2812
PATENT ABSTRACTS OF JAPAN vol. 017, no. 689 (C - 1143) 16 December 1993 (1993-12-16) *

Cited By (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7696233B2 (en) 2001-08-13 2010-04-13 E. I. Du Pont De Nemours And Company Method for controlling particular insect pests by applying anthranilamide compounds
US7232836B2 (en) 2001-08-13 2007-06-19 E. I. Du Pont De Nemours And Company Arthropodicidal anthranilamides
US9049862B2 (en) 2001-08-13 2015-06-09 E I Du Pont De Nemours And Company Arthropodicidal anthranilamides
US9445593B1 (en) 2001-08-13 2016-09-20 E I Du Pont De Nemours And Company Arthropodicidal anthranilamides
US8158802B2 (en) 2001-08-13 2012-04-17 E.I. Du Pont De Nemours And Company Arthropodicidal anthranilamides
US7902231B2 (en) 2001-08-13 2011-03-08 E.I. Du Pont De Nemours And Company Anthropodicidal anthranilamides
US9049861B2 (en) 2001-08-13 2015-06-09 E I Du Pont De Nemours And Company Arthropodicidal anthranilamides
WO2003015519A1 (en) * 2001-08-13 2003-02-27 E.I. Du Pont De Nemours And Company Arthropodicidal anthranilamides
US9113630B2 (en) 2001-08-13 2015-08-25 E I Du Pont De Nemours And Company Method of controlling particular insect pests by applying anthranilamide compounds
US9084422B2 (en) 2001-08-13 2015-07-21 E I Du Pont De Nemours And Company Anthranilamides compositions
US8148521B2 (en) 2001-08-13 2012-04-03 E.I. Du Pont De Nemours And Company Arthropodicidal anthranilamides
US9078437B2 (en) 2001-08-13 2015-07-14 E I Du Pont De Nemours And Company Arthropodicidal anthranilamides
US8921400B2 (en) 2001-08-13 2014-12-30 E I Du Pont De Nemours And Company Arthropodicidal anthranilamides
US9029365B2 (en) 2001-08-13 2015-05-12 E I Du Pont De Nemours And Company Arthropodicidal anthranilamides
US8697734B2 (en) 2001-08-13 2014-04-15 E I Du Pont De Nemours And Company Method for controlling particular insect pests by applying anthranilamide compounds
US9173400B2 (en) 2001-09-21 2015-11-03 E I Du Pont De Nemours And Company Anthranilamide arthropodicide treatment
US7696232B2 (en) 2001-09-21 2010-04-13 E. I. Du Pont De Nemours And Company Anthranilamide arthropodicide treatment
US8637552B2 (en) 2001-09-21 2014-01-28 E I Du Pont De Nemours And Company Anthranilamide arthropodicide treatment
US7205307B2 (en) * 2002-02-14 2007-04-17 Icagen, Inc. Pyrimidines as novel openers of potassium ion channels
WO2004046129A3 (en) * 2002-11-15 2004-07-15 Du Pont Novel anthranilamide insecticides
JP4648705B2 (en) * 2002-11-15 2011-03-09 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー New anthranilamide insecticide
WO2004046129A2 (en) * 2002-11-15 2004-06-03 E.I. Du Pont De Nemours And Company Novel anthranilamide insecticides
US7666882B2 (en) 2002-11-15 2010-02-23 E.I. Du Pont De Nemours And Company Anthranilamide insecticides
JP2006514632A (en) * 2002-11-15 2006-05-11 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー New anthranilamide insecticide
US7825140B2 (en) 2003-07-22 2010-11-02 Astex Therapeutics, Ltd. 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
US8080666B2 (en) 2003-07-22 2011-12-20 Astex Therapeutics, Ltd. 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
US9051278B2 (en) 2003-07-22 2015-06-09 Astex Therapeutics, Ltd. 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
US7385059B2 (en) 2003-07-22 2008-06-10 Astex Therapeutics Limited 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
US8779147B2 (en) 2003-07-22 2014-07-15 Astex Therapeutics, Ltd. 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
US7745638B2 (en) 2003-07-22 2010-06-29 Astex Therapeutics Limited 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
JP4865695B2 (en) * 2004-03-03 2012-02-01 シンジェンタ パーティシペーションズ アクチェンゲゼルシャフト New insecticide
WO2005115986A1 (en) * 2004-05-25 2005-12-08 Astrazeneca Ab Therapeutic compounds: pyridine as scaffold
JP2008500336A (en) * 2004-05-25 2008-01-10 アストラゼネカ・アクチエボラーグ Therapeutic compounds: Pyridine as a skeleton
CN101061110B (en) * 2004-10-11 2010-09-29 辛根塔参与股份公司 Heterlcyclic diamide insecticides
US8106075B2 (en) 2004-10-11 2012-01-31 Syngenta Crop Protection, Inc. Insecticides
WO2006040113A3 (en) * 2004-10-11 2006-09-14 Syngenta Participations Ag Heterocyclic diamide insecticidal agents
US8293767B2 (en) 2005-01-21 2012-10-23 Astex Therapeutics Limited 4-(2,6-dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide acid addition salts as kinase inhibitors
US8013163B2 (en) 2005-01-21 2011-09-06 Astex Therapeutics Limited 4-(2,6-dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide acid addition salts as kinase inhibitors
US8404718B2 (en) 2005-01-21 2013-03-26 Astex Therapeutics Limited Combinations of pyrazole kinase inhibitors
US9365543B2 (en) 2005-07-07 2016-06-14 Basf Se N-Thio-anthranilamid compounds and their use as pesticides
US9056853B2 (en) 2005-07-07 2015-06-16 Basf Se N-Thio-anthranilamid compounds and their use as pesticides
WO2008064891A1 (en) * 2006-12-01 2008-06-05 Syngenta Participations Ag N-cyanoalkylanthranilamides as insecticides
US8501950B2 (en) 2006-12-01 2013-08-06 Syngenta Crop Protection Llc N-cyanoalkylanthranilamides as insecticides
US8247431B2 (en) 2007-04-12 2012-08-21 Sumitomo Chemical Company, Limited Heterocyclic hydrazide compound and pesticidal use of the same
WO2008130021A3 (en) * 2007-04-12 2009-01-22 Sumitomo Chemical Co Heterocyclic hydrazide compound and pesticidal use of the same
US9204647B2 (en) 2007-08-27 2015-12-08 Basf Se Pyrazole compounds for controlling invertebrate pests
US8642597B2 (en) 2007-08-27 2014-02-04 Basf Se Pyrazole compounds for controlling invertebrate pests
US9375008B2 (en) 2008-09-24 2016-06-28 Basf Se Pyrazole compounds for controlling invertebrate pests
US8853125B2 (en) 2008-09-24 2014-10-07 Basf Se Pyrazole compounds for controlling invertebrate pests
US8729083B2 (en) 2008-09-24 2014-05-20 Basf Se Pyrazole compounds for controlling invertebrate pests
WO2010034738A3 (en) * 2008-09-24 2010-10-07 Basf Se Pyrazole compounds for controlling invertebrate pests
US9029639B2 (en) 2009-07-06 2015-05-12 Basf Se Pyridazine compounds for controlling invertebrate pests
US8710056B2 (en) 2009-07-06 2014-04-29 Basf Se Pyridazine compounds for controlling invertebrate pests
US9125414B2 (en) 2009-07-24 2015-09-08 Basf Se Pyridine derivatives compounds for controlling invertebrate pests
WO2012034959A2 (en) 2010-09-13 2012-03-22 Basf Se Pyridine compounds for controlling invertebrate pests iii
WO2012076704A2 (en) 2010-12-10 2012-06-14 Basf Se Pyrazole compounds for controlling invertebrate pests
WO2013024006A1 (en) 2011-08-12 2013-02-21 Basf Se Anthranilamide compounds and their use as pesticides
WO2013024005A1 (en) 2011-08-12 2013-02-21 Basf Se Anthranilamide compounds and their use as pesticides
US8921567B2 (en) 2011-08-12 2014-12-30 Basf Se Process for preparing N-substituted 1H-pyrazole-5-carbonylchloride compounds
US9044016B2 (en) 2011-08-12 2015-06-02 Basf Se N-thio-anthranilamide compounds and their use as pesticides
US9556141B2 (en) 2011-11-21 2017-01-31 Basf Se Process for preparing N-substituted 1H-pyrazole-5-carboxylate compounds and derivatives thereof
WO2013076092A1 (en) 2011-11-21 2013-05-30 Basf Se Process for preparing n-substituted 1h-pyrazole-5-carboxylate compounds and derivatives thereof
US9533968B2 (en) 2012-05-24 2017-01-03 Basf Se N-thio-anthranilamide compounds and their use as pesticides
EP2865667A4 (en) * 2012-06-26 2015-12-16 Sumitomo Chemical Co Amide compound and use thereof for pest control
WO2014060381A1 (en) 2012-10-18 2014-04-24 Bayer Cropscience Ag Heterocyclic compounds as pesticides
US9458110B2 (en) 2013-02-28 2016-10-04 Bristol-Myers Squibb Company Phenylpyrazole derivatives as potent ROCK1 and ROCK2 inhibitors
US9828345B2 (en) 2013-02-28 2017-11-28 Bristol-Myers Squibb Company Phenylpyrazole derivatives as potent ROCK1 and ROCK2 inhibitors
US9126944B2 (en) 2013-02-28 2015-09-08 Bristol-Myers Squibb Company Phenylpyrazole derivatives as potent ROCK1 and ROCK2 inhibitors
CN108699045A (en) * 2016-02-11 2018-10-23 拜耳作物科学股份公司 Substitution 2- oxo-imidazole yl-carboxamides as pest control agent
US10544124B2 (en) 2016-02-11 2020-01-28 Bayer Cropscience Aktiengesellschaft Substituted 2-(het)arylimidazolylcarboxyamides as pesticides
WO2017137338A1 (en) * 2016-02-11 2017-08-17 Bayer Cropscience Aktiengesellschaft Substituierted 2-(het)aryl-imidazolyl-carboxyamides as pest control agents
WO2017137337A1 (en) * 2016-02-11 2017-08-17 Bayer Cropscience Aktiengesellschaft Substituted imidazolyl-carboxamides as pest control agents
WO2017137319A1 (en) * 2016-02-11 2017-08-17 Bayer Cropscience Aktiengesellschaft Substituted -oxyimidazolyl-carboxamides as pest control agents
CN108713017A (en) * 2016-02-11 2018-10-26 拜耳作物科学股份公司 Substituted oxygroup imidazoles yl-carboxamides as pest control agent
TWI721097B (en) 2016-02-11 2021-03-11 德商拜耳作物科學股份有限公司 Substituted 2-oxyimidazolylcarboxamides as pesticides
CN109071507A (en) * 2016-02-11 2018-12-21 拜耳作物科学股份公司 Substituted imidazoles yl-carboxamides as pest control agent
JP2019507747A (en) * 2016-02-11 2019-03-22 バイエル・クロップサイエンス・アクチェンゲゼルシャフト Substituted oxyimidazolyl-carboxamides as pest control agents
CN108699045B (en) * 2016-02-11 2021-02-12 拜耳作物科学股份公司 Substituted 2-oxoimidazolyl carboxamides as pest control agents
US10807968B2 (en) 2016-02-11 2020-10-20 Bayer Cropscience Aktiengesellschaft Substituted 2-(het)arylimidazolylcarboxyamides as pesticides
US10349657B2 (en) 2016-02-11 2019-07-16 Bayer Cropscience Aktiengesellschaft Substituted imidazolylcarboxamides as pesticides
US10501441B2 (en) 2016-02-11 2019-12-10 Bayer Cropscience Aktiengesellschaft Substituted imidazolylcarboxamides as pesticides
WO2017137339A1 (en) * 2016-02-11 2017-08-17 Bayer Cropscience Aktiengesellschaft Substituted 2-oxyimidazolyl-carboxamides as pest control agents
US10647699B2 (en) 2016-02-11 2020-05-12 Bayer Cropscience Aktiengesellschaft Substituted 2-oxyimidazolylcarboxamides as pesticides
WO2018199175A1 (en) 2017-04-27 2018-11-01 石原産業株式会社 N-(4-pyridyl) nicotinamide compound or salt thereof
US11912684B2 (en) 2017-04-27 2024-02-27 Ishihara Sangyo Kaisha, Ltd. N-(4-pyridyl)nicotinamide compound or salt thereof
US10647661B2 (en) 2017-07-11 2020-05-12 Vertex Pharmaceuticals Incorporated Carboxamides as modulators of sodium channels
US11603351B2 (en) 2017-07-11 2023-03-14 Vertex Pharmaceuticals Incorporated Carboxamides as modulators of sodium channels
WO2019128871A1 (en) 2017-12-29 2019-07-04 江苏中旗科技股份有限公司 N-alkyl-n-cyanoalkylbenzamide compound and use thereof
WO2019128872A1 (en) 2017-12-29 2019-07-04 江苏中旗科技股份有限公司 Pyrazole amide compound having pesticidal activity and use thereof
US11390602B2 (en) 2017-12-29 2022-07-19 Jiangsu Flag Chemical Industry Co., Ltd. N-alkyl-N-cyanoalkylbenzamide compound and use thereof
US11834441B2 (en) 2019-12-06 2023-12-05 Vertex Pharmaceuticals Incorporated Substituted tetrahydrofurans as modulators of sodium channels
US11919887B2 (en) 2019-12-06 2024-03-05 Vertex Pharmaceuticals Incorporated Substituted tetrahydrofurans as modulators of sodium channels
US11827627B2 (en) 2021-06-04 2023-11-28 Vertex Pharmaceuticals Incorporated N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels
WO2023012081A1 (en) 2021-08-05 2023-02-09 Syngenta Crop Protection Ag Method for controlling diamide resistant pests & compounds therefor
EP4197333A1 (en) 2021-12-15 2023-06-21 Syngenta Crop Protection AG Method for controlling diamide resistant pests & compounds therefor

Also Published As

Publication number Publication date
AR035763A1 (en) 2004-07-07
AU2002254107B2 (en) 2006-12-21
JP2004521924A (en) 2004-07-22
RU2003129504A (en) 2005-02-27
BR0207996A (en) 2004-03-02
ATE509913T1 (en) 2011-06-15
KR20030081492A (en) 2003-10-17
PL364660A1 (en) 2004-12-13
ZA200305582B (en) 2004-07-19
TWI234561B (en) 2005-06-21
ES2364550T3 (en) 2011-09-06
EP1373210A1 (en) 2004-01-02
KR100874324B1 (en) 2008-12-18
CA2437840A1 (en) 2002-09-12
HUP0303183A2 (en) 2003-12-29
CN100352808C (en) 2007-12-05
JP4370098B2 (en) 2009-11-25
EP1373210B1 (en) 2011-05-18
IL156994A0 (en) 2004-02-08
MXPA03007935A (en) 2003-12-04
CN1494530A (en) 2004-05-05

Similar Documents

Publication Publication Date Title
EP1373210B1 (en) Heterocyclic diamide invertebrate pest control agents
US7560564B2 (en) Heterocyclic diamide invertebrate pest control agents
US7541377B2 (en) Substituted anthranilamides for controlling invertebrate pests
AU2009202871B2 (en) Quinazoline(DI)ones for invertebrate pest control
US7375232B2 (en) Ortho-heterocyclic substituted aryl amides for controlling invertebrate pests
US7087598B2 (en) Diamide invertebrate pest control agents containing a non-aromatic heterocyclic ring
AU2002254107A1 (en) Heterocyclic diamide invertebrate pest control agents
US20040192731A1 (en) Ortho-substituted aryl amides for controlling invertebrate pests
AU2002326748A1 (en) Substituted anthranilamides for controlling invertebrate pests
AU2003212811A1 (en) Quinazoline(di) ones for invertebrate pest control
AU2002331706A1 (en) Ortho-substituted aryl amides for controlling invertebrate pests
AU2005277228A1 (en) Novel anthranilamides useful for controlling invertebrate pests
US20040214828A1 (en) Iminobenzoxazines, iminobenzthiazines and iminoquinazolines for controlling invertebrate pests
US7157475B2 (en) Diamide invertebrate pest control agents
AU2002343512A1 (en) Iminobenzoxazines, iminobenzthiazines and iminoquinazolines for controlling invertebrate pests
US20040235959A1 (en) Insecticidal diamides
AU2003202966A1 (en) Diamide invertebrate pest control agents
AU2002331708A1 (en) Ortho-heterocyclic substituted aryl amides for controlling invertebrate pests
AU2002334581A1 (en) Insecticidal diamides

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 156994

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 2003/05582

Country of ref document: ZA

Ref document number: 200305582

Country of ref document: ZA

WWE Wipo information: entry into national phase

Ref document number: 720/MUMNP/2003

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2002254107

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 527220

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 2437840

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 10469263

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2002723322

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: PA/a/2003/007935

Country of ref document: MX

Ref document number: 1-2003-500829

Country of ref document: PH

WWE Wipo information: entry into national phase

Ref document number: 1020037011596

Country of ref document: KR

Ref document number: 2002569803

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 028060164

Country of ref document: CN

Ref document number: 03077934

Country of ref document: CO

WWE Wipo information: entry into national phase

Ref document number: 1200300876

Country of ref document: VN

WWP Wipo information: published in national office

Ref document number: 1020037011596

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 2002723322

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642